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reagents a Lewis acidic byproduct (lithium halide) was generated which would catalyze a racemic background
reaction. The problem was addressed finding an additive, tetraethylethylenediamine (TEEDA), which could
selectively inhibit the background reaction discriminating between the two Lewis acidic species present in the
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first chapter a novel catalytic asymmetric method for the synthesis of (Z)-disubstituted allylic alcohols is
presented. Our one-pot procedure entails hydroboration of chloro alkynes and addition of a hydride source
(t-BuLi), which results in formation of a (Z)-alkenylborane. Boron to zinc transmetalation of the alkenyl
group with ZnEt2, addition of a chiral ligand, the inhibitor (TEEDA) and the substrate aldehyde results in
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chapter we describe a method for the synthesis of diarylmethanols generating the desired arylzinc reagent in
situ and adding it to both aromatic and heteroaromatic aldehydes. The one pot procedure entails lithium/
halogen exchange, transmetallation with a zinc species, with generation of undesired LiCl that can be
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ABSTRACT 
 
Catalytic Asymmetric Additions of in situ Generated Functionalized Zinc 
Reagents to Aldehydes 
 
Luca Salvi 
 
Professor Patrick J. Walsh 
Supervisor of Dissertation 
 
Enantioenriched secondary alcohols are ubiquitous moieties in natural products.  The 
current methods to achieve their synthesis often times rely on complicated synthesis and 
isolation of fairly reactive and unstable organometallic reagents. 
To address these issues our group developed one-pot catalytic asymmetric methods 
toward the synthesis of E-allylic alcohols and diarylmethanols employing in situ 
synthesized functionalized Lewis acidic zinc reagents in the presence of chiral amino 
alcohols ligands.  However, analogous methods for the synthesis of equally useful Z-
allylic alcohols and diheteroaryl methanols were lacking. 
The reason why this task was more challenging is because en route toward the 
synthesis of the appropriate functionalized zinc reagents a Lewis acidic byproduct 
(lithium halide) was generated which would catalyze a racemic background reaction. 
The problem was addressed finding an additive, tetraethylethylenediamine (TEEDA), 
which could selectively inhibit the background reaction discriminating between the two 
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Lewis acidic species present in the flask.  The asymmetric addition could now take place 
giving the product in high yield and ee in one-pot. 
In the first chapter a novel catalytic asymmetric method for the synthesis of (Z)-
disubstituted allylic alcohols is presented.  Our one-pot procedure entails hydroboration 
of chloro alkynes and addition of a hydride source (t-BuLi), which results in formation of 
a (Z)-alkenylborane.  Boron to zinc transmetalation of the alkenyl group with ZnEt2, 
addition of a chiral ligand, the inhibitor (TEEDA) and the substrate aldehyde results in 
formation of (Z)-allylic alcohols with excellent ee’s.  In the effort of streamlining the 
synthesis of compounds with multiple stereocenters, tandem protocols were devised to 
synthesize cyclopropyl- and epoxy-alcohols. 
Finally a brief study for the synthesis of racemic Z-trisubstituted allylic alcohols is 
presented. 
In the second chapter we describe a method for the synthesis of diarylmethanols 
generating the desired arylzinc reagent in situ and adding it to both aromatic and 
heteroaromatic aldehydes. 
The one pot procedure entails lithium/halogen exchange, transmetallation with a zinc 
species, with generation of undesired LiCl that can be sequestered in situ by an additive 
(TEEDA).  The functionalized zinc reagent, in the presence of the chiral catalyst (–)-
MIB, adds to a variety of aromatic and heteroaromatic aldehydes in excellent ee, thus 
enabling the formation of highly desirable diheteroarylmethanols as well as many other 
compounds. 
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Introduction 
 
Asymmetric synthesis is a broad field, which overlaps with many other disciplines.  
The synthesis of molecules with high levels of stereocontrol is an essential requirement in 
the chemical industry and in academic laboratories.  Applications are found in many 
processes involving pharmaceutical industry, agriculture, fragrance and material 
chemistry. 
 
In the pharmaceutical industry, designing a new drug relies on the understanding of 
very subtle differences that are at the core of complicated recognition mechanisms. It is 
known that drug-receptor interactions involve chiral entities and that one enantiomer of a 
medication can interact with a receptor in the desired fashion, while the other enantiomer 
can interact with a different receptor and have a negative impact on the organism.  In the 
case of thalidomide, one enantiomer had the desired effect while the other caused severe 
birth defects.  Thus, it is crucial to develop practical, scalable methods for the synthesis 
of chiral entities as single enantiomers. 
 
Asymmetric syntheses of chiral molecules have proven to be challenging.  
Considering only the instance in which a prochiral substrate is transformed into a chiral 
product, an asymmetric reaction uses a chiral auxiliary (the catalyst if it is used in much 
lower amount than the substrate), to form only one of the two possible enantiomers.  
Upon coordination of the catalyst to the prochiral substrate, the two diastereomeric 
reaction pathways leading to the product are now ideally much different in energy.  This 
difference has to be >2 kcal to develop an efficient and practical process. 
 
Ideally, asymmetric syntheses should be catalytic to reduce the amounts of very 
valuable reagents that are not going to be incorporated in the final product.  Even today, 
however, industrial processes involve stoichiometric amounts of chiral auxiliaries, or 
kinetic resolutions of racemic mixtures.  Fortunately, many catalytic processes have been 
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developed, but few have been applied to large scale synthetic application.  One of the 
goals of our research is to develop scalable methods, which is why our new methods are 
conducted on at least 5 mmol scale (and in some cases up to 30 mmol are employed). 
 
Designing an efficient catalyst for a specific reaction is still a daunting exercise.  In 
fact, most new catalysts are developed by a trial and error process, which involves a 
number of optimization studies.  The quest for a perfect match is thus approached in two 
ways: 1) seeking reactions that could potentially work with available catalysts, or 2) 
targeting a desired reaction and screening a library of different catalysts until one that 
gives promising enantioinduction is identified.  The next step then calls for the synthesis 
of various derivatives of that catalyst.  Ligand or catalyst modularity then become 
essential to perform this screening without spending most of the time synthesizing 
ligands rather than applying them to the targeted reactions. 
 
The programs developed in our laboratory rely on organometallic catalysts.  These 
catalysts have played an important role in asymmetric catalysis.  Our group aim is not 
only to develop asymmetric reactions, but also to combine multiple steps in one flask, 
thus enabling the efficient synthesis of complex building blocks with minimal 
purifications.  The key to succeed in such a task relies on the control of potential 
background reactions, caused both by the reagents and by-products generated en route to 
the desired product.  Thus when the background reaction is either absent or slow, it is 
possible to synthesize relatively complicated molecules in high yield with regio- and 
stereocontrol from readily available materials. 
 
The projects developed in the Walsh group involve the in situ generation of 
organozinc species, thus avoiding the need for cumbersome syntheses, isolation and 
storage of these reactive and pyrophoric compounds.  In the past our group has developed 
several methods for the synthesis of (E)-vinylzinc species starting from terminal alkynes 
employing the procedure developed by Srebnik and Oppolzer. 
The organozinc species thus generated are added to aldehydes in the presence of an 
enantioenriched amino alcohol ligand forming allylic zinc alkoxides, which provide 
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enantioenriched secondary alcohols after treatment with water in high yields and 
enantioselectivities. 
 
Our group also explored the possibility of developing other functionalized zinc 
reagents in situ to use in asymmetric addition reactions.  The problem we faced was that 
when employing either terminal halo alkynes or aryl- and heteroaryl bromides, necessary 
for the synthesis of either (Z)-vinylzinc or aryl- and heteroaryl species, a Lewis acidic by-
product was generated such as LiCl, LiBr or EtZnBr.  These Lewis acids promoted a 
background reaction that yields racemic products, even in the presence of the 
enantioenriched catalyst. 
 
To develop a successful asymmetric reaction it is crucial that the byproduct promoted 
background reaction be suppressed.  Employing TEEDA (tetraethylethylene diamine) or 
TMEDA (tetramethylethylene diamine) as an additive to inhibit the Lewis acidic by-
products selectively provides an alternative to centrifugation or filtration of sensitive 
intermediates. Centrifugation and filtration have been used by others, but are impractical 
on large scale.  Our approach is very remarkable considering that both the background 
and the catalyzed reactions are Lewis acid catalyzed.  There are subtle difference between 
the Li and the Zn center that enable selective inhibition to be possible. 
 
Having successfully developed methods for the asymmetric synthesis of allylic 
alcohols we wanted to investigate the possibility of increasing the complexity of the 
product maintaining the one-pot nature of our protocols.  The synthesis of molecules with 
more than one stereocenter is a challenging problem.  In most cases, the existing 
stereocenter in a molecule influences the substrate-reagent interactions, resulting in 
diastereomeric transition states and leading to the prevalent formation of one 
diastereomer.  This is true in the instances in which the transformation occurs in the 
vicinity of the stereocenter, especially when the reaction is a directed reaction.1  It is 
common practice to perform this operation in two steps, isolating first the 
enantioenriched product, and then subjecting the clean material to the diastereoselective 
transformation.  Employing our methods for Oppolzer’s syntheses of (E)-vinylzinc 
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species and additions to either aldehydes or ketones, our group developed tandem 
protocols not requiring isolation of the intermediates.  The zinc alkoxide formed in the 
asymmetric addition controls the outcome of the diastereoselective reaction involving the 
allylic double bond. 
 
In the projects herein presented, the possibility of performing tandem reactions was 
particularly challenging due to the presence of inorganic salts formed during the synthesis 
of the organozinc species, and also because of the presence of the inhibitor, which was 
not necessary in the earlier protocols. 
 
Thus instead of stopping at the synthesis of the secondary alcohols by quenching the 
zinc allylic alkoxides, a directed epoxidation or cyclopropanation was successfully 
performed.  In such a reaction, five synthetic steps were performed in one flask, 
generating up to three stereocenters with complete control over the enantio- and 
diastereoselectivity. 
 
The present introduction aims to highlight the main factors in the field of asymmetric 
catalysis, along with a brief introduction to the research in the Walsh group, in order to 
prepare the reader for the more in depth discussion following in the next two chapters. 
 
 1 
 
 
 
 
 
 
 
 
1. Usefulness of (Z)-Vinyl Organometallic Reagents 
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1.1. Catalytic Asymmetric Generation of (Z)-Disubstituted Allylic Alcohols 
 
1.1.1. Introduction 
 
1.1.1.1. Synthesis of (Z)-Disubstituted Allylic Alcohols 
 
Enantioenriched allylic alcohols are among the most commonly used chiral building 
blocks and have been widely applied in natural and non-natural product synthesis.2-5 They 
are also precursors to enantioenriched epoxy alcohols,2,5-11 allylic amines,12 α- and β-
amino acids,13,14 and cyclopropyl alcohols.15-18  Enantioenriched allylic alcohols are often 
isolated via kinetic resolution (KR) with the Sharpless-Katsuki asymmetric epoxidation 
catalyst.5-8  Although (E)-allylic alcohols are excellent substrates for KR, (Z)-
disubstituted allylic alcohols are not (Scheme 1-1).5-8 Other drawbacks to KR include the 
need to separate the desired allylic alcohol from the epoxy alcohol product and a 
maximum yield of 50%.19 
 
 
Scheme 1-1. Application of the Sharpless-Katsuki Catalyst to the Kinetic Resolution of 
(E)- and (Z)-Allylic Alcohols. 
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More efficient methods to prepare enantioenriched allylic alcohols include asymmetric 
vinylation of aldehydes9-11,13,14,20-27 or ketones28,29 (Scheme 1-2) and reductive coupling of 
alkynes and carbonyl compounds.30-35  These methods simultaneously generate a C-C 
bond and a stereogenic center in a single step.  Most vinylation methods are initiated by 
hydrometallation of terminal alkynes, via hydroboration20-22,36 or hydrozirconation,23,24,37 
followed by addition of the resulting (E)-vinyl organometallic reagents to aldehydes or 
ketones to furnish (E)-allylic alcohols (Scheme 1-2).  Similar methods to prepare (Z)-
allylic alcohols would require trans hydrometallations, which are rarely observed.38 
 
 
Scheme 1-2. Catalytic Asymmetric Vinylation of Aldehydes and Ketones via 
Hydrometallation of Terminal Alkynes, Transmetallation, and Addition.   
 
Only one direct (Z)-vinylation of aldehydes has been reported involving the Nozaki-
Hiyama-Kishi reaction with (Z)-vinyl halides. 
 
 
Scheme 1-3. Enantioselective (Z)-Allylic Alcohol from (Z)-Vinyl Iodide. 
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The single (Z)-vinyl halide substrate tested in this study, however, underwent addition 
with 40% enantioselectivity (Scheme 1-3).39 
Progress toward the generation of enantioenriched (Z)-dienyl alcohols has recently 
been reported by the Krische group.35  Employing acetylene gas and hydrogen in the 
presence of a rhodium catalyst and an aldehyde or α-ketoester, these researchers found 
that dienyl alcohols could be isolated in good yields (Scheme 1-4).  The (Z)-geometry is 
believed to arise via reductive coupling of two acetylenes to generate a 
metallocyclopentadiene.  Insertion of an aldehyde followed by protonation or 
hydrogenolysis of the metal carbon bond provides the observed (Z)-dienyl alcohol. 
Preliminary studies directed toward enantioselective versions of this dienylation reaction 
are promising. 
 
 
Scheme 1-4. Generation of (Z)-Dienyl Alcohols and Proposed Intermediates by Krische 
and Coworkers. 
 
1.1.1.2. Synthesis by the Walsh Group 
 
We have been interested in the development and applications of vinyl organometallic 
reagents that enable the construction of di- and trisubstituted olefins and allylic alcohols.9-
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11,13,14,18,28,29  Synthons for these species are shown in Figure 1-1.  The synthon for the (E)-
disubstituted vinyl groups represented in Scheme 1-2 (A, Figure 1-1) is readily derived 
from the hydrometallation of terminal alkynes.  It contains one nucleophilic site trans to 
R1.  A synthon for a (Z)-di- or trisubstituted vinyl group (Figure 1-1, B), on the other 
hand, contains two reactive positions, a nucleophilic site cis to R1 and an electrophilic site 
trans to R1.  For generation of (Z)-disubstituted allylic alcohols, the nucleophilic reagent 
that adds to the electrophilic site is a hydride.  The increased functionality of this synthon 
provides greater flexibility and enables the formation of multiple bonds, potentially 
through synthetically efficient tandem reactions.  In the development of reagents for 
synthon B, it is critical that the double bond stereochemistry be preserved during bond-
forming processes. 
 
Figure 1-1. Synthon A Represents (E)-Disubstituted Vinyl Organometallics while 
Synthon B Represents (Z)-Di- or Trisubstituted Reagents. 
 
We recently reported a one-pot stereospecific method for the synthesis of (Z)-
disubstituted allylic alcohols based on synthon B (Scheme 1-5).40  Initial hydroboration of 
1-bromo-1-alkynes with dicyclohexylborane furnishes 1-bromo-1-alkenylboranes with 
excellent regioselectivity.  It is known that nucleophiles react with 1-bromo-1-
alkenylboron derivatives via addition of the nucleophile to the open coordination site on 
boron followed by migration of the nucleophile or a boron alkyl to the vinylic position 
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with inversion at the vinylic center.41-46  In our investigations we chose to use t-BuLi, 
which had been shown to be an excellent hydride source by Molander44 for the formation 
of (Z)-vinylboranes.  Vinylboranes are fairly unreactive and have not been widely used in 
synthesis outside of Suzuki cross-coupling reactions.  We envisioned that the (Z)-vinyl 
group would undergo boron to zinc transmetallation with dialkylzinc reagents to generate 
more reactive vinylzinc reagents.  In fact, the increased reactivity of the vinylzinc reagent 
enabled additions to aldehydes to proceed smoothly to generate (Z)-allylic alcohols.40  
Using this method, a variety of racemic (Z)-allylic alcohols were prepared in high yields.  
Additions of (Z)-vinyl groups to enantioenriched protected α- and β-hydroxy aldehydes 
resulted in formation of (Z)-allylic alcohols with high diastereoselectivity.40  
Unfortunately, attempts at enantioselective versions of this transformation afforded only 
racemic allylic alcohol products.  An additional problem with our original (Z)-vinylation 
of aldehydes was that it required a solvent switch from THF to toluene, which 
complicated the procedure. 
 
 
Scheme 1-5. Our Stereospecific Method for the Synthesis of (Z)-Allylic Alcohols. 
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The next section describes the first general and direct catalytic asymmetric synthesis of 
(Z)-allylic alcohols.  The application of this method to the one-pot preparation of highly 
functionalized epoxy alcohols and allylic epoxy alcohols is demonstrated in Section 1.2, 
while the application to the preparation of cyclopropyl alcohols is demonstrated in 
Section 1.3.  These reactions lead to a rapid increase in molecular complexity and enable 
the synthesis of highly functionalized chiral building blocks. 
 
1.1.2. Results and Discussion 
 
1.1.2.1. Optimization of the Reaction Conditions 
 
When our (Z)-vinylation of aldehydes (Scheme 1-5) was conducted in the presence of 
the amino alcohol-based catalyst derived from (–)-MIB, the (Z)-allylic alcohol product 
was isolated in good yields, but the product was found to be racemic.  This result was 
surprising because the zinc-based catalyst derived from (–)-MIB is one of the most 
efficient and enantioselective amino alcohol-based catalysts known for carbonyl 
additions.  The absence of enantioselectivity was attributed to the rapid addition reaction 
promoted by the liberated Lewis acid byproduct, LiBr (Scheme 1-5). Rather than attempt 
to remove the LiBr byproduct by filtration47 or centrifugation,48 which would be 
impractical on large scale, we attempted to deactivate it. 
Our first attempts to inhibit the salt byproduct were based on observations reported by 
Bolm.  In a study involving the addition of Ph2Zn to aldehydes, Bolm and coworkers 
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emphasized the beneficial effect of dimethoxy poly(ethyleneglycol) (DiMPEG) on the 
reaction enantioselectivity.47  They proposed that DiMPEG suppressed reactions 
catalyzed by trace achiral Lewis acids, including LiBr, allowing most of the arylation 
reaction to proceed via the ligand accelerated49 Lewis acid catalyzed pathway.50 
To suppress the LiBr-promoted vinyl addition to aldehydes, we employed DiMPEG as 
an inhibitor (Table 1-1).  Addition of 5-7 mol of % DiMPEG (MW 2000 g/mol) proved 
most effective, with enantioselectivities in the (Z)-vinylation reaching 86% (Table 1-1, 
entries 1-4). 
Table 1-1. Enantioselective Addition of (Z)-Vinylzinc Reagents to Aldehydes in the 
Presence of Various Inhibitors. 
 
 
Although this result was exciting and promising, we found that the reactions were very 
sensitive to the mol % DiMPEG and enantioselectivities were difficult to reproduce.  
Tetraglyme was used as a DiMPEG analog but was dramatically less effective at 
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inhibiting LiBr (Table 1-1, entries 5-7).  After significant effort to identify reliable 
polyether inhibitors, this strategy was abandoned. 
Instead, we turned to a diamine inhibitor that we had successfully used to solve a 
similar problem in our development of the first highly enantioselective one-pot 
asymmetric synthesis of enantioenriched diarylmethanols beginning from aryl bromides 
(Scheme 1-6).51  Like the vinylation in Scheme 1-5, initial attempts at the asymmetric 
arylation reactions also resulted in formation of essentially racemic products.  In the 
transmetallation reactions used to generate the aryl group donor, ArZn(n-Bu), over 4 
equiv of LiCl were formed.  As seen in the vinylation reactions, this Lewis acidic 
byproduct was significantly faster at promoting the aryl addition to provide 
diarylmethanols than the chiral amino alcohol-based catalyst, resulting in formation of 
racemic product.  The key to the successful development of an asymmetric arylation 
system was inhibition of the LiCl byproduct with tetraethylethylene diamine (TEEDA).  
The diamine is believed to chelate LiCl to form a chloride-bridged dimer 
[(TEEDA)LiCl]2 that is coordinatively saturated and catalytically inactive (Figure 
1-2).52,53  Using this technique, the racemic background reaction was completely 
suppressed, resulting in formation of diarylmethanols with enantioselectivities as high as 
97%. 
 
 
Scheme 1-6. Asymmetric Arylation of Aldehydes with TEEDA to Inhibit LiCl. 
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Figure 1-2. Possible Structure of the Coordinatively Saturated TEEDA Adduct of 
LiCl. 
 
When the diamine-based strategy in Scheme 1-6 was applied to the synthesis of (Z)-
allylic alcohols in Table 1-1, enantioselectivities peaked at 10% under our best conditions 
(Table 1-1, entries 8 and 9).  These results suggested that inhibition of LiBr would be 
significantly different from inhibition of LiCl.  It was speculated that the bromide analogs 
of [(TEEDA)LiCl]n (Figure 1-2) dissociate more readily to generate an open coordination 
site capable of aldehyde activation.  Rather than search for a new inhibitor for LiBr, 1-
chloro-1-alkynes were examined in this process, which would generate LiCl. 
Examination of 1-chloro-1-alkynes was approached in a similar fashion to the 
optimization of 1-bromo-1-alkynes.  When 1-bromo-1-alkynes were employed in a 
previous study40 (Scheme 1-5), it was found to be necessary to perform the addition of t-
BuLi in THF.  A solvent switch was then needed, because the vinylzinc addition proceeds 
with low enantioselectivity in THF.  Using the 1-chloro-1-alkynes, however, the entire 
reaction could be performed in t-BuOMe solvent, without the need to switch solvents.  
Hydroboration of 1-chloro-1-alkynes with Cy2BH proceeds in 1 h at 0 ºC to room 
temperature with excellent regioselectivity.  Reaction of the resulting 1-chloro-1-
vinylborane with t-BuLi occurred with inversion at the vinylic center, generating the (Z)-
vinylborane.  Transmetallation with diethylzinc and addition to an aldehyde in the 
presence of the (–)-MIB-based catalyst provided the racemic allylic alcohol.  Repeating 
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the sequence with the addition of increasing amounts of TEEDA resulted in the formation 
of enantioenriched (Z)-allylic alcohol products (Table 1-1, entries 10 - 16).  The highest 
enantioselectivities were obtained with 20-30 mol % TEEDA.  Further increases in the 
mol % diamine caused a decrease in both enantioselectivity and yield.  This observation 
is likely due to inhibition of the chiral zinc-based catalyst by the diamine, allowing the 
uncatalyzed background reaction to become competitive with the catalyzed addition, 
eroding the product ee. 
 
1.1.2.2. Catalytic Asymmetric Synthesis of (Z)-Disubstituted Allylic Alcohols 
 
With the optimized conditions in Table 1-1, we examined the scope of the asymmetric 
vinylation (Table 1-2).  Employing 20-30 mol % TEEDA, a variety of 1-chloro-1-alkynes 
and aldehydes underwent the addition with good yields (61-84%) and good-to-excellent 
enantioselectivities (76-98%).  1-Chloro-1-alkynes bearing a TBDPS-protected alcohol 
(entries 1 - 5), alkyl (entries 6 and 7), phenyl groups (entries 8 and 9) or chloroalkyl 
(entries 10 - 17) groups were successfully employed in the asymmetric vinylation 
reaction.  Although aliphatic aldehydes with α-branching underwent addition with high 
enantioselectivity (84 – 90% ee, entries 1, 7, and 12), β-branched isovaleraldehyde was a 
more challenging substrate, undergoing addition with 76% enantiomeric excess (entry 2).  
α,β-Unsaturated aldehydes reacted to form dienols with 88-94% ee (entries 16 and 17).  
Aryl aldehydes were also good substrates for the vinylation reaction, providing benzylic 
alcohols with ee between 86 and 98%. 
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Table 1-2. Scope of the Catalytic Asymmetric Synthesis of (Z)-Allylic Alcohols. 
 
The electron withdrawing trifluoromethyl benzaldehyde exhibited the lowest 
enantioselectivity of this class of substrates, possibly due to an earlier transition state with 
less bond formation and reduced steric bias.  The heterocyclic aldehyde, 2-thiophene 
carboxaldehyde, proved to be an excellent substrate for (Z)-vinylations proceeding in 92-
94% ee (entries 5, 9, and 11).  This route to thiophene-containing allylic alcohols avoids 
potential problems with catalyst poisoning that can arise in the hydrogenation of 
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thiophene-containing propargylic alcohols.  Similarly, the alkyne-bearing product in 
entry 4 would be difficult to prepare by selective Lindlar reduction. 
 
1.1.2.3. Large Scale Application 
 
The evaluation of scalability is essential in the development of practical methods with 
potential utility in target oriented synthesis.  With this in mind, we examined the substrate 
combination in entry 15 using 5.0 mmol of the aldehyde.  The desired (Z)-allylic alcohol 
was obtained in 79% yield at this scale with 96% ee.  The high yield and 
enantioselectivity in this reaction bode well for large-scale applications of these 
asymmetric addition reactions. 
Currently we are also preparing an Organic Synthesis paper employing chloro alkyne 
1-d and tolualdehyde to generate 1-15.  The two runs necessary for publication were 
performed on a 30 mmol scale, yielding the product in 77% yield and 92% ee.  Slight 
adjustments were necessary to obtain this result.  As in any scale-up process, temperature 
needs to be monitored closely.  For example, the addition of either t-BuLi or ZnEt2 at −78 
ºC needed to be performed dropwise while making sure that the temperature remained 
below −65 ºC.  The aldehyde was diluted in 20 mL of hexanes and added slowly at 0 ºC 
with the aid of a syringe pump (5 mL/h) while maintaining the temperature at −10 ºC 
instead of 0 ºC as in the small scale reaction.  Without these modifications, the product 
was obtained in 60% ee. 
Additionally, the purity of the terminal chloro alkyne is crucial to provide the product 
in high purity.  In fact, while preparing 1-d in large amounts for this scale-up study, the 
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purification was performed by distillation of the crude chloro alkyne, which by 1H NMR 
looked pure.  However in the final product 3-5% of the (E)-allylic alcohol was detected 
by proton NMR. 
To address this problem the (E)-allylic alcohol was synthesized separately to compare 
both the 1H NMR and the retention times in the HPLC plot to those of the (Z)-product.  
Indeed traces of the (E)-allylic alcohol were present in the large scale reactions. 
The possibilities were that the rearrangement upon t-BuLi addition was not 100% 
regioselective, or that the terminal chloro alkyne was contaminated by the terminal 
alkyne.  By GC analysis we observed 3-5% of the terminal alkyne in the starting material 
used for this reaction, which could account for the observed formation of the (E)-allylic 
alcohol.  The solution to this problem was found by purifying the terminal chloro alkyne 
by column chromatography while checking the purity of the fractions by GC analysis. 
Using 1-d purified in this way gave the desired (Z)-allylic alcohol in 77% yield and 
92% ee.  These results bode well for the use of this chemistry on large scale. 
 
1.1.2.4. Outlook and Conclusions 
 
The asymmetric synthesis of (Z)-allylic alcohols has been achieved utilizing 1-chloro 
alkynes as the precursor to provide the vinyl moiety.  This method not only provides 
access to an important and challenging class of enantioenriched allylic alcohols, it also 
allows for a new synthon, which could be very useful in complex molecule synthesis. 
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Key to success in this endeavor is the discovery that TEEDA can inhibit the 
background reaction caused by LiCl, a by-product generated en route to the 
functionalized vinylzinc reagent.  Most noteworthy is the fact that these additives do not 
inhibit the Zn-amino alcohol-based catalyst. 
Some of the applications of the (Z)-allylic alcohols presented in this chapter will 
become evident in the next sections, in particular in Section 1.2 and Section 1.3.  This 
work has been highlighted in the Organic Chemistry Portal edited by Professor Douglas 
Taber, and it has been cited already 8 times. 
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1.2. Developing a Diastereoselective One-Pot Epoxidation Protocol 
 
1.2.1. Introduction 
 
1.2.1.1. Synthesis of Epoxy Alcohols 
 
Two of the most significant developments in the history of asymmetric catalysis were 
the introduction of the Sharpless-Katsuki asymmetric epoxidation of prochiral allylic 
alcohols5,8,54 and the application of this reaction to the kinetic resolution of racemic allylic 
alcohols (Scheme 1-7).6 
 
 
Scheme 1-7. a) Epoxidation of Prochiral Allylic Alcohols and b) Kinetic Resolution of 
Racemic Allylic Alcohols 
 
The products of these processes, enantioenriched epoxy alcohols, are among the most 
valuable and versatile intermediates in organic synthesis3 because they readily undergo 
regioselective ring-opening reactions.7  As a result, the Sharpless-Katsuki asymmetric 
epoxidation has found extensive utility in the synthesis of natural products.5 
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Despite the enduring success of the Sharpless kinetic resolution, there remain 
significant limitations.  If the desired product is the epoxy alcohol, the kinetic resolution 
must be quenched at low conversion to ensure product of high ee.7  Alternatively, the 
resolved allylic alcohol is often isolated and epoxidized in a separate step.  Of course, an 
inherent problem with kinetic resolutions is that the maximum yield is 50%. 
In contrast to the synthesis of epoxy alcohols from achiral allylic alcohols, the direct 
synthesis of epoxy alcohols containing a stereogenic center at the carbanol carbon from 
achiral reagents requires that three contiguous stereocenters be established with high 
enantio- and diastereoselectivity.  This transformation, therefore, is typically performed 
in a multistep procedure involving synthesis of a secondary allylic alcohol with high 
enantioselectivity, or racemic synthesis and resolution of the allylic alcohol, followed by 
a directed epoxidation reaction. The epoxidation of chiral secondary allylic alcohols is 
generally carried out using an organic peracid, such as mCPBA, or with a transition-metal 
catalyst in combination with a stoichiometric oxidant.1  The diastereoselectivity of the 
directed epoxidation step ranges from poor to excellent, depending on the nature of the 
allylic alcohol. 
Good to excellent diastereoselectivities have been achieved with cyclic allylic alcohols 
and with acyclic allylic alcohols having substitution on the olefin such that significant 
A1,3 or A1,2 strain exists in one of the diastereomeric transition states (Figure 1-3, Table 
1-3).  Thus, A1,3 strain encountered in the transition state leading to the minor 
diastereomer can result in high diastereoselectivity for allylic alcohols that are Z-
substituted with respect to the carbanol moiety (entries 1 and 2, Table 1-3). Likewise, 
substrates with substitution geminal to the carbanol group can exhibit A1,2 strain in one of 
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the diastereomeric transition states and be epoxidized with high diastereoselectivity 
(entry 3, Table 1-3). 
 
Figure 1-3. Transition States for the Directed Epoxidation of Chiral Allylic Alcohols 
via a Peracid or a Transition-Metal Peroxide 
 
On the other hand, allylic alcohols containing disubstituted (E)-olefins are among the 
most difficult substrates for directed epoxidation. In the absence of significant A1,3 and/or 
A1,2 strain in the diastereomeric transition states, diastereoselectivities for these substrates 
are typically less than 2:1 with both peracid- and transition metal-catalyzed epoxidation 
reactions (entry 4, Table 1-3).55-58 
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Table 1-3. Diastereomeric Ratios for the Directed Epoxidation of Chiral Secondary 
Allylic Alcohols with Various Oxidizing Agents59 
 
 
1.2.1.2. Contributions from the Walsh Group 
 
Having developed a viable method for the catalytic asymmetric synthesis of (Z)-
disubstituted allylic alcohols, we wanted to examine briefly the potential application of 
this process in tandem addition/epoxidation reactions.  We recently developed methods 
for tandem asymmetric alkylation of enones (Scheme 1-8)60,61 and enals (Scheme 1-9)9-11 
followed by diastereoselective epoxidation of the resulting allylic alkoxides to provide 
epoxy alcohols with up to three contiguous stereogenic centers.62  The oxidant in the 
epoxidation was a zinc peroxide generated upon reaction of either TBHP or dioxygen 
with dialkylzinc reagents. 
 
Scheme 1-8. Tandem Asymmetric Alkylation/Epoxidation of Enones 
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Scheme 1-9. (a) Tandem Asymmetric Alkylation/Epoxidation of Enals, (b) 
Vinylation/Epoxidation of Aldehydes 
 
1.2.2. Results and Discussion 
 
1.2.2.1. Developing an Enantioselective (Z)-Vinylation/Diastereoselective 
Epoxidation Tandem Protocol 
 
Initially we were concerned that the reaction would be hampered by the presence of the 
TEEDA, due to its known coordination to titanium alkoxides63 or oxidation to the N-
oxide, as was observed in the KR of racemic β-amino alcohols by Sharpless (Scheme 
1-10).64 Fortunately, these side reactions did not interfere with the epoxidation. 
 
 
Scheme 1-10. Sharpless N-Oxide KR of Nitrogen Containing Substrates 
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Adaptation of our addition/epoxidation method to the (Z)-vinylation reaction is 
illustrated in Scheme 1-11.  The generation of the allylic zinc alkoxide was performed as 
outlined in Table 1-1.  Rather than addition of water to quench the allylic alkoxide 
intermediate, however, 2 equiv of diethylzinc were injected into the flask.  Dropwise 
addition of a 5.5 M solution of TBHP in decane was then followed by titanium 
tetraisopropoxide (20 mol %).  The epoxidations were conducted at –20 ºC and stirred for 
24 h before workup.  The crude epoxy alcohols were chromatographed and isolated in 52 
– 67% yield with excellent dr (>19:1 in each case, Scheme 1-11). 
 
 
Scheme 1-11. Tandem Asymmetric Addition/Diastereoselective Epoxidation. 
 
To aid in the assignment of the relative stereochemistry in the epoxy alcohol products 
in Scheme 1-11, we examined the diastereoselective epoxidation of an isolated allylic 
alcohol with the complementary epoxidizing agents mCPBA and VO(acac)2/TBHP 
(Scheme 1-13).  It is well known that VO(acac)2/TBHP exhibits high diastereoselectivity 
with allylic alcohols that possess A1,2 strain in one of the diastereomeric epoxidation 
transition states.  In contrast, mCPBA is known to epoxidize with high 
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diastereoselectivity when allylic alcohols lead to an A1,3 strain in one of the 
diastereomeric epoxidation transition states (Scheme 1-12).4 
 
 
Scheme 1-12. Determining the Favored Diastereomer Formed According to the A1,2 or 
A1,3 Strain. 
 
Subjecting the preformed allylic alcohol in Scheme 1-13 to the typical epoxidation 
conditions with VO(acac)2/TBHP and mCPBA afforded the epoxy alcohols with 2.3 : 1 
and 10 : 1 dr, respectively.  The mCPBA epoxidation resulted in high stereoselectivity 
and formed the same diastereomer as our one-pot addition/epoxidation procedure. 
 
 
Scheme 1-13. Epoxidation of the Isolated Allylic Alcohol with VO(acac)2/TBHP and 
mCPBA. 
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This observation indicates that the syn diastereomer is formed in the tandem reaction, 
as shown in Scheme 1-11.  Furthermore, the stereochemistry of 1-20 was assigned by 
derivatization with (–)-camphanic acid chloride to afford the expected ester, which was 
characterized by X-ray crystallography (Figure 1-4). 
 
  
Figure 1-4. X-ray Structure of the Camphanic Ester of 1-20. 
 
1.2.2.2. Regioselectivity of Tandem Addition/Epoxidation Reactions 
 
Having demonstrated that the epoxidation of the (Z)-allylic alkoxide could be 
performed in the tandem addition/epoxidation reaction, we wanted to explore the 
preferential epoxidation of a more substituted double bond in the presence of the (Z)-
vinyl group.  Thus, addition of the (Z)-vinylzinc reagent to cyclohexenecarboxaldehyde 
generated the intermediate dienyl alkoxide, which was subsequently exposed to zinc 
peroxide and titanium tetraisopropoxide.  This reaction furnished the allylic epoxy 
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alcohol derived from oxidation of the more electron-rich trisubstituted double bond in 
52% yield with 94% ee and 19 : 1 dr.  The results in Scheme 1-11 and Scheme 1-14 
highlight a unique feature of this epoxidation system: the ability to perform highly 
diastereoselective epoxidations with either A1,2 or A1,3 strain in one of the diastereomeric 
epoxidation transition states.  In contrast, low diastereoselectivity is observed with 
mCPBA when selectivity is dependent on A1,2 strain in one of the diastereomeric 
transition states and with VO(acac)2/THBP or Ti(Oi-Pr)4/TBHP when selectivity is 
dependent on A1,3 strain. 
 
 
Scheme 1-14. Tandem Asymmetric Addition/Diastereo- and Chemoselective 
Epoxidation. 
 
The apparent low yield for the synthesis of 1-21 in Scheme 1-14 needs further 
clarification. The overall sequence entails five synthetic steps in a tandem fashion. The 
52% yield is the equivalent of an 88% yield for each individual transformations. 
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1.2.2.3. Future Directions 
 
The asymmetric synthesis of epoxy alcohols was achieved in a simple protocol 
beginning from readily available starting materials.  This method can provide new 
disconnections in the retrosynthetic analysis. 
Currently, after succeeding in the synthesis of 1-15 on a 30 mmol scale, the synthesis of 
1-19 is being attempted on the same scale.  Preliminary results show that the tandem 
addition/epoxidation reaction needs a slightly different approach than the one used in the 
small scale reactions, because the generation of the Zn/peroxoalkyl reagent does not 
provide the same result on a 30 mmol scale.  This result likely arises from  precipitation 
of the zinc peroxide under the large scale conditions.  Byeong-Seon Kim is testing other 
peroxide sources such as cumene hydroperoxide, which could be a more active and 
soluble reagent. 
Moving into a different direction, epoxy alcohols with suitable functional groups such 
as halogens, generate in situ suitable species for intramolecular ring closing reactions.  
The epoxide serves as the internal electrophile upon treatment with ammonia or 
benzylamine (Scheme 1-15).65,66 
 
Scheme 1-15. Intramolecular Cyclization Reactions Employing the Epoxide as the 
Internal Electrophile. 
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The epoxy alcohols generated in this project could undergo a similar transformation 
providing either substituted pyrrolidine or piperidine depending on the length of the alkyl 
chain (Scheme 1-16). 
 
 
Scheme 1-16. Proposed Ring Closing Reaction Employing the Epoxy Alcohols 
Described Herein. 
 
The epoxy alcohols synthesized herein also appear to be suitable substrates for 
collaboration with professor Babak Borhan from Michigan State University.  Their group 
has developed a porphyrin tweezer that would bind in a different way according to the 
absolute stereochemistry of the epoxy alcohol (Scheme 1-17).  
 
Scheme 1-17. Borhan’s Zinc Porphyrin Tweezers for Determination of Absolute 
Stereochemistry of Epoxy Alcohols. 
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Measuring the Exciton Coupled Circular Dichroism (ECCD) of the epoxy alcohol 
bound to the zinc porphyrin would provide the necessary information to determine the 
absolute stereochemistry without need for Mosher’s ester analysis or other derivatization 
means.67 
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1.3. Developing Diastereoselective One-pot Cyclopropanation Protocols 
 
1.3.1. Introduction 
 
1.3.1.1. Background on the Cyclopropanation Reaction 
 
Cyclopropane containing compounds often exhibit important biological activity68-71 and 
are commonly encountered in natural products.  These strained structural motifs are also 
valuable building blocks in organic chemistry that can be elaborated to provide 
functionalized cyclopropanes or ring-opened products.72  The synthetic utility and 
medicinal properties of enantioenriched cyclopropanes have inspired many investigations 
into their preparation.15,17,73-75  The need for the synthesis of chiral enantioenriched 
cyclopropyl alcohols to access natural products and biologically active compounds with 
control of stereochemistry, has driven the effort of many laboratories toward the 
development of enantioselective methods. 
Three main methods have been widely utilized to synthesize cyclopropanes.  The first 
two have seen a noteworthy development with regard to asymmetric catalytic synthesis, 
involving either organocatalytic cyclopropanation,75-80 which proceeds via Michael-
initiated ring-closure reactions,81 or rhodium-catalyzed reactions of diazoesters and 
related precursors to afford enantio- and diastereoenriched cyclopropanes, although 
certain disubstituted alkenes remain challenging substrates.75,82-84 
 The Simmons-Smith cyclopropanation reaction, the third available method, was first 
discovered in 1959.  Since then, it has been one of the premiere methods for the synthesis 
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of cylopropanes.  In the first report, the active Cu/Zn couple was obtained by heating a 
mixture of zinc dust and cupric oxide to 500 ºC under an atmosphere of hydrogen. The 
resulting couple, which contained 90% zinc and 10% copper, gave reproducible results in 
the cyclopropane synthesis. Once the Cu/Zn couple was synthesized, it was added to a 
solution of iodine in diethyl ether.  After the iodine color was observed to have faded, 
methylene diiodide and the olefin were added and refluxed for a period of up to three 
days.73,85 
Since this first report, several modifications have been performed to improve the 
reaction’s noticeably harsh conditions.  In 1968, Furukawa was the first to employ ZnEt2 
and CH2I2 for the cyclopropanation reaction, resulting in higher yields with significantly 
milder conditions.86  Subsequently, in 1985, Yamamoto introduced aluminum reagents to 
perform the cyclopropanation,87 and in 1987 Molander successfully used samarium to 
obtain excellent diastereoselectivity in the cyclopropanation of allylic alcohols.88,89 
In addition to improving reaction conditions, researchers were quick to understand the 
role of vicinal hydroxyl groups in enhancing both the rate of the reaction and the 
diastereoselectivity.90-93  In particular Pereyre found that employing (Z)-allylic alcohols 
gave better diastereoselection than (E)-allylic alcohols.94,95 
A significant contribution came from the laboratories of Charette, which enabled the 
synthesis of enantioenriched cyclopropyl alcohols starting from prochiral allylic alcohols, 
albeit with the need of stoichiometric amounts of a chiral auxiliary.  Alternatively, 
employing previously synthesized chiral enantioenriched allylic alcohol, Charette 
demonstrated the possibility of performing highly diastereoselective cyclopropanation 
reactions with the addition of functionalized methylene groups.96 
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Despite these important improvements, there are still a number of limitations: 1) the 
need to isolate the allylic alcohol, which requires additional synthetic steps or 2) in the 
case of enantioselective synthesis, there is still the need for stoichiometric amounts of a 
chiral auxiliary. 
Even though the Simmons-Smith-type cyclopropanation reaction has been known for 
half a century, many enantioselective methods are limited.  These shortcomings prompted 
our group to attempt to address these problems using a different approach. 
 
1.3.1.2. Walsh Group Contribution 
 
Given the formidable challenge of developing catalytic enantioselective Simmons-
Smith reactions, we considered alternative strategies for the catalytic enantio- and 
diastereoselective synthesis of cyclopropanes from achiral reagents.  We envisioned a 
catalytic enantioselective carbonyl addition to generate an allylic zinc alkoxide 
intermediate followed by a diastereoselective cyclopropanation. Performing these 
reactions in tandem would enable the formation of three C-C bonds and stereocenters in a 
one-pot procedure with excellent stereoselectivity. Thus, the allylic zinc alkoxide would 
be formed via asymmetric alkyl addition to α,β-unsaturated aldehydes in the presence of 
4 mol % of Nugent’s (−)-MIB ligand (Scheme 1-18, route A),97,98 or via an asymmetric 
addition of a vinyl group, generated by Oppolzer’s method,20 to saturated aldehydes 
(Scheme 1-18, route B). Subsequent cyclopropanation would be performed using 
modified Simmons-Smith type reagents. Wipf and coworkers recently reported a similar 
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procedure, vinyl addition/cyclopropanation with imines, to afford anti-cyclopropyl 
amines, however analogous reactions with aldehydes were reported to be unsuccessful 
(Scheme 1-19).99 
 
 
Scheme 1-18. Two Tandem Asymmetric Addition/Diastereoselective 
Cyclopropanations. 
 
 
Scheme 1-19. Formation of Allylic Amine and Diastereoselective Cyclopropanation by 
Wipf. 
 
Although diastereoselective cyclopropanations of chiral allylic alcohols have been 
studied in the past, our work presents the first example of assembly of enantio- and 
diastereoenriched cyclopropyl alcohols from achiral precursors in a one-pot procedure. 
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1.3.2. Results and Discussion 
 
1.3.2.1. Developing Tandem Protocols 
 
As introduced above, alkoxide-directed Simmons-Smith cyclopropanations of both (E)- 
and (Z)-chiral allylic alcohols are highly syn selective. The presence of a proximal 
hydroxy group plays a predominant role in assisting the delivery of the carbenoids.  
However, in most instances the enantioenriched chiral allylic alcohol is synthesized 
separately, and then subjected to diastereospecific cyclopropanation.  The asymmetric 
synthesis of (E)-allylic alcohols is well documented as opposed to the synthesis of (Z)-
allylic alcohols as we described earlier in Section 1.1. 
Our strategy to synthesize (Z)-cyclopropyl alcohols blends our one-pot synthesis of (Z)-
disubstituted allylic alcohols with optimized cyclopropanation conditions developed in 
our laboratories.18 
Upon generation of the allylic zinc alkoxide (performed as outlined in Table 1-1), 
instead of addition of water to quench the allylic alkoxide intermediate, 5 equiv of 
diethylzinc and 5 equivalents of CF3CH2OH are injected into the flask at 0 ºC.  After 5 
min of stirring, 5 equiv of CH2I2 are added and the flask is wrapped in aluminum foil to 
exclude light. The resulting solution is stirred at room temperature for 24 h (Table 1-4).  
The generation of a more reactive carbenoid employing diethylzinc and CF3CH2OH is 
crucial to the development of a synthetically useful method.  This reagent was first 
devised by the Shi group100 and then extensively studied by Dr.  Hun-Young Kim a 
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former member of the Walsh group.  Employing other less reactive species would yield a 
mixture of inseparable allylic alcohol and cyclopropyl alcohol. 
Table 1-4. Tandem Asymmetric Addition/Cyclopropanation 
 
 
In prior optimized conditions, the volatile materials were removed under reduced 
pressure after the addition step was completed.  This operation was performed in order to 
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increase the molarity of the reaction and to remove the volatile by-products.  Employing 
this procedure however, the product was obtained, in low yield.  In this current protocol, 
Cy2BH is used in place of Et2BH, thus leading us to reason that the removal of the 
volatile materials was not that important, at least for what concerns the removal of the 
volatile by-products.  On a practical level it is not easy and desirable to remove large 
amount of solvent and volatiles when scaling-up the procedure.  Employing the same 
reaction conditions without removing the volatile materials did indeed give the desired 
product in good yield and excellent dr.  Aliphatic, aromatic and heteroaromatic aldehydes 
were suitable for asymmetric addition/diastereoselective cyclopropanation under these 
conditions (Table 1-4). 
The syn diastereomer was expected to be formed based on our knowledge of Zn-alkoxy 
directed cyclopropanation reactions. 18,101  The stereochemistry of 1-28 was assigned as 
syn by derivatization with (–)-camphanic acid chloride to afford the expected ester, which 
was characterized by X-ray crystallography (Figure  A-1). 
 
Figure 1-5. X-ray Structure of the Camphanic Ester of 1-28. 
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1.3.2.2. Summary and Outlook 
 
Employing the method developed in our laboratory for the asymmetric synthesis of (Z)-
allylic alcohols, a tandem protocol for the diastereoselective synthesis of cis disubstituted 
cyclopropyl alcohols has been described.  Given the rapid increase in molecular 
complexity with defined stereochemical outcome and the ease and efficiency of our one-
pot procedures, we envision this procedure will be useful in enantioselective and in 
diversity-oriented synthesis. 
The most important future studies with these substrates involve the possibility of 
performing the cyclopropanation reaction chemoselectively when more than one double 
bond is present in the substrate, which so far has been elusive. 
Mahmud Hussain in our group is also investigating the possibility of opening the 
cyclopropyl ring employing both the (Z)- and the (E)-cyclopropyl alcohols.  Since we 
have developed methods to synthesize both stereoisomers, these substrates would enable 
us to compare their reactivity in this process.  Upon treatment with HF in pyridine the 
cyclopropyl ring could rearrange to form a cyclobutane ring (Scheme 1-20).102 
 
 
Scheme 1-20. Shimizu Ring Opening Reaction Mediated by HF. 
 
Since the mechanism proceeds via formation of a carbocation, the stereocenter on the 
alcohol position would be racemized.  However the other two stereocenters are expected 
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to be maintained in the product, which would be a very valuable building block (Scheme 
1-21).  In a similar fashion our group observed an excellent diastereoselectivity in the 
formation of cyclobutanones promoted by either Lewis or protic acid.103 
Remaining questions include whether we would be able to obtain only one of the four 
possible diastereomers, and whether the (E)- and (Z)-cyclopropyl alcohol would provide 
the same or the opposite product, as depicted in Scheme 1-21, where all the possible 
products are drawn. 
 
 
Scheme 1-21. Possible Diastereomers in the HF Mediated Ring Opening Reaction 
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1.4. Synthesis of (Z)-Trisubstituted Allylic Alcohols 
 
1.4.1. Introduction 
 
Allylic alcohols are exceptionally useful building blocks that can be readily 
transformed into numerous other valuable compounds, such as allylic amines,12 amino 
acids,13,14 cyclopropyl alcohols15-18 and epoxy alcohols.2,5-11  They are also prevalent in 
natural products.2-5  As a result, much focus has been placed on their asymmetric 
synthesis, particularly through vinylzinc additions to aldehydes.104 While significant 
progress has been made in the selective formation of (E)-di- and (E)-trisubstituted allylic 
alcohols,13,20-22,30,105-107 and more recently (Z)-disubstituted allylic alcohols,40,108 general 
methods for the direct, efficient, and stereoselecive synthesis of asymmetric (Z)-
trisubstituted allylic alcohols remain sparse.109 
 
1.4.1.1. Current Methods 
 
One of the most common methods for synthesizing (Z)-trisubstituted allylic alcohols is 
the Still-Gennari modification of the Horner-Wadsworth-Emmons (HWE) olefination.110 
This popular method generates (Z)-trisubstituted α,β-unsaturated esters with good to 
excellent control of the double-bond geometry and yield (Scheme 1-22, a).  However, this 
reaction is a two-carbon homologation and requires further functional group manipulation 
and additional steps to couple large fragments.  Furthermore, the bis(trifluoroethyl) 
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phosphonoester reagent, which is synthesized in 3-steps from trialkyl phosphite, requires 
up to 5 equiv of expensive and toxic 18-crown-6 to maximize the diastereoselectivity. 
Additions of (Z)-vinylorganometallic reagents to aldehydes, such as the Nozaki-
Hiyama-Kishi (NHK) reaction,111 would appear to be a favorable method, but the 
difficulty in generating the requisite (Z)-alkenyliodide and the harsh reaction conditions 
often result in unfavorable mixtures of double bond isomers, which can be challenging to 
separate (Scheme 1-22, b). Denmark and coworkers devised a method for the generation 
of (Z)-trisubstituted allylic alcohols from 2-butyn-1-ol via silylation of the alcohol, 
platinum catalyzed syn-hydrosilation, and palladium catalyzed cross-coupling with aryl 
iodides (c).112 While this three-step process gives fair to good yields and excellent control 
of the double bond geometry, 2-butyn-1-ol is the only substrate shown to work, 
significantly limiting the reaction scope.  The only modulation is obtained through choice 
of the aryl iodide. 
 
 
Scheme 1-22. Common methods for generating (Z)-trisubstituted allylic alcohols. 
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Of great interest to synthetic chemists is the development of methods to form chiral 
(Z)-trisubstituted allylic alcohols selectively and efficiently.  Similar in principle to the 
NHK reaction, metallation of a (Z)-alkenyliodide with butyllithium or i-PrMgBr and 
addition to a chiral aldehyde yields diastereomeric mixtures of (Z)-allylic alcohols 
(Scheme 1-23).113,114 The highly reactive nature of alkenyllithium and magnesium 
nucleophiles can frequently cause poor diasteroselectivity, thus softer nucleophiles (Zn, 
Al), additives and Lewis acids are often employed to increase the selectivity.113-116 The 
overall efficiency of the process may be the larger issue as (Z)-alkenyliodides are 
precious and sensitive starting materials. 
 
 
Scheme 1-23. Potential synthesis of enantioenriched (Z)-trisubstituted allylic alcohols. 
 
The ability to create molecular complexity rapidly in a single flask is of great 
importance to researchers.  A great advantage to this chemistry would be the creation of 
both the (Z)-geometry as well as a new stereocenter in tandem using relatively simple 
starting materials.  Dr. Young Chen, a former member of the Walsh group, first sought to 
develop a multicomponent C-C bond-forming reaction for the efficient and 
stereoselective synthesis of (Z)-trisubstituted allylic alcohols that would address the 
deficiencies in the state-of-the-art methods.  Such a protocol would utilize an easily 
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accessible organometallic reagent with broad substrate scope and functional group 
tolerance as well as being capable of coupling large fragments to maximize efficiency. 
 
1.4.2. Walsh Group Contribution 
 
1.4.2.1. Development of a One-Pot Method for the Synthesis of (Z)-
Trisubstituted Allylic Alcohols 
 
This approach was largely based on the work of Zweifel,41 who investigated the 
reactivity of the hydroborated 1-halo-1-alkynes with dicyclohexylborane (Scheme 1-24, 
a).  The hydroboration step is highly regioselective, providing 1-halo-alken-1-ylborane as 
the only observed product by NMR.117  Addition of sodium methoxide to 1-halo-alken-1-
ylborane allowed the cyclohexyl group to undergo a 1,2-alkyl shift at the vinylic center, 
recently referred to as a 1,2-metallate rearrangement.118,119  Other nucleophiles such as 
Grignard reagents,45,120 alkyllithiums45,120 (b), and hydrides43,44,121 (c) have also permitted 
similar 1,2-metallate rearrangements to occur with 1-halo-1-alkenylboranes.  This 
process is equivalent to performing a rare trans-hydrometallation on an internal alkyne 
regioselectively.  The resulting (E)-vinylboranes are fairly unreactive toward nucleophilic 
addition, thus the vinylboranes were either oxidized to ketones or protodeborated with 
acid forming trans-alkenes.  
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Scheme 1-24. 1,2-Metallate Rearrangements with 1-Halo-1-Alkenyl Boranes. 
 
Since Zweifel first reported the synthesis of these (E)-alkenylboranes, Srebnik36 and 
Oppolzer20 have pioneered an alkenylboron-zinc transmetallation, generating a more 
reactive alkenylzinc species capable of adding to carbonyl groups.  Based on these 
developments, our group sought to use these technologies in tandem to develop a 
stereoselective (Z)-trisubstituted alkenylzinc reagent capable of readily adding to 
aldehydes, thus directly coupling large fragments in a general and efficient manner. 
 
1.4.2.2. Development of (Z)-Trisubstituted Alkenylzinc Additions to Aldehydes 
 
Dr. Young Chen attempted to generate a (Z)-trisubstituted alkenylzinc reagent in situ 
for the generation of (Z)-trisubstituted allylic alcohols.46  Initially, hydroboration with 
diethyl- and dicyclohexylborane was investigated.  Hydroboration of a 1-bromo-1-alkyne 
generated the 1-bromo-alk-1-enylborane as the only observed regioisomer (Scheme 1-25 
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- A).  Addition of diethylzinc causes a 1,2-alkyl shift to occur with loss of halogen, 
forming an (E)-alkenylborane species (B).  An additional equivalent of diethylzinc 
resulted in a boron-zinc transmetallation generating the (Z)-alkenylzinc reagent (D) and 
trialkylborane, which is observed at ~86 ppm by 11B NMR.  Addition of aldehyde 
furnishes (Z)-trisubstituted allylic alcohols in good yield as the only diastereomer 
observed (see Table 1-5 for selected examples). 
 
 
 
Scheme 1-25. Proposed Mechanism for our (Z)-Trisubstituted Allylic Alcohol Synthesis. 
 
Table 1-5. Multicomponent Synthesis of (Z)-Trisubstituted Allylic Alcohols with 
Ethyl and Cyclohexyl Installation 
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1.4.2.3. Diastereoselective Synthesis of Allylic Alcohols with Ethyl and 
Cyclohexyl Group Installation 
 
Dr. Michael Kerrigan, now a former member of the Walsh group, employed the 
conditions used in Scheme 1-25 for the diastereoselective addition to enantioenriched 
aldehydes.  The results were excellent as shown in Table 1-6 where it is evident that the 
ethyl alkenyl zinc group gives generally higher yields than when the reaction is 
performed with HBCy2 (compare 1-34, 1-38 and 1-39 against 1-36). 
 
Table 1-6. Diastereoselective Synthesis of Allylic Alcohols with α-Ethyl and α-
Cyclohexyl Substituents 
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Methyl addition was more challenging. In fact, Dr. Michael Kerrigan had to employ 
Br2BH or Cl2BH for the initial hydroboration followed by addition of 4.5 equiv of Me2Zn.  
In these cases, the dr’s were generally very high, but the yields were lower than those 
obtained with ethyl and cyclohexyl installation (compare for example 1-38 versus 1-44). 
It is possible that the lower yields in Table 1-7 relative to those in Table 1-6 are due to 
the reactivity and the Lewis acidity of the haloboranes, which are known to cleave ethers. 
Table 1-7. Diastereoselective Synthesis of α-Methyl Substituted Allylic Alcohols  
 
 
To our surprise, almost all the compounds synthesized in Table 1-6 gave the anti-
Felkin product.  By varying the protecting groups on the α-hydroxy-aldehyde, it was 
expected that the TBS (1-34) protecting group would block chelation, thus giving the 
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Felkin product, while the Bn (1-36) and PMB (1-37) would allow chelation.  This 
suggests that the alkylzinc halide byproduct might be a sufficiently Lewis acidic to 
chelate both alkyl and silyl ethers.  After viewing this trend, use of the TIPS (1-35) 
protected derivative was employed; again the anti-Felkin product was observed in 
excellent diastereoselectivity.  These puzzling results have been investigated further 
studying the role of the in situ generated alkyl zinc halides as possible Lewis acid 
coordinative center.122 
 
1.4.2.4. Catalytic Asymmetric (Z)-Trisubstituted Vinylzinc Additions to 
Aldehydes with Ethyl and Cyclohexyl Installation 
 
Our group became interested in the asymmetric synthesis of (Z)-trisubstituted allylic 
alcohols due to our central focus of developing novel tandem and C-C bond forming 
reactions.  We were curious as to whether our developed (Z)-trisubstituted alkenylzinc 
reagents46,123 would be capable of participating in catalytic asymmetric additions to 
prochiral aldehydes in the presence of a chiral ligand.  Compared to the number of chiral 
ligands capable of catalyzing the asymmetric addition of alkylzinc reagents to prochiral 
aldehydes, ligands capable of catalyzing asymmetric alkenylzinc additions to prochiral 
aldehydes are fairly rare.20,23,24,124,125  Dr. Michael Kerrigan and Dr. Sang-Jin Jeon decided 
to tackle this problem using Nugent’s chiral amino alcohol ligand (–)-MIB.97,98  The zinc-
based catalyst derived from (–)-MIB has been shown to exhibit excellent 
enantioselectivities in asymmetric alkenylzinc additions to aldehydes.18,108,126 
 46 
The general procedure for the addition of our (Z)-trisubstituted alkenylzinc reagents to 
aldehydes now included addition of the chiral catalyst just prior to the addition of the 
aldehyde.  With Nugent’s (–)-MIB,97,98 use of up to 20 mol % catalyst was investigated, 
rendering only racemic product (Table 1-8).  After further consideration of the 
mechanism in Scheme 1-25, we postulated that the alkylzinc halide byproduct might 
promote a rapid background reaction. 
It was also observed in Section 1.1.2.1 and in Chapter 2 that the addition of diamines in 
zinc vinylations and zinc arylation of aldehydes in the presence of in situ generated 
lithium halides significantly increased product ee’s. 
Table 1-8. Additive Screening in the Catalytic Asymmetric Formation of Allylic 
Alcohols by Dr. Sang-Jin Jeon. 
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This increase in ee presumably arises by diamine binding to lithium salts, preventing 
them from catalyzing the background reactions.51,108  Based on these precedents, Dr. 
Sang-Jin Jeon investigated several Lewis basic additives as inhibitors of these Lewis 
acidic materials.  Additives were screened including the polymer DiMPEG and several 
diamines. In α-ethyl and cyclohexyl installed (Z)-trisubstituted alkenylzinc additions to 
benzaldehyde, one equivalent of either tetramethylethylenediamine (TMEDA) or 
tetraethylethylenediamine (TEEDA) resulted in greater than 95% ee with 5 mol % 
catalyst loading (Table 1-8, entries 6 and 7). 
Following this initial lead, 1 equiv TMEDA was added just before addition of (–)-MIB 
and aldehyde in the general procedure.  The resulting (Z)-trisubstituted allylic alcohols 
were generated in good to excellent yields and excellent enantioselectivity. Table 1-9 
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displays the compatibility of this chemistry to catalytic asymmetric conditions. Sang-Jin 
showed that alkyl substituted bromoalkynes and silyl protected propargylic and 
homopropargylic alcohols could be successfully applied to this chemistry in conjunction 
with alkyl, aryl, and α,β-unsaturated aldehydes.  In the ethyl installation series (Table 
1-9, compounds 1-46, 1-47 and 1-50), all substrates underwent addition with excellent ee 
and good to excellent yields.  Cyclohexyl installation gave fair to excellent ee (Table 1-9, 
compounds 1-48, 1-49 and 1-51), but the yields varied significantly, as is often the trend 
with bulky reagents. 
Attempts to adapt this procedure to the synthesis of α-methyl-substituted allylic 
alcohols with Br2BH and Cl2BH and varying amounts of DiMPEG or diamine inhibitor 
resulted in enantioselectivities below 30% and low yields (15–40%). 
Table 1-9. α-Ethyl and Cyclohexyl Installation for the Synthesis of Enantioenriched 
(Z)-Trisubstituted Allylic Alcohols by Dr. Sang-Jin Jeon. 
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The hypothesis is that the low enantioselectivities arise from the additional 2 equiv of 
zinc halide byproduct generated when using X2BH, as outlined in Scheme 6.  Increasing 
the equivalents of diamine to inhibit the additional zinc halide (>300 mol %) also 
appeared to inhibit the Lewis acidic MIB-based catalyst (5–20 mol %). 
Use of Me2BH was plagued with problems.  As in the synthesis of α-ethyl- and α-
cyclohexyl-substituted allylic alcohols, use of Me2BH generates only 1 equiv of zinc 
halide.  The use of TMEDA was ineffective, however, and levels of enantioselectivity did 
not surpass 24%.  The issue could be that the gaseous Me2BH is generated as a solution 
in diethyl ether, which coordinates to the boron.  Traces of Lewis basic solvent inhibit the 
MIB-based Lewis acid catalyst.  Thus, it is believed that a different strategy will be 
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necessary for the enantioselective synthesis of α-methyl (Z)-trisubstituted allylic 
alcohols. 
 
1.4.3. Results and Discussion 
 
1.4.3.1. Zinc/Boron Alkyl Migration – Mechanistic Insight 
 
The successful application of the method for the formation of (Z)-trisubstituted allylic 
alcohols relies on the migration of a single R group from the boron to the vinylic carbon. 
In the case of the ethyl installation both R groups are ethyls since Et2BH and ZnEt2 are 
employed.  Substitution of dicyclohexylborane for diethylborane was next examined to 
generate the cyclohexyl-substituted product (Scheme 1-25, R2 = Cy). Interestingly, 
hydroboration of the bromoalkyne with dicyclohexylborane followed by addition of 
diethylzinc at 0 °C and p-tolualdehyde led to the expected cyclohexylsubstituted product 
with up to 20% ethyl migration product (Table 1-10, entry 1, R1 = Cy, R2 = Et). 
This result prompted a brief study of various hydroborating and transmetalating 
reagents to examine their impact on the product mixture and to identify conditions to 
more strongly favor migration of the B-alkyl over the Zn-alkyl. In contrast to addition of 
the diethylzinc at 0 °C, when the diethylzinc addition was performed at –78 °C, Cy:Et 
migration increased to a synthetically useful 14:1 ratio (Table 1-10, entry 2).  When these 
conditions were used, the cyclohexyl-substituted allylic alcohols with p-tolualdehyde (1-
56) was obtained in approximately 60% yield. 
 51 
 
Table 1-10. Examination of the Impact of Dialkylborane and Dialkylzinc Reagents on 
the 1,2-Metalate Rearrangement 
 
Next, the origin of the primary and secondary alkyl groups was reversed by using 
Et2BH and (i-Pr)2Zn with the dialkylzinc added at –78 °C (Table 1-10, entry 3).  In this 
case, the ethyl migration product predominated (Et:i-Pr = 4:1 – 1-53:1-54).  Two primary 
alkyl group donors were used to compare groups with similar migratory aptitudes.  In 
these experiments, hydroboration was performed with Et2BH and transmetalation with (n-
Bu)2Zn (Table 1-10, entry 4) or Me2Zn (entry 5) at –78 °C.  With (n-Bu)2Zn, the product 
contained a 4:1 mixture of Et:n-Bu substituted allylic alcohols (1-53:1-55).  When Me2Zn 
was employed, the ratio of Et:Me was closer to statistical (2.5:1, entry 5 – 1-53:1-52).  
Use of Cy2BH and ZnMe2 resulted in a 3:1 ratio of cyclohexyl to methyl migration (entry 
6 – 1-56:1-52).  Taken together, these results lead us to believe that a discrete trialkyl 
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alkenylboronate intermediate is involved in these processes.  In this intermediate, 
migration of the alkyl group originally attached to boron (R2 Scheme 1-25) is favored 
over the alkyl originating from the dialkylzinc.  It is noteworthy that, when a hydride is 
added to the empty site on boron (from t-BuLi, for example),44 only hydride migration to 
the vinylic center is observed and no alkyl migration is detected (Scheme 1-5 and Table 
1-10, entry 7 – 1-3).108  Insight into the ease with which 1,2-metalate rearrangement and 
transmetalation occur was gained by hydroboration with Et2BH and transmetalation at –
78 °C with Me2Zn followed by quenching the reaction mixture with methanol after 30 
min at that temperature.  The ethyl- and methyl-substituted (Z)-olefins were obtained in a 
2.7:1 ratio (Scheme 1-26 – 1-58:1-57). This result indicates that both the 1,2-metalate 
rearrangement and the transmetalation take place at a surprisingly low temperature. It is 
noteworthy that the protonolysis of vinylboranes is typically performed with acetic acid 
at 0 °C.127,128 
 
 
 
Scheme 1-26. Protonolysis of Intermediates in the Generation of Trisubstituted 
Vinylzinc Species 
1.4.3.1. Summary and Outlook 
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Reported herein is a simple and efficient method for the stereospecific generation of 
(Z)-trisubstituted alkenylzinc reagents.  Beginning with readily accessible 1-halo-1-
alkynes, hydroboration with diethyl- or dicyclohexylborane provides 1-halo-1-
alkenylboranes with excellent regioselectivity.  The key to success of this method is our 
discovery that dialkylzinc reagents can both induce the 1,2-metalate rearrangement with 
formation of a C-C bond and promote the boron-to-zinc transmetalation to generate the 
requisite (Z)-trisubstituted alkenylzinc reagents.  These reagents smoothly add to 
prochiral aldehydes to generate a variety of (Z)-trisubstituted allylic alcohols.  It is 
noteworthy that no contamination by the thermodynamically more favorable (E)-allylic 
alcohols was observed by 1H NMR spectroscopy. 
The in depth understanding of the transmetalation-1,2 metalate rearrangement 
mechanism gained in this brief study opens up the possibility to address the problem of 
the synthesis of methyl trisubstituted alkenylzinc reagents.  In fact, by blocking the 
migration of the alkyl groups on the boron using 9-BBN one could envision the 1,2 
metalate rearrangement to occur with Me migration (Scheme 1-27).  The final product of 
this reaction could be the (Z)-trisubstituted allylic alcohol with methyl installation.  This, 
as we have seen in the previous sections, is a very challenging problem and we have not 
been able to develop an asymmetric version. 
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Scheme 1-27. Possible Route for the Methyl Installation 
 
The initial studies in Scheme 1-27 have led to no addition product, but this is probably 
due to the lack of knowledge on how to perform the transmetallation of the alkenylborane 
bearing the BBN group quantitatively instead of diethyl or dicyclohexyl.  More studies to 
develop a catalytic asymmetric synthesis of methyl trisubstituted allylic alcohols are 
being performed by Kevin Cheng, taking the results presented herein as the starting point. 
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1.5. Conclusions 
 
Presented herein are the first general highly enantioselective addition of (Z)-alkenyl 
groups to aldehydes to afford enantioenriched (Z)-allylic alcohols. 
Employing readily available 1-chloro-1-alkynes, hydroboration, addition of t-BuLi and 
transmetallation to zinc affords (Z)-disubstituted alkenylzinc intermediates.  The resulting 
(Z)-alkenylzinc reagents undergo addition to aldehydes with high enantioselectivity in the 
presence of a zinc-based catalyst derived from MIB.  A variety of enantioenriched (Z)-
disubstituted allylic alcohols can be accessed in this simple one-pot procedure, including 
some that would be difficult to prepare using Lindlar hydrogenations of enantioenriched 
propargylic alcohols due to catalyst poisoning or functional group incompatibility. 
Furthermore, in the attempt to increase molecular complexity, we have found the 
conditions for the (Z)-vinylation of aldehydes are compatible with both our 
diastereoselective epoxidation procedure and with our diastereoselective 
cyclopropanation procedure, allowing access to epoxy alcohols and allylic epoxy 
alcohols as well as cyclopropyl alcohols with three contiguous stereogenic centers with 
high ee and dr.  Previous methods to prepare such compounds required several synthetic 
steps and purifications.  Using the procedures introduced herein, such compounds can be 
readily synthesized in a single flask without isolation or purification of intermediates. 
(Z)-Trisubstituted allylic alcohols have been synthesized with a simple and efficient 
method for the stereospecific generation of (Z)-trisubstituted alkenylzinc reagents.  
Beginning with readily accessible 1-halo-1-alkynes, hydroboration with diethyl- or 
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dicyclohexylborane provide 1-halo-1-alkenylboranes with excellent regioselectivity.  The 
key to success of this method is our discovery that dialkylzinc reagents can both induce 
the 1,2-metallate rearrangement with formation of a C-C bond and promote the boron-to-
zinc transmetallation to generate the requisite (Z)-trisubstituted alkenylzinc reagents.  The 
understanding of the mechanism of this particular step gained by the survey of a 
combination of different dialkylborane and dialkyl sources, may provide potential new 
routes to address the problems of the catalytic asymmetric generation of α-methyl-
trisubstituted allylic alcohols. 
Given the rapid increase in molecular complexity with defined stereochemical 
outcome, we anticipate that these methods will be very useful in enantioselective 
synthesis. 
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1.6. Experimental Section 
 
General Methods.  All reactions were performed under a nitrogen atmosphere with 
oven-dried glassware using standard Schlenk or vacuum line techniques. The progress of 
all reactions was monitored by thin-layer chromatography which was performed on 
Whatman precoated silica gel 60 K6F plates and visualized by ultra-violet light or by 
staining with phosphomolybdic acid. t-BuOMe was distilled from Na/benzophenone and 
hexanes was dried through alumina columns. Tetraethylethylene diamine (TEEDA) was 
distilled and stored under nitrogen. The 1H NMR and 13C{1H} NMR spectra were 
obtained on a Brüker AM-500 Fourier transform NMR spectrometer at 500 and 125 
MHz, respectively. 1H NMR spectra were referenced to tetramethylsilane in CDCl3 or 
residual protonated solvent; 13C{1H} NMR spectra were referenced to residual solvent. 
Analysis of enantiomeric excess was performed using a Hewlett-Packard 1100 Series 
HPLC and a chiral column specific for each compound. The optical rotations were 
recorded using a JASCO DIP-370. Infrared spectra were obtained using a Perkin-Elmer 
Spectrum 100 series spectrometer.  All reagents were purchased from Aldrich or Acros 
unless otherwise described. 1-Bromo-1-alkynes129 and 1-chloro-1-alkynes130 were made 
according to known procedure.  All commercially available aldehyde substrates were 
distilled prior to use. Silica gel (Silicaflash P60 40-63 µm, Silicycle) was used for air-
flashed chromatography and deactivated silica gel was prepared by addition of 15 mL 
NEt3 to 1 L of silica gel.  Complete experimental procedures and characterization are 
located in the Supporting Information. 
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Caution.  Dialkylzinc reagents and t-BuLi are pyrophoric. Care must be used when 
handling solutions of these reagents. 
 
1.6.1. Characterization of 1-chloroalkynes 
 
tert-Butyl-(4-chloro-but-3-ynyloxy)-diphenyl-silane (1-a).  
Compound 1-a was prepared from the corresponding alkyne131 
using the literature method.130  It was purified by column chromatography on silica gel; 
(hexanes / EtOAc 95 / 5) to afford 1-a (3.19 g, 48.6% yield) as a liquid.  1H NMR 
(CDCl3, 500 MHz): δ 1.14 (s, 9H), 2.49 (t, J = 6.7 Hz, 2H), 3.82 (t, J = 6.9 Hz, 2H), 7.46 
(m, 5H), 7.75 (m, 5H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 19.4, 22.8, 27.0, 58.6, 
62.4, 67.1, 128.0, 130.0, 133.8, 135.8 ppm; HRMS calcd for C20H24O1SiCl (MH)+: 
343.1285, found 343.1296. 
 
1-Chloro-oct-1-yne (1-b).  Compound 1-b was prepared using 
the literature method.130  The crude product was purified by 
column chromatography on silica gel (pentane) to give 1-b (1.80 g, 62% yield) as a 
liquid.  1H NMR (CDCl3, 500 MHz): δ 0.85 (m, 3H), 1.26 (m, 6H), 1.81 (m, 2H), 2.12 (t, 
J = 7.0 Hz, 2H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 14.2, 19.0, 22.7, 28.6, 28.7, 
31.5, 57.1, 70.0 ppm. 
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Chloroethynyl-benzene (1-c).  Compound 1-c was prepared using the 
literature method.130  The crude product was purified by column 
chromatography on silica gel (pentane) to give 1-c (1.62 g, 59% yield) as an oil.  1H 
NMR (CDCl3, 500 MHz): δ 7.33 (m, 3H), 7.46 (m, 2H) ppm; 13C{1H} NMR (CDCl3, 125 
MHz): δ 68.2, 69.6, 122.4, 128.6, 128.9, 132.2 ppm. 
 
1,6-Dichloro-hex-1-yne (1-d). Compound 1-d was prepared using 
the literature method.130  The crude product was purified by 
column chromatography on silica gel (pentane) to give 1-d (2.02 g, 67.4% yield) as a 
liquid.  1H NMR (CDCl3, 500 MHz): δ 1.65 (qui, J = 7.3 Hz, 2H), 1.85 (qui, J = 7.0 Hz, 
2H), 2.23 (t, J = 6.9 Hz, 2H), 3.56 (t, J = 6.9 Hz, 2H), ppm; 13C{1H} NMR (CDCl3, 125 
MHz): δ 18.3, 25.7, 31.7, 44.6, 58.0, 69.0 ppm. 
 
Characterization of 4-phenylethynyl-benzaldehyde (1-e).  
Compound 1-e was prepared using the literature method.132  The 
product was purified by chromatography in silica gel (hexanes/EtOAc 
95/5) to give the product 1-e (555.7 mg, 98.6% yield) as yellowish solid.132  1H NMR 
(CDCl3, 500 MHz): δ 7.39 (m, 3H), 7.57 (m, 2H), 7.68 (d, J = 8.3 Hz, 2H), 7.87 (d, J = 
8.2 Hz, 2H), 10.03 (s, 1H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 89.0, 93.9, 122.9, 
128.9, 129.4, 130.0, 132.2, 132.6, 135.8, 191.9 ppm; IR (neat): 3387, 3068, 3050, 2846, 
2744, 2409, 1948, 1876, 1814, 1698, 1602, 1563, 1508, 1487, 1441, 1384, 1303, 1287, 
1206, 1176, 1160 cm-1; HRMS calcd for C15H10O1 (M)+: 206.0732 found 206.0721. 
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1.6.2. Catalytic Asymmetric Synthesis of (Z)-Disubstituted Allylic Alcohols 
 
General Procedure A.  Dicyclohexylborane (88 mg, 0.5 mmol) was weighed into a 
Schlenk flask under nitrogen and dry t-BuOMe (1 mL) was added.  The 1-chloro-1-
alkyne (0.5 mmol) was then added slowly to the reaction mixture at 0 °C.  After 15 min, 
the reaction was warmed to room temperature and stirred for 45 min during which time 
the dicyclohexylborane dissolved leaving a clear solution.  t-BuLi (0.365 mL, 0.55 mmol, 
1.5 M pentane solution) was added dropwise at –78 °C and stirred for 60 min, warmed to 
room temperature and stirred for an additional 60 min.  A precipitate formed during this 
time. Diethylzinc (0.275 mL, 0.55 mmol, 2 M hexanes solution) was slowly added to the 
reaction mixture at –78 °C and stirred for 20 min.  Addition of TEEDA (14 µL, 0.066 
mmol) and hexanes (4 mL) was next performed at –78 °C, followed by warming to 0 °C 
and addition of (–)-MIB (166 µL, 0.017 mmol) and neat aldehyde (0.333 mmol).  The 
reaction was then slowly warmed to room temperature and stirred 12-16 h.  After the 
reaction was complete by TLC analysis, it was diluted with 3 mL hexanes and quenched 
with water.  The organic layer was next separated and the aqueous solution extracted with 
EtOAc (2 × 10 mL).  The combined organic layer was dried over MgSO4, filtered, and 
the solvent was removed under reduced pressure.  The crude product was purified by 
column chromatography on silica gel.  
 
General Procedure B.  This procedure is exactly the same as Procedure A except that 
the amount of TEEDA was adjusted to 30 mol %.  Thus 21 µL (0.099 mmol) was used. 
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(Z)-7-(tert-butyl-diphenyl-silanyloxy)-2-methyl-hept-4-en-3-
ol (1-1).  General Procedure A was applied to isobutyraldehyde 
(15 µL, 0.166 mmol) and tert-butyl-(4-chloro-but-3-ynyloxy)-diphenyl-silane (80 µL, 
0.25 mmol).  The crude product was purified by column chromatography on silica gel 
(hexanes/EtOAc : 95/5) to give 1-1 (38.0 mg, 61% yield) as an oil. Enantiomeric excess 
was determined by HPLC with a Chiralcel OD-H column (hexanes:2-propanol = 99:1, 
flow rate = 0.5 mL/min), tr (1) = 15.0 min, tr (2) = 16.7 min  = +2.79 (c = 0.045, 
CHCl3, 90% ee).  1H NMR and 13C NMR spectra for this compound compare with 
previously reported literature data.40 
 
(Z)-8-(tert-butyl-diphenyl-silanyloxy)-2-methyl-oct-5-en-4-
ol (1-2).  General Procedure A was applied to 
isovaleraldehyde (35 µL, 0.332 mmol) and tert-butyl-(4-chloro-but-3-ynyloxy)-diphenyl-
silane (160 µL, 0.5 mmol).  The crude product was purified by column chromatography 
on silica gel (hexanes/EtOAc : 95/5) to give 1-2 (97.9 mg, 74% yield) as an oil.  
Enantiomeric excess was determined by HPLC with a Chiralcel OD-H column 
(hexanes:2-propanol = 99:1, flow rate = 0.5 mL/min), tr (1) = 14.9 min, tr (2) = 16.9 min 
 = +10.20 (c = 0.039, CHCl3, 76% ee).  1H NMR and 13C NMR spectra for this 
compound compare with previously reported literature data.40 
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 (Z)-5-(tert-butyl-diphenyl-silanyloxy)-1-phenyl-pent-2-
en-1-ol (1-3).  General Procedure A was applied to 
benzaldehyde (34 µL, 0.332 mmol) and tert-butyl-(4-chloro-but-3-ynyloxy)-diphenyl-
silane (160 µL, 0.5 mmol).  The crude product was purified by column chromatography 
on silica gel (hexanes/EtOAc : 95/5) to give 1-3 (83.8 mg, 61% yield) as an oil.  
Enantiomeric excess was determined by HPLC with a Chiralcel AD-H column 
(hexanes:2-propanol = 99:1, flow rate = 0.5 mL/min), tr (1) = 38.2 min, tr (2) = 44.6 min 
 = +131.11 (c = 0.001, CHCl3, 95% ee); 1H NMR (CDCl3, 500 MHz): δ 1.12 (s, 
9H), 2,20 (br, 1H), 2.45-2.51 (m, 1H), 2.58-2.65 (m, 1H), 3.73-3.80 (m, 2H), 5.50-5.51 
(dd, J = 1.9, 8.0 Hz, 1H), 5.60-5.67 (dt, J = 7.8, 11.2 Hz, 1H), 5.77-5.81 (dd, J = 8.5, 10.9 
Hz, 1H), 7.40 (m 10H), 7.71 (m, 5H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 19.4, 
27.1, 31.4, 63.5, 69.9, 126.1, 127.6, 127.9, 128.7, 128.8, 129.9, 133.8, 134.5, 135.8, 143.7 
ppm; IR (neat): 3369, 3069, 2931, 1958, 1890, 1824, 1656, 1589, 1472, 1427, 1389 cm-1; 
HRMS calcd for C27H32NaO2Si (M+Na)+: 439.2069, found 439.2054. 
 
(Z)-5-(tert-Butyl-diphenyl-silanyloxy)-1-(4-
phenylethynyl-phenyl)-pent-2-en-1-ol (1-4).  
General Procedure A was applied to 4-
phenylethynyl-benzaldehyde (68.5 mg, 0.332 mmol, dissolved in 0.5 mL toluene) and 
tert-butyl-(4-chloro-but-3-ynyloxy)-diphenyl-silane (160 µL, 0.5 mmol).  Upon addition 
of TEEDA, 3.5 mL of toluene were added instead of the 4 mL of hexanes to serve the 
same purpose.  The crude product was purified by column chromatography on silica gel 
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(hexanes/EtOAc : 95/5) to give 1-4 (145.0 mg, 84% yield) as an oil.  Enantiomeric excess 
was determined by HPLC with a Chiralcel AD-H column (hexanes:2-propanol = 99:1, 
flow rate = 0.5 mL/min), tr (1) = 52.2 min, tr (2) = 64.3 min  = +1.65 (c = 0.025, 
CHCl3, 98% ee); 1H NMR (CDCl3, 500 MHz): δ 1.07 (s, 9H), 2,20 (br, 1H), 2.44-2.46 
(m, 1H), 2.56-2.58 (m, 1H), 3.70-3.75 (m, 2H), 5.46-5.48 (d, J = 7.9 Hz, 1H), 5.63-5.67 
(dt, J = 7.4, 11.2 Hz, 1H), 5.71-5.75 (dd, J = 9.0, 11.0 Hz, 1H), 7.35-7.57 (m, 15H), 7.70-
7.73 (m, 5H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 19.4, 27.1, 31.4, 63.4, 69.5, 89.5, 
89.6, 122.4, 123.5, 126.1, 127.9, 128.4, 128.6, 129.3, 130.0, 131.8, 132.0, 133.8, 134.2, 
135.8, 143.9 ppm; IR (neat): 3393, 3070, 3050, 2957, 2930, 2857, 1597, 1486, 1427, 
1361, 1111 cm-1; HRMS calcd for C35H36NaO2Si (M+Na)+: 539.2382, found 539.2394. 
 
(Z)-5-(tert-butyl-diphenyl-silanyloxy)-1-phenyl-pent-2-en-
1-ol (1-5).  General Procedure A was applied to 
thiophenecarboxaldehyde (31 µL, 0.332 mmol) and tert-butyl-(4-chloro-but-3-ynyloxy)-
diphenyl-silane (160 µL, 0.5 mmol).  The crude product was purified by column 
chromatography on silica gel (hexanes/EtOAc : 95/5) to give 1-5 (98.8 mg, 69% yield) as 
an oil.  Enantiomeric excess was determined by HPLC with a Chiralcel AS-H column 
(hexanes:2-propanol = 99:1, flow rate = 0.5 mL/min), tr (1) = 20.0 min, tr (2) = 28.4 min 
 = +55.97 (c = 0.093, CHCl3, 93% ee); 1H NMR (CDCl3, 500 MHz): δ 1.08 (s, 9H), 
2.27 (d, J = 4.0 Hz 1H), 2.39-2.46 (m, 1H), 2.49-2.56 (m, 1H), 3.69-3.78 (m, 2H), 5.65-
5.70 (m, 2H), 5.82-5.86 (m, 1H), 6.93-6.97 (m, 2H), 7.24-7.27 (m, 1H), 7.39-7.46 (m, 
5H), 7.68-7.71 (m, 5H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 19.4, 27.0, 31.3, 63.4, 
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66.3, 124.0, 125.0, 126.9, 127.9, 129.4, 129.9, 133.6, 133.8, 135.8, 147.7 ppm; IR (neat): 
3390, 3070, 2930, 1960, 1891, 1826, 1656, 1589, 1471, 1427, 1389 cm-1; HRMS calcd 
for C25H30NaO2SSi (M+Na)+: 445.1633, found 445.1612. 
 
(Z)- 1-phenyl-non-2-en-1-ol (1-6).  General Procedure A was 
applied to benzaldehyde (34 µL, 0.332 mmol) and 1-chloro-oct-
1-yne (94 µL, 0.5 mmol).  The crude product was purified by column chromatography on 
silica gel (hexanes/EtOAc : 95/5) to give 1-6 (45.5 mg, 63% yield) as an oil.  
Enantiomeric excess was determined by HPLC with a Chiralcel AS-H column 
(hexanes:2-propanol = 99.5:0.5, flow rate = 0.5 mL/min), tr (1) = 26.0 min, tr (2) = 29.0 
min  = +143.56 (c = 0.060, CHCl3, 93% ee); 1H NMR (CDCl3, 500 MHz): δ 0.90 (t, 
3H), 1.31 (br, 8H), 1.84 (d, J = 8.0 Hz, 1H), 2.22 (m, 2H), 5.59 (m, 3H), 7.26-7.30 (m, 
1H) 7.34-7.42 (m, 4H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 14.3, 22.8, 28.0, 29.2, 
29.8, 31.9, 70.0, 126.1, 127.6, 128.7, 132.1, 132.7, 144.0 ppm; IR (neat): 3340, 3085, 
3063, 3028, 3012, 2956, 2926, 2855, 1655, 1603, 1492, 1452, 1378, 1282, 1192, 1079, 
1023 cm-1; HRMS calcd for C15H22O (M)+: 218.1671, found 218.1665. 
 
(Z)- 1-cyclohexyl-non-2-en-1-ol (1-7).  General Procedure A 
was applied to cyclohexanecarboxaldehyde (40 µL, 0.332 mmol) 
and 1-chloro-oct-1-yne (94 µL, 0.5 mmol). The crude product was purified by column 
chromatography on silica gel (hexanes/EtOAc : 95/5) to give 1-7 (60.2 mg, 81% yield) as 
an oil.  Enantiomeric excess was determined by HPLC with a Chiralcel OD-H column 
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(hexanes:2-propanol = 99.5 : 0.5, flow rate = 0.5 mL/min), tr (1) = 17.0 min, tr (2) = 19.0 
min  = +8.74 (c = 0.057, CHCl3, 84% ee); 1H NMR (CDCl3, 500 MHz): δ 0.88 (m, 
6H), 1.48 (br, 12H), 1.68 (br, 4H), 1.93 (m, 1H), 2.05 (m, 3H), 4.14 (t, J = 7.9 Hz, 1H), 
5.37 (dd, J = 9.0, 11.1 Hz, 1H), 5.52 (dt, J = 7.6, 13.2 Hz, 1H) ppm; 13C{1H} NMR 
(CDCl3, 125 MHz): δ 14.3, 22.8, 26.2, 26.4, 26.8, 28.0, 28.8, 29.0, 29.2, 29.9, 31.9, 44.2, 
72.1, 131.2, 133.3 ppm; IR (neat): 3411, 3008, 2924, 2853, 2668, 1733, 1658, 1449, 
1394, 1361, 1316, 1256, 1217, 1192, 1148, 1112, 1081, 1047, 1007 cm-1; HRMS calcd 
for C15H27O (M-H)+: 223.2062, found 223.2056. 
 
(Z)-1,3-diphenyl-prop-2-en-1-ol (1-8).  General Procedure A was 
applied to benzaldehyde (34 µL, 0.332 mmol) and chloroethynyl-
benzene (60 µL, 0.5 mmol).  The crude product was purified by column chromatography 
on silica gel (hexanes/EtOAc: 95/5) to give 1-8 (69.8 mg, 82% yield) as an oil.  
Enantiomeric excess was determined by HPLC with a Chiralcel AD column (hexanes:2-
propanol = 97.5 : 2.5, flow rate = 0.5 mL/min), tr (1) = 38.4 min, tr (2) = 52.3 min  = 
+461.6 (c = 0.168, CHCl3, 97% ee); 1H NMR (CDCl3, 500 MHz): δ 1.94 (d, J = 3.6 Hz, 
1H), 5.58 (dd, J = 3.7, 9.4 Hz, 1H), 5.87 (dd, J = 9.4, 11.7 Hz, 1H), 6.63 (d, J = 11.0 Hz, 
1H), 7.20-7.35 (m, 8H), 7.36-7.41 (m, 2H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 
70.2, 126.5, 127.7, 128.0, 128.6, 128.9, 129.0, 131.6, 133.4, 136.6, 143.4 ppm; IR (neat): 
3543, 3346, 3081, 3059, 3026, 2923, 1952, 1888, 1810, 1761, 1639, 1600, 1575, 1493, 
1447, 1403, 1336, 1261, 1220, 1193, 1157, 1079, 1043, 1028, 1005 cm-1; HRMS calcd 
for C15H14O (M)+: 210.1045, found 210.1053. 
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(Z)-3-phenyl-1-thiophen-2-yl-prop-2-en-1-ol (1-9).  General 
Procedure A was applied to thiophenecarboxaldehyde (31 µL, 0.332 
mmol) and chloroethynyl-benzene (60 µL, 0.5 mmol).  The crude product was purified 
by column chromatography on silica gel (hexanes/EtOAc: 95/5) to give 1-9 (45.0 mg, 
63% yield) as an oil.  Enantiomeric excess was determined by HPLC with a Chiralcel 
AD-H column (hexanes:2-propanol = 97.5:2.5, flow rate = 0.5 mL/min), tr (1) = 49.2 min, 
tr (2) = 60.1 min  = +367.2 (c = 0.012, CHCl3, 92% ee); 1H NMR (CDCl3, 500 
MHz): δ 2.1 (d, J = 4.5 Hz, 1H), 5.79 (dd, J = 4.5, 9.4 Hz, 1H), 5.93 (dd, J = 9.7, 11.0 
Hz, 1H), 6.66 (d, J = 11.0 Hz, 1H), 6.93 (m, 1H), 6.98 (m, 1H) 7.24 (m, 6H) ppm; 
13C{1H} NMR (CDCl3, 125 MHz): δ 66.7, 124.6, 125.6, 127.1, 127.8, 128.6, 129.0, 
131.8, 132.7 136.5, 147.8 ppm; IR (neat): 3554, 3443, 3103, 3060, 3025, 2923, 2853, 
2626, 1952, 1886, 1800, 1725, 1644, 1599, 1576, 1493, 1447, 1413, 1352, 1286, 1265, 
1229, 1204, 1178, 1036 cm-1; HRMS calcd for C13H12OS (M)+: 216.0609, found 
216.0611. 
 
(Z)-7-chloro-1-phenyl-hept-2-en-1-ol (1-10).  General 
Procedure B was applied to benzaldehyde (34 µL, 0.332 mmol) 
and 1,6-dichloro-hex-1-yne (66 µL, 0.5 mmol).  The crude product was purified by 
column chromatography on silica gel (hexanes/EtOAc : 95/5) to give 1-10 (62.4 mg, 84% 
yield) as an oil. Enantiomeric excess was determined by HPLC with a Chiralcel AS-H 
column (hexanes:2-propanol = 99:1, flow rate = 0.5 mL/min), tr (1) = 52.0 min, tr (2) = 
59.5 min  = +101.3 (c = 0.203, CHCl3, 88% ee); 1H NMR (CDCl3, 500 MHz): δ 
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1.56 (m, 2H), 1.81 (m, 2H), 1.87 (d, J = 3.5 Hz, 1H), 2.26 (m, 2H), 3.54 (t, J = 6.60 Hz, 
2H), 5.51-5.54 (dd, J = 3.6, 8.0 Hz, 1H), 5.55-5.59 (dt, J = 7.6, 10.7 Hz, 1H), 5.67 (dd, J 
= 8.9, 10.7 Hz, 1H), 7.27-7.31 (m, 1H), 7.34-7.42 (m, 4H) ppm; 13C{1H} NMR (CDCl3, 
125 MHz): δ 26.9, 27.2, 32.3, 45.0, 70.0, 126.1, 127.8, 128.8, 131.6, 132.8, 143.8 ppm; 
IR (neat): 3352, 3062, 3012, 2937, 2864, 1951, 1881, 1810, 1654, 1602, 1492, 1451, 
1384, 1300, 1276, 1191, 1076, 1036, 1009 cm-1; HRMS calcd for C13H15Cl (M-H2O)+: 
206.0862, found 206.0851. 
 
(Z)-7-chloro-1-thiophen-2-yl-hept-2-en-1-ol (1-11).  General 
Procedure B was applied to thiophenecarboxaldehyde (31 µL, 
0.332 mmol) and 1,6-dichloro-hex-1-yne (66 µL, 0.5 mmol).  The crude product was 
purified by column chromatography on silica gel (hexanes/EtOAc: 95/5) to give 1-11 
(56.0 mg, 73% yield) as an oil.  Enantiomeric excess was determined by HPLC with a 
Chiralcel AS-H column (hexanes:2-propanol = 99:1, flow rate = 0.5 mL/min), tr (1) = 
84.0 min, tr (2) = 93.0 min  = +167.9 (c = 0.031, CHCl3, 94% ee); 1H NMR (CDCl3, 
500 MHz): δ 1.57 (m, 2H), 1.79 (m, 2H), 1.99 (d, J = 3.3 Hz, 1H), 2.23 (m, 2H), 3.54 (t, 
J = 6.6 Hz, 2H), 5.61 (m, 1H), 5.75 (m, 2H), 6.98 (m, 2H), 7.27 (m, 1H) ppm; 13C{1H} 
NMR (CDCl3, 125 MHz): δ 26.9, 27.1, 32.2, 45.0, 66.3, 124.1, 125.3, 127.0, 132.0, 132.3 
ppm; IR (neat): 3376, 3106, 3013, 2932, 2857, 2664, 1793, 1646, 1532, 1450, 1364, 
1296, 1228, 1164, 1140, 1059, 1034 cm-1; HRMS calcd for C11H14ClS (M-OH)+: 
213.0505, found 213.0491. 
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(Z)-7-chloro-1-cyclohexyl-hept-2-en-1-ol (1-12).  General 
Procedure B was applied to cyclohexanecarboxaldehyde (40 µL, 
0.332 mmol) and 1,6-dichloro-hex-1-yne (66 µL, 0.5 mmol).  The crude product was 
purified by column chromatography on silica gel (hexanes/EtOAc: 95/5) to give 1-12 
(57.1 mg, 74% yield) as an oil.  Enantiomeric excess was determined by HPLC with a 
Chiralcel AS-H column (hexanes:2-propanol = 99.5:0.5, flow rate = 0.5 mL/min), tr (1) = 
35.8 min, tr (2) = 39.3 min  = +21.4 (c = 0.040, CHCl3, 88% ee); 1H NMR (CDCl3, 
500 MHz): δ 0.98 (m, 2H), 1.24 (m, 2H), 1.39 (m, 2H), 1.55 (m, 2H), 1.69 (m, 2H), 1.79 
(m, 4H), 1.94 (d, J = 3.3 Hz, 1H), 2.12 (m, 2H), 3.55 (t, J = 6.6 Hz, 2H), 4.13 (t, J = 7.9 
Hz, 1H), 5.41 (dd, J = 9.4, 11.1 Hz, 1H), 5.55 (dt, J = 7.5, 11.3 Hz, 1H) ppm; 13C{1H} 
NMR (CDCl3, 125 MHz): δ 26.2, 26.3, 26.7, 27.1, 27.2, 28.8, 29.0, 32.3, 44.2, 45.0, 72.1, 
131.9, 132.2 ppm; IR (neat): 3370, 3005, 2926, 2853, 2667, 1707, 1655, 1450, 1307, 
1273, 1140, 1080, 1050 cm-1; HRMS calcd for C13H21Cl (M-H2O)+: 212.1332, found 
212.1321. 
 
(Z)-7-chloro-1-(4-trifluoromethyl-phenyl)-hept-2-en-1-
ol (1-13).  General Procedure A was applied to p-
trifluoromethyl-benzaldehyde (45 µL, 0.332 mmol) and 
1,6-dichloro-hex-1-yne (66 µL, 0.5 mmol).  The crude product was purified by column 
chromatography on silica gel (hexanes/EtOAc : 95/5) to give 1-13 (70.4 mg, 72% yield) 
as an oil.  Enantiomeric excess was determined by HPLC with a Chiralcel AS-H column 
(hexanes:2-propanol = 99:1, flow rate = 0.5 mL/min), tr (1) = 48.0 min, tr (2) = 55.8 min 
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 = +119.9 (c = 0.01, CHCl3, 86% ee); 1H NMR (CDCl3, 500 MHz): δ 1.58 (m, 3H), 
1.83 (m, 2H), 2.28 (m, 2H), 3.56 (t, J = 6.5 Hz, 2H), 5.62 (m, 3H), 7.51 (d, J = 8.2 Hz, 
2H) 7.62 (d, J = 8.2 Hz, 2H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 26.9, 27.3, 32.3, 
44.5, 69.4, 125.7 (q), 126.4, 130.0, 132.1, 132.7, 147.5 ppm; 19F{1H} NMR (CDCl3, 282 
MHz): δ -62.64 (s) ppm;  IR (neat): 3350, 3014, 2939, 2866, 2360, 2097, 1924, 1807, 
1654, 1619, 1588, 1446, 1417, 1266, 1164, 1125, 1067, 1046, 1016 cm-1; HRMS calcd 
for C14H14ClF3 (M-H2O)+: 274.0736, found 274.0724. 
 
(Z)-7-chloro-1-(4-methoxy-phenyl)-hept-2-en-1-ol (1-14).  
General Procedure A was applied to p-
methoxybenzaldehyde (40 µL, 0.332 mmol) and 1,6-
dichloro-hex-1-yne (66 µL, 0.5 mmol).  The crude product was purified by column 
chromatography on silica gel (hexanes/EtOAc : 90 / 10) to give 1-14 (71.1 mg, 84% 
yield) as an oil.  Enantiomeric excess was determined by HPLC with a Chiralcel AS-H 
column (hexanes:2-propanol = 95:5, flow rate = 0.5 mL/min), tr (1) = 32.0 min, tr (2) = 
42.0 min  = +120.0 (c = 0.047, CHCl3, 93% ee); 1H NMR (CDCl3, 500 MHz): δ 
1.58 (m, 3H), 1.81 (m, 2H), 2.25 (m, 2H), 3.56 (t, J = 6.6 Hz, 2H), 3.84 (s, 3H), 5.49-5.52 
(dd, J = 3.6, 8.3 Hz, 1H), 5.53-5.59 (dd, J = 8.0, 10.9 Hz, 1H), 5.71 (dd, J = 9.1, 11.0 Hz, 
1H), 6.92 (d, J = 8.5 Hz, 2H) 7.34 (d, J = 8.7 Hz, 2H) ppm; 13C{1H} NMR (CDCl3, 125 
MHz): δ 26.9, 27.1, 32.3, 45.0, 55.5, 69.7, 114.2, 127.4, 131.2, 133.0, 136.1, 159.3 ppm; 
IR (neat): 3394, 2935, 1610, 1585, 1511, 1459, 1302, 1247, 1173, 1110, 1035 cm-1; 
HRMS calcd for C14H17ClO (M-H2O)+: 236.0968, found 236.0969. 
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(Z)-7-chloro-1-p-tolyl-hept-2-en-1-ol (1-15). General 
Procedure A was applied to p-methylbenzaldehyde (39 µL, 
0.332 mmol) and 1,6-dichloro-hex-1-yne (66 µL, 0.5 mmol). The crude product was 
purified by column chromatography on silica gel (hexanes/EtOAc : 95 / 5) to give 1-15 
(73.0 mg, 93% yield) as an oil. Enantiomeric excess was determined by HPLC with a 
Chiralcel AS-H column (hexanes:2-propanol = 99 : 1, flow rate = 0.5 mL/min), tr (1) = 
74.0 min, tr (2) = 90.0 min  = +141.6 (c = 0.044, CHCl3, 97% ee); 1H NMR (CDCl3, 
500 MHz): δ 1.57 (m, 2H), 1.80 (m, 3H), 2.23 (m, 2H), 2.27 (s, 3H), 3.54 (t, J = 6.6 Hz, 
2H), 5.48-5.52 (dd, J = 3.6, 8.7 Hz, 1H), 5.53 (dt, J = 7.8, 10.5 Hz, 1H), 5.67 (dd, J = 8.4, 
10.7 Hz, 1H), 7.17 (d, J = 7.9 Hz, 2H), 7.28 (m, 2H) ppm; 13C{1H} NMR (CDCl3, 125 
MHz): δ 21.3, 26.9, 27.1, 32.3, 45.0, 69.9, 126.1, 129.5, 131.4, 132.9, 137.5, 140.1 ppm; 
IR (neat): 3368, 3012, 2932, 2861, 2361, 1903, 1654, 1512, 1452, 1230, 1193, 1177, 
1111, 1039 cm-1; HRMS calcd for C14H17Cl (M-H2O)+: 220.1019, found 220.1027. 
 
(Z)-9-chloro-2-methyl-1-phenyl-nona-1,4-dien-3-ol (1-
16). General Procedure B was applied to α-methyl trans 
cinnamaldehyde (46 µL, 0.332 mmol) and 1,6-dichloro-
hex-1-yne (66 µL, 0.5 mmol). The crude product was purified by column 
chromatography on silica gel (hexanes/EtOAc : 95/5) to give 1-16 (64.6 mg, 73% yield) 
as an oil. Enantiomeric excess was determined by HPLC with a Chiralcel AS-H column 
(hexanes:2-propanol = 99:1, flow rate = 0.5 mL/min), tr (1) = 67.0 min, tr (2) = 73.5 min 
 = +167.9 (c = 0.03, CHCl3, 88% ee); 1H NMR (CDCl3, 500 MHz): δ 1.58 (qui, J = 
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7.4 Hz, 2H), 1.64 (d, J = 3.3 Hz, 1H), 1.82 (m, 2H), 1.88 (d, J = 1.3 Hz, 3H), 2.24 (m, 
2H), 3.55 (t, J = 6.8 Hz, 2H), 4.99 (dd, J = 3.0, 7.5 Hz, 1H), 5.58 (m, 2H), 6.61 (s, 1H), 
7.28 (m, 5H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 14.3, 26.9, 27.3, 32.3, 45.0, 73.5, 
125.4, 126.7, 128.3, 129.2, 131.2, 132.5, 137.8, 139.8 ppm; IR (neat): 3370, 3020, 2937, 
2861, 1949, 1886, 1654, 1599, 1575, 1491, 1444, 1413, 1383, 1360, 1300, 1180, 1010 
cm-1; HRMS calcd for C16H21OCl (M)+: 264.1281, found 264.1278. 
 
(Z)-7-chloro-1-cyclohex-1-enyl-hept-2-en-1-ol (1-17). General 
Procedure A was applied to cyclohexenecarboxaldehyde (38 µL, 
0.332 mmol) and 1,6-dichloro-hex-1-yne (66 µL, 0.5 mmol). The crude product was 
purified by column chromatography on silica gel (hexanes/EtOAc : 95/5) to give 1-17 
(61.1 mg, 80% yield) as an oil. Enantiomeric excess was determined by HPLC with a 
Chiralcel AD-H column (hexanes:2-propanol = 97.5:2.5, flow rate = 0.5 mL/min), tr (1) = 
28.2 min, tr (2) = 32.9 min  = +88.55 (c = 0.078, CHCl3, 94% ee); 1H NMR (CDCl3, 
500 MHz): δ 1.45 (d, J = 3.2 Hz, 1H), 1.52-1.67 (m, 6H), 1.80 (m, 2H), 2.04 (m, 4H), 
2.16 (m, 2H), 3.54 (t, J = 6.6 Hz, 2H), 4.78 (d, J = 6.8 Hz, 1H), 5.48 (m, 2H), 5.75 (m, 
1H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 22.7, 22.8, 24.4, 25.2, 26.9, 27.1, 32.3, 
45.1, 72.2, 122.7, 131.6, 131.7, 139.7 ppm; IR (neat): 3350, 2929, 2858, 1655, 1437, 
1268, 1137, 1006 cm-1; HRMS calcd for C13H19Cl (M-H2O)+: 210.1175, found 210.1176. 
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1.6.3. Asymmetric Addition/Diastereoselective Epoxidation Reactions 
 
General procedure C.  Dicyclohexylborane (88 mg, 0.5 mmol) was weighed into a 
Schlenk flask under nitrogen and dry t-BuOMe (1 mL) was added. The 1-chloroalkyne 
(0.5 mmol) was then added slowly to the reaction mixture at 0 °C. After 15 min the 
reaction mixture was warmed to room temperature and stirred for 45 min resulting in a 
clear solution.  t-BuLi (0.365 mL, 0.55 mmol, 1.5 M pentane solution) was added 
dropwise at –78 °C and stirred for 60 min.  The solution was warmed to room 
temperature and stirred for an additional 60 min during which time a precipitate formed. 
Diethylzinc (0.275 mL, 0.55 mmol, 2 M hexanes solution) was slowly added to the 
reaction mixture at –78 °C and stirred for 20 min. Addition of TEEDA (14 µL, 0.066 
mmol) and hexanes (4 mL) was performed while at –78 °C.  The solution was warmed to 
0 °C.  (–)-MIB (166 µL, 0.017 mmol) and neat aldehyde (0.333 mmol) were then added. 
The reaction mixture was then slowly warmed to room temperature and stirred 12-16 h. 
After the reaction was complete by TLC analysis, the temperature was lowered to –20 °C 
and ZnEt2 (0.275 mL, 0.55 mmol, 2 M solution in hexanes) was added. The solution was 
stirred for 30 min and TBHP (0.300 mL, 1.68 mmol, 5.5 M solution in decanes) was 
added. After 30 min the Ti(O-iPr)4 (48 µL, 0.067 mmol, 1.4 M solution in hexanes) was 
added and the reaction was stirred until completion (about 16 h). The reaction was 
quenched with 2 mL saturated aq. NH4Cl, allowed to stir for 30 minutes at room 
temperature, and poured into a separatory funnel with a solution of aq. Na2S2O3. The 
organic and aqueous layers were separated, and the aqueous layer was extracted with 
diethyl ether (3 × 5 mL). The combined organic layers were then washed with 5 mL 
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brine, 5 mL H2O and then dried over MgSO4. The filtrate was concentrated in vacuo and 
the crude product was purified by column chromatography on deactivated silica gel. 
Analysis of diastereomeric excess was performed via NMR before purification. The 
relative stereochemistry was determined by comparison of NMR data for known 
epoxidation methods (vide 1-19) and by derivatization and single crystal X-ray analysis. 
 
General Procedure D. This procedure is exactly the same as procedure C except that 
the amount of TEEDA necessary to obtain optimum results was adjusted to 30 mol %.  
Thus, 21 µL (0.099 mmol) were used. 
 
(3-Hexyl-oxiranyl)-phenyl-methanol (1-18). General Procedure 
C was applied to benzaldehyde (34 µL, 0.332 mmol) and 1-
chloro-oct-1-yne (94 µL, 0.5 mmol). The crude product was purified by column 
chromatography on deactivated silica gel (hexanes/EtOAc : 90/10) to give 1-18 (40.1 mg, 
52% yield) as an oil.  = +35.9 (c = 0.026, CHCl3); 1H NMR (CDCl3, 500 MHz): δ 
0.92 (t, J = 7.1 Hz 3H), 1,37 (m, 8H), 1,71 (m, 2H), 2.53 (br, 1H), 3.09 (dt, J = 4.7, 7.7 
Hz, 1H), 3.21 (dd, J = 4.3, 8.2 Hz, 1H), 4.60 (d, J = 8.0 Hz, 1H), 7.43 (m, 5H) ppm; 
13C{1H} NMR (CDCl3, 125 MHz): δ 14.2, 22.7, 27.0, 28.8, 29.3, 31.9, 58.7, 61.5, 72.4, 
126.4, 128.4, 128.9, 140.3 ppm; IR (neat): 3415, 3087, 3063, 3031, 2955, 2857, 1604, 
1494, 1454, 1378, 1267, 1234, 1194, 1145, 1080, 1042 cm-1; HRMS calcd for C15H21O 
(M-OH)+: 217.1592, found 217.1586. 
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[3-(4-Chloro-butyl)-oxiranyl]-phenyl-methanol (1-19). 
General Procedure D was applied to benzaldehyde (34 µL, 0.332 
mmol) and 1,6-dichloro-hex-1-yne (66 µL, 0.5 mmol). The crude product was purified by 
column chromatography on deactivated silica gel (hexanes/EtOAc : 90/10) to give 1-19 
(53.6 mg, 67% yield) as an oil.  = +56.0 (c = 0.041, CHCl3); 1H NMR (CDCl3, 500 
MHz): δ 1.64 (m, 6H), 2.46 (d, J = 2.9 Hz, 1H), 3.1 (m, 1H), 3.20 (dd, J = 4.4, 8.4 Hz, 
1H), 3.56 (t, J = 6.8 Hz, 2H), 4.58 (dd, J = 2.8, 8.0 Hz, 1H), 7.31 (m, 5H) ppm; 13C{1H} 
NMR (CDCl3, 125 MHz): δ 24.5, 28.0, 32.3, 44.9, 58.3, 61.4, 72.5, 126.4, 128.6, 129.0, 
140.1 ppm; IR (neat): 3419, 3062, 3031, 2955, 2866, 1807, 1604, 1492, 1454, 1278, 
1195, 1040 cm-1; HRMS calcd for C13H16OCl (M-OH)+: 223.0889, found 223.0888. 
 
(Z)-phenyl-(3-phenyl-oxiranyl)-methanol (1-20). General Procedure 
C was applied to benzaldehyde (33 µL, 0.327 mmol) and 
chloroethynyl-benzene (60 µL, 0.5 mmol). The crude product was purified by column 
chromatography on deactivated silica gel (hexanes/EtOAc : 90/10) to give 1-20 (43.5 mg, 
59% yield) as an oil.  = +60.5 (c = 0.026, CHCl3); 1H NMR (CDCl3, 500 MHz): δ 
2.42 (d, J = 2.3 Hz, 1H), 3.44 (dd, J = 4.5, 8.5 Hz, 1H), 4.26 (d, J = 4.4 Hz, 1H), 4.30 
(dd, J = 1.9, 8.5 Hz, 1H), 6,97 (m, 2H), 7.28 (m, 3H), 7.40 (m, 5H) ppm; 13C{1H} NMR 
(CDCl3, 125 MHz): δ 58.3, 63.4, 71.9, 126.1, 126.6, 128.3, 128.4, 128.6, 128.7, 135.0, 
139.4 ppm; IR (neat): 3412, 3031, 2980, 2923, 1956, 1888, 1815, 1604, 1495, 1453, 
1254, 1199 cm-1; HRMS calcd for C15H18NO2 (M+NH4)+: 244.1338, found 244.1326. 
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(Z)-7-Chloro-1-(7-oxa-bicyclo[4.1.0]hept-1-yl)-hept-2-en-1-ol 
(1-21). General Procedure C was applied to 
cyclohexenecarboxaldehyde (76 µL, 0.667 mmol) and 1,6-dichloro-hex-1-yne (132 µL, 
1.0 mmol). The crude product was purified by column chromatography on deactivated 
silica gel (hexanes/EtOAc : 90/10) to give 1-21 (85.7 mg, 52% yield) as an oil.  = 
+43.8 (c = 0.016, CHCl3); 1H NMR (CDCl3, 500 MHz): δ 1.27 (m, 2H), 1.58 (m, 4H), 
1.81 (m, 5H), 1.99 (m, 1H), 2.20 (m, 3H), 3.30 (d, J = 2.8 Hz, 1H), 3.56 (d, J = 7.0 Hz, 
2H), 4.40 (d, J = 9.2 Hz, 1H), 5.33 (dd, J = 9.3, 10.9 Hz, 1H), 5.68 (dt, J = 7.3, 10.9 Hz, 
1H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 19.7, 20.2, 24.5, 25.0, 26.7, 27.2, 32.1, 
44.8, 54.9, 62.1, 67.5, 128.1, 135.0 ppm; IR (neat): 3438, 2936, 2861, 2673, 1715, 1659, 
1446, 1434, 1359, 1344, 1298, 1275, 1192, 1177, 1164, 1108, 1078, 1047 cm-1; HRMS 
calcd for C13H21O2NaCl (M+Na)+: 267.1128, found 267.1136. 
 
1.6.4. Determination of Absolute Configuration of Secondary Alcohols 
 
The configuration of the secondary alcohols from addition reactions was determined by 
X-ray diffraction analysis.  In the case of the epoxy alcohol epoxidation reagents with 
known diastereoselectivity were employed and the products compared by 1H NMR 
spectrometry. 
 
Epoxidation with mCPBA. To a solution of 1-10 (168 mg, 0.748 mmol) dissolved in 
CH2Cl2 (2 mL) mCPBA (142 mg, 0.823 mmol) was added. The solution was stirred 
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magnetically at room temperature and the reaction progress was monitored by TLC. 
Upon completion, the reaction mixture was quenched by addition of 0.50 g of K2CO3 
generating a suspension that was stirred another 30 min. The suspension was removed by 
filtration, the filtrate washed with saturated aq. NaHCO3 (3 × 5 mL) and water (2 × 5 
mL), the organic phase dried over MgSO4. The filtrate was concentrated in vacuo and the 
crude product was purified by column chromatography on deactivated silica gel. Analysis 
of diastereomeric excess was performed by 1H NMR spectroscopy. The epoxy alcohol 1-
19 was obtained as a mixture of diastereomers (10:1). 
 
Epoxidation with VO(acac)2/t-BuOOH. To a solution of 1-10 (180 mg, 0.8 mmol) in 
CH2Cl2 (2 mL) was added VO(acac)2 (21 mg, 0.08 mmol). After stirring for 5 min at 
room temperature, t-BuOOH was added (0.73 mL, 4 mmol, 5.5 M in decane) and the 
mixture changed from blue to red.  The reaction progress was monitored by TLC until 
completion. The reaction was then quenched with 1M Na2S2O3, diluted with EtOAc (3 
mL) and the layers were separated. The aqueous layer was extracted with EtOAc and the 
combined organic layers were washed with brine, dried over anhydrous MgSO4, filtered 
and concentrated in vacuo giving a crude product that was purified by chromatography 
on deactivated silica gel. Analysis of diastereomeric excess was performed by 1H NMR 
spectroscopy before purification. The epoxy alcohol 1-19 was obtained as a mixture of 
diastereomers (2.3:1). 
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1.6.5. Derivatization of alcohols for X-ray Diffraction Analysis. 
 
General procedure E. A solution of the desired alcohol (0.42 mmol) and 
(dimethylamino)pyridine (DMAP) (103 mg, 0.84 mmol) in 2 mL dichloromethane was 
treated with (–)-camphanic acid chloride (136 mg, 0.63 mmol), and the mixture was 
allowed to stand at room temperature for 2 h. The crude product was purified by column 
chromatography on silica gel to give the title compound. Clear crystals suitable for an X-
ray diffraction study were formed by a slow vapor diffusion of dry hexanes into a THF 
solution of the compound. 
 
(Z)-4,7,7-Trimethyl-3-oxo-2-oxa-bicyclo[2.2.1]heptane-1-carboxylic 
acid 1,3-diphenyl-allyl ester (derivative of 1-8). General procedure E 
was applied to 1-8 (90 mg, 0.42 mmol). The crude product was purified 
by column chromatography on silica gel (hexanes/EtOAc : 95/5) to give 
the derivate of 1-8 (125 mg, 74% yield) as an oil.  = +42.5 (c = 0.016, CHCl3); 1H 
NMR (CDCl3, 500 MHz): δ 0.91 (s, 3H), 1.01 (s, 3H), 1.10 (s, 3H), 1.67 (m, 1H), 1.90 
(m, 1H), 2.01 (m, 1H), 2.40 (m, 1H), 5.99 (dd, J = 9.7, 11.3 Hz, 1H), 6.74 (d, J = 11.2 
Hz, 1H), 6.84 (d, J = 9.8 Hz, 1H), 7.37 (m, 10H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): 
δ 9.9, 16.9, 17.0, 29.2, 30.7, 54.5, 55.0, 74.0, 91.2, 127.3, 128.0, 128.6, 128.7, 128.8, 
128.9, 129.0, 133.1, 136.1, 139.2, 166.7, 178.4; IR (neat): 3060, 3028, 2969, 2876, 1955, 
1888, 1790, 1751, 1664, 1601, 1576, 1494, 1448, 1397, 1378, 1356, 1318, 1264, 1228, 
1168, 1125, 1102, 1061, 1017 cm-1; HRMS calcd for C25H26O4 (M)+: 390.1831, found 
390.1827. 
 78 
 
Preparation of 4,7,7-Trimethyl-3-oxo-2-oxa-bicyclo[2.2.1]heptane-1-
carboxylic acid phenyl-(3-phenyl-oxiranyl)-methyl ester (derivative 
of 1-20). General Procedure E was applied to 1-20 (95 mg, 0.42 mmol). 
The crude product was purified by column chromatography on silica gel 
(hexanes/EtOAc: 95/5) to give the derivate of 1-20 (120 mg, 70% yield) as an oil.  = 
–5.78 (c = 0.038, CHCl3); 1H NMR (CDCl3, 500 MHz): δ 1.08 (s, 3H), 1.11 (s, 3H), 1.15 
(s, 3H), 1.70 (m, 1H), 1.94 (m, 1H), 2.05 (m, 1H), 2.48 (m, 1H), 3.57 (dd, J = 4.3, 8.7 Hz, 
1H), 4.20 (d, J = 4.3 Hz, 1H), 5.62 (d, J = 8.7 Hz, 1H), 6.89 (m, 2H), 7.25 (m, 3H), 7.40 
(m, 5H); 13C{1H} NMR (CDCl3, 125 MHz): δ 10.1, 17.0, 17.1, 29.3, 30.9, 54.8, 55.2, 
57.7, 60.9, 75.7, 91.6, 126.7, 126.8, 128.7, 128.8, 128.9, 129.1, 134.2, 135.7, 166.9, 178.8 
ppm; IR (neat): 3110, 3063, 3034, 2974, 2935, 2874, 2337, 1959, 1901, 1789, 1732, 
1606, 1587, 1497, 1454, 1396, 1379, 1360, 1343, 1322, 1269, 1223, 1165, 1125, 1099, 
1064, 1022 cm-1; HRMS calcd for C25H26O5Na (M + Na)+: 429.1678, found 429.1698. 
1.6.6. Asymmetric Addition/Diastereoselective Cyclopropanation Reactions 
 
General procedure F.  Dicyclohexylborane (88 mg, 0.5 mmol) was weighed into a 
Schlenk flask under nitrogen and dry t-BuOMe (1 mL) was added. The 1-chloroalkyne 
(0.5 mmol) was then added slowly to the reaction mixture at 0 °C. After 15 min the 
reaction mixture was warmed to room temperature and stirred for 45 min resulting in a 
clear solution. t-BuLi (0.365 mL, 0.55 mmol, 1.5 M pentane solution) was added 
dropwise at –78 °C and stirred for 60 min.  The solution was warmed to room 
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temperature and stirred for an additional 60 min during which time a precipitate formed. 
Diethylzinc (0.275 mL, 0.55 mmol, 2 M hexanes solution) was slowly added to the 
reaction mixture at –78 °C and stirred for 20 min. Addition of TEEDA (14 µL, 0.066 
mmol) and hexanes (4 mL) was performed while at –78 °C.  The solution was warmed to 
0 °C.  (–)-MIB (166 µL, 0.017 mmol) and neat aldehyde (0.333 mmol) were then added. 
The reaction mixture was then slowly warmed to room temperature and stirred 12-16 h. 
After the reaction was complete by TLC analysis, the temperature was lowered to 0 °C 
and ZnEt2 (0.83 mL, 1.66 mmol, 2 M solution in hexanes) was added. CF3CH2OH (120 
µL, 1.65 mmol) was then added dropwise. After stirring at 0 ºC for 10 min, CH2I2 (135 
µL, 1.67 mmol) was added. The reaction continued to stir with light exclusion at room 
temperature for 24 h. It was then quenched with saturated solution of NH4Cl. The organic 
and aqueous layers were separated and the aqueous layer was extracted with 
dichloromethane (3 × 5 mL). The combined organic layers were then washed with brine 
and dried over MgSO4. The filtrate was concentrated in vacuo and the crude product was 
purified by column chromatography on deactivated silica gel. Analysis of diastereomeric 
excess was performed via NMR before purification. 
 
General Procedure G. This procedure is exactly the same as General Procedure E 
except that the amount of TEEDA necessary to obtain optimum results was adjusted to 30 
mol %.  Thus, 21 µL (0.099 mmol) were used. 
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(Z)-1-(2-(2-(tert-butyldiphenylsilyloxy)ethyl)cyclopropyl)-2-
methylpropan-1-ol (1-22). General Procedure F was applied to 
isobutyraldehyde (30 µL, 0.332 mmol) and tert-butyl-(4-chloro-but-3-ynyloxy)-diphenyl-
silane (160 µL, 0.5 mmol). The crude product was purified by column chromatography 
on deactivated silica gel (hexanes/EtOAc : 95/5) to give 1-22 (92.1 mg, 70% yield) as an 
oil.  = +4.41 (c = 0.026, CHCl3); 1H NMR (CDCl3, 500 MHz): δ 0.05 (m, 1H), 0.67 
(m, 1H), 0.93 (m, 2H), 0.98 (t, J = 7.9 Hz, 6H), 1.1 (m, 9H), 1.23 (m, 1H), 1.3 (d, J = 3.6 
Hz, 1H), 1.74 (m, 1H), 1.91 (m, 1H), 2.96 (m, 1H), 3.76 (m, 2H), 7.42 (m, 6H), 7.7 (m, 
4H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 8.9, 14.8, 17.6, 19.2, 19.4, 21.1, 27.1, 
32.8, 34.7, 64.5, 76.7, 127.8, 129.8, 134.2, 135.8 ppm; IR (neat): 3599, 3411, 3134, 3070, 
3050, 3013, 2952, 2912, 2895, 2858, 2739, 2319, 1958, 1888, 1823, 1589, 1486, 1471, 
1428, 1362, 1331, 1306, 1260, 1235, 1187, 1157, 1110 1029, 1007 cm-1; HRMS calcd for 
C25H36O2NaSi (M+Na)+: 419.2382, found 419.2377. 
 
(Z)-(2-(2-(tert-butyldiphenylsilyloxy)ethyl)cyclopropyl) 
(phenyl)methanol (1-23). General Procedure F was applied 
to benzaldehyde (34 µL, 0.332 mmol) and tert-butyl-(4-chloro-but-3-ynyloxy)-diphenyl-
silane (160 µL, 0.5 mmol). The crude product was purified by column chromatography 
on deactivated silica gel (hexanes/EtOAc : 95/5) to give 1-23 (88.1 mg, 62% yield) as an 
oil.  = +35.4 (c = 0.023, CHCl3); 1H NMR (CDCl3, 500 MHz): δ 0.27 (dd, J = 5.4, 
10.5 Hz, 1H), 0.83 (dt, J = 5.4, 8.3 Hz, 1H), 1.05 (s, br, 10H), 1.26 (m, 1H), 1.40 (m, 
1H), 1.83 (d, J = 3.4 Hz, 1H), 1.86 (m, 1H), 3.66 (t, J = 6.6 Hz, 2H), 4.20 (dd, J = 3.4, 
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10.5 Hz, 1H), 7.34 (m, 11H), 7.63 (m, 4H); 13C{1H} NMR (CDCl3, 125 MHz): δ 9.9, 
13.6, 19.1, 23.6, 26.8 32.3, 64.1, 74.7, 126.1, 127.5, 128.4, 129.5, 133.9, 135.5, 144.2; IR 
(neat): 3564, 3365, 3069, 3029, 2997, 2955, 2892, 2857, 2318, 1958, 1888, 1823, 1774, 
1660, 1602, 1589, 1567, 1557, 1487, 1471, 1461, 1427, 1361, 1322, 1302, 1287, 1232, 
1190, 1157, 1110, 1030, 992 cm-1; HRMS calcd for C28H34O2NaSi (M+Na)+: 453.2226, 
found 453.2229. 
 
(Z)-(2-(2-(tert-butyldiphenylsilyloxy)ethyl)cyclopropyl) 
(thiophen-2-yl)methanol (1-24). General Procedure F was 
applied to 2-thiopenecarboxaldehyde (31 µL, 0.332 mmol) and tert-butyl-(4-chloro-but-
3-ynyloxy)-diphenyl-silane (160 µL, 0.5 mmol). The crude product was purified by 
column chromatography on deactivated silica gel (hexanes/EtOAc : 95/5) to give 1-24 
(69.0 mg, 48% yield) as an oil.  = +26.6 (c = 0.022, CHCl3); 1H NMR (CDCl3, 500 
MHz): δ 0.27 (dd, J = 6.9, 11.4 Hz, 1H), 0.87 (m, 1H), 0.98 (m, 1H), 1.05 (s, 9H), 1.12 
(m, 1H), 1.35 (m, 2H), 1.99 (d, J = 4.4 Hz, 1H), 3.7 (t, J = 6.9 Hz, 2H), 4.45 (dd, J = 4.4, 
9.7 Hz, 1H), 6.98 (m, 2H), 7.25 (m, 1H), 7.40 (m, 6H), 7.66 (m, 4H); 13C{1H} NMR 
(CDCl3, 125 MHz): δ 10.4, 13.9, 19.4, 24.1, 27.1, 32.3, 64.3, 71.1, 124.0, 124.9, 127.8, 
129.8, 134.2, 135.8, 148.4; IR (neat): 3374, 3070, 3049, 3012, 2929, 2857, 2739, 1959, 
1889, 1825, 1778, 1729, 1656, 1589, 1471, 1462, 1446, 1389, 1306, 1264, 1230, 1188, 
1157, 1107, 1030, 1008, 997 cm-1; HRMS calcd for C26H31O2SSi (M-H)+: 435.1811, 
found 435.1814. 
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(Z)-(2-(4-chlorobutyl)cyclopropyl)(cyclohexyl)methanol (1-
25). General Procedure G was applied to 
cyclohexanecarboxaldehyde (40 µL, 0.332 mmol) and 1,6-dichloro-hex-1-yne (66 µL, 
0.5 mmol). The crude product was purified by column chromatography on deactivated 
silica gel (hexanes/EtOAc : 95/5) to give 1-25 (57.1 mg, 70% yield) as an oil.  = 
+17.1 (c = 0.086, CHCl3); 1H NMR (CDCl3, 500 MHz): δ 0.20 (dd, J = 5.4, 10.7 Hz, 1H), 
0.69 (m, 1H), 0.86 (m, 1H), 0.99 (m, 2H), 1.05 (m, 3H), 1.23 (m, 2H), 1.30 (d, J = 3.8 
Hz, 1H), 1.39 (m, 1H), 1.53 (m, 2H), 1.64 (m, 2H), 1.77 (m, 5H), 1.91 (d, J = 12.7 Hz, 
1H), 2.94 (m, 1H), 3.52 (t, J = 6.4 Hz, 2H); 13C{1H} NMR (CDCl3, 125 MHz): δ 8.8, 
17.4, 21.4, 26.2, 26.4, 26.5, 27.2, 28.1, 28.8, 29.2, 32.3, 44.7, 45.0, 76.0; IR (neat): 3390, 
3062, 2991, 2922, 2852, 2667, 2044, 1634, 1448, 1416, 1309, 1262, 1220, 1188, 1150, 
1099, 1084, 1069, 1025, 982 cm-1; HRMS calcd for C14H24Cl (M-OH)+: 227.1567, found 
227.1574. 
 
(Z)-(2-(4-chlorobutyl)cyclopropyl)(phenyl)methanol (1-26). 
General Procedure G was applied to 
cyclohexenecarboxaldehyde (34 µL, 0.332 mmol) and 1,6-dichloro-hex-1-yne (66 µL, 
0.5 mmol). The crude product was purified by column chromatography on deactivated 
silica gel (hexanes/EtOAc : 95/5) to give 1-26 (55.8 mg, 70% yield) as an oil.  = 
+53.8 (c = 0.037, CHCl3); 1H NMR (CDCl3, 500 MHz): δ 0.29 (d, J = 5.3 Hz, 1H), 0.89 
(m, 2H), 1.19 (m, 1H), 1.28 (m, 1H), 1.40 (m, 1H), 1.48 (m, 1H), 1.56 (m, 1H), 1.74 (m, 
2H), 1.87 (br, 1H), 3.47 (t, J = 6.7 Hz, 2H), 4.24 (d, J = 9.6 Hz, 1H), 7.28 (m, 1H), 7.35 
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(m, 2H), 7.43 (m, 2H); 13C{1H} NMR (CDCl3, 125 MHz): δ 10.5, 17.0, 24.2, 27.6, 28.8, 
32.6, 45.2, 75.0, 126.5, 127.9, 128.7, 144.5; IR (neat): 3367, 3062, 3029, 2993, 2932, 
2858, 2048, 1950, 1882, 1809, 1758, 1603, 1492, 1454, 1408, 1307, 1195, 1140, 1031, 
915 cm-1; HRMS calcd for C14H18Cl (M-OH)+: 221.1097, found 221.1097. 
 
(Z)-(2-(4-chlorobutyl)cyclopropyl)(thiophen-2-yl)methanol 
(1-27). General Procedure G was applied to 2-
thiophenecarboxaldehyde (31 µL, 0.332 mmol) and 1,6-dichloro-hex-1-yne (66 µL, 0.5 
mmol). The crude product was purified by column chromatography on deactivated silica 
gel (hexanes/EtOAc : 95/5) to give 1-27 (50.3 mg, 62% yield) as an oil.  = +78.4 (c 
= 0.063, CHCl3); 1H NMR (CDCl3, 500 MHz): δ 0.30 (dd, J = 5.4, 10.4 Hz, 1H), 0.90 (m, 
1H), 0.97 (m, 1H), 1.15 (m, 1H), 1.35 (m, 1H), 1.52 (m, 3H), 1.76 (m, 2H), 1.98 (d, J = 
3.9 Hz, 1H), 3.48 (t, J = 6.6 Hz, 2H), 4.47 (dd, J = 3.9, 9.6 Hz, 1H), 6.96 (m, 1H), 7.04 
(dd, J = 3.4, 5.1 Hz, 1H), 7.26 (dd, J = 1.1, 5.1 Hz, 1H); 13C{1H} NMR (CDCl3, 125 
MHz): δ 10.5, 16.7, 24.2, 27.2, 28.2, 32.3, 44.9, 70.8, 123.8, 124.7, 126.5, 148.2; IR 
(neat): 3364, 3105, 3068, 2993, 2934, 2857, 2051, 1794, 1729, 1645, 1543, 1455, 1393, 
1359, 1300, 1267, 1229, 1167, 1136, 1106, 1073 1031 cm-1; HRMS calcd for C12H16SCl 
(M-OH)+: 227.0661, found 227.0668. 
 
(Z)-phenyl(2-phenylcyclopropyl)methanol (1-28). General Procedure 
F was applied to benzaldehyde (34 µL, 0.332 mmol) and 
chloroethynyl-benzene (60 µL, 0.5 mmol). The crude product was purified by column 
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chromatography on deactivated silica gel (hexanes/EtOAc : 95/5) to give 1-28 (48.2 mg, 
65% yield) as an oil.  = +47.2 (c = 0.045, CHCl3); 1H NMR (CDCl3, 500 MHz): δ 
1.18 (dt, J = 5.7, 8.3 Hz, 1H), 1.28 (dd, J = 5.7, 11.5 Hz, 1H), 1.60 (m, 1H), 1.71 (d, J = 
3.3 Hz, 1H), 2.29 (m, 1H), 3.91 (dd, J = 2.5, 9.4 Hz, 1H), 6.97 (m, 2H), 7.12 (m, 2H), 
7.22 (m, 6H); 13C{1H} NMR (CDCl3, 125 MHz): δ 8.0, 21.5, 26.8, 73.9, 126.0, 126.1, 
127.4, 127.9, 128.1, 128.9, 137.8, 143.6; IR (neat): 3360, 3061, 3028, 3005, 2923, 2851, 
2245, 1948, 1882, 1807, 1754, 1602, 1582, 1541, 1495, 1454, 1411, 1384, 1335, 1285, 
1256, 1224, 1197, 1137, 1108, 1083, 1015, 971, 920 cm-1; HRMS calcd for C16H15 (M-
OH)+: 207.1174, found 207.1168. 
 
(Z)-(2-phenylcyclopropyl)(thiophen-2-yl)methanol (1-29). General 
Procedure F was applied to 2-thiophenecarboxaldehyde (31 µL, 0.332 
mmol) and chloroethynyl-benzene (60 µL, 0.5 mmol). The crude product was purified by 
column chromatography on deactivated silica gel (hexanes/EtOAc : 95/5) to give 1-29 
(31.6 mg, 42% yield) as an oil. 24.4 mg of the allylic alcohol were recovered accounting 
for the relatively low yield.  = +28.7 (c = 0.061, CHCl3); 1H NMR (CDCl3, 500 
MHz): δ 1.20 (dt, J = 5.5, 8.3 Hz, 1H), 1.26 (dd, J = 5.5, 11.8 Hz, 1H), 1.66 (m, 1H), 1.85 
(d, J = 4.0 Hz, 1H), 2.35 (m, 1H), 4.12 (dd, J = 4.0, 9.3 Hz, 1H), 6.55 (m, 1H), 6.85 (dd, J 
= 3.5, 5.0 Hz, 1H), 7.13 (m, 2H), 7.18 (m, 2H), 7.21 (m, 2H); 13C{1H} NMR (CDCl3, 125 
MHz): δ 8.2, 21.5, 26.8, 70.2, 123.7, 124.4, 126.2, 126.3, 128.0, 128.9, 137.4, 147.4; IR 
(neat): 3928, 3824, 3363, 3106, 3064, 3026, 3006, 2922, 2850, 2340, 2067, 1947, 1885, 
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1799, 1728, 1652, 1602, 1580, 1535, 1497, 1446, 1372, 1301, 1259, 1230, 1165, 1134, 
1083, 1011 cm-1; HRMS calcd for C14H14ONaS (M+Na)+: 253.0663, found 263.0656. 
 
(Z)-(1S)-phenyl(2-phenylcyclopropyl)methyl 4,7,7-trimethyl-3-oxo-
2-oxabicyclo[2.2.1]heptane-1-carboxylate (derivative of 1-28). 
General Procedure E was applied to 1-28 (106.7 mg, 0.476 mmol). The 
crude product was purified by column chromatography on deactivated 
silica gel (hexanes/EtOAc : 95/5) to give derivative of 1-28 (70.0 mg, 36% yield) as a 
solid. 50.0 mg of 1-28 were recovered accounting for the low yield.  = –32.9 (c = 
0.031, CHCl3); 1H NMR (CDCl3, 500 MHz): δ 0.94 (s, 3H), 1.05 (s, 3H), 1.09 (s, 3H), 
1.16 (dd, J = 5.6, 8.2 Hz, 1H), 1.34 (q, J = 5.9 Hz, 1H), 1.65 (m, 1H), 1.75 (m, 1H), 1.88 
(m, 1H), 1.97 (m, 1H), 2.36 (m, 2H), 5.31 (d, J = 5.4 Hz, 1H), 6.89 (m, 2H), 7.12 (m, 
2H), 7.19 (m, 4H), 7.25 (m, 2H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 9.0, 9.6, 16.6, 
16.7, 21.9, 24.7, 28.9, 30.4, 54.0, 54.7, 78.1, 91.0, 126.3, 126.6, 127.9, 128.0 128.1, 
128.2, 128.5, 128.7, 136.9, 139.1,166.8, 178.1; IR (in CH2Cl2): 3944, 3756, 3689, 3554, 
3055, 2975, 2935, 2877, 2685, 2522, 2410, 2305, 2126, 1952, 1884, 1788, 1744, 1603, 
1497, 1450, 1422, 1397, 1383, 1359, 1319, 1265, 1217, 1169, 1125, 1103, 1062 cm-1; 
HRMS calcd for C26H28O4Na (M+Na)+: 427.1885, found 427.1874. 
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1.6.7. Synthesis of (Z)-Trisubstituted Allylic Alcohols 
 
Compounds 1-30 to 1-51 were presented to display the entire process but were already 
reported in Michael Kerrigan thesis. 
1.6.7.1. Examination of the Impact of Dialkylborane and Dialkylzinc Reagents 
on the 1,2-Metallate Rearrangement (Table 1-10). 
 
 
(Z)-5-(tert-butyldiphenylsilyloxy)-2-cyclohexyl-1-
p-tolylpent-2-en-1-ol (1-56).  A dry 10 mL Schlenk 
flask, which was evacuated under vacuum and 
backfilled with N2 (g) three times, was charged with dicyclohexylborane (1 mmol) and 
toluene (1 mL) under a nitrogen atmosphere.  The solution was cooled to 0 ºC followed 
by addition of (4-bromobut-3-ynyloxy)(tert-butyl)diphenylsilane (386.4 mg, 1 mmol).  
The reaction was stirred for 5 min, warmed to room temperature, and stirred for 15 min.  
The solution was cooled to –78 °C and diethylzinc (3 mL, 3 mmol, 1.0 M in toluene) was 
added.  After stirring for 20 min, the reaction flask was warmed to 0 ºC.  Under a steady 
flow of N2 (g), the rubber septum was replaced with a glass stopper coated with silicon 
grease and high vacuum was gradually applied to remove the volatile contents.  The 
resulting vinylzinc reagent was redissolved in toluene (1 mL) followed by addition of p-
tolualdehyde (0.67 mmol).  The reaction mixture was gradually warmed to ambient 
temperature and stirred until no aldehyde remained by TLC (usually 7-16 h).  Quenching 
by saturated aq. NH4Cl (2 mL), followed by addition of 2 N HCl (1 mL) and 5 mL of 
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EtOAc.  The organic layer was separated and the aqueous layer was extracted 
successively with EtOAc (2 × 10 mL).  The combined organic layers were successively 
washed with saturated NaHCO3 and brine, dried over MgSO4, and filtered.  The filtrate 
was concentrated in vacuo and the residue was purified by column chromatography on 
silica gel to yield a mixture of 1-56 (173 mg, 50.7%) and (Z)-5-(tert-
butyldiphenylsilyloxy)-2-ethyl-1-p-tolylpent-2-en-1-ol (1-53) (11.0 mg, 3.6%) in a 14:1 
ratio, respectively.  When diethylzinc was added to the reaction solution at 0 °C, the ratio 
changed to 4:1.  1H NMR (CDCl3, 500 MHz): δ 7.72 (m, 4H), 7.44 (m, 6H), 7.31 (d, J = 
7.9 Hz, 2H), 7.14 (d, J = 7.9 Hz, 2H), 5.54 (d, 4.0 Hz, 1H), 5.48 (t, J = 7.8 Hz, 1H), 3.69 
(m, 2H), 2.61 (m, 1H), 2.37 (s, 3H), 1.96 (m, 1H), 1.79 (m, 2H), 1.68 (m, 2H), 1.51 (d, J 
= 9.4 Hz, 1H), 1.28 (m, 2H), 1.11 (s, 9H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 
149.9, 140.5, 136.4, 135.9, 133.7, 129.9, 128.9, 127.9, 126.1, 123.2, 72.6, 63.9, 41.6, 
34.6, 34.3, 31.4, 27.2, 26.5, 21.3, 19.4 ppm; HRMS-CI calcd for C34H44O2SiCl (M+Cl)-: 
547.2797, found 547.2799. 
 
(Z)-5-(tert-butyldiphenylsilyloxy)-2-ethyl-1-p-
tolylpent-2-en-1-ol (1-53).  A dry 10 mL Schlenk 
flask, which was evacuated under vacuum and backfilled with N2 (g) three times, was 
charged with (4-bromobut-3-ynyloxy)(tert-butyl)diphenylsilane (128.13 mg, 0.33 mmol) 
and toluene (1 mL) under a nitrogen atmosphere.  The solution was cooled to 0 ºC 
followed by slow addition of diethylborane (0.33 mL, 1.0 M in toluene, 0.33 mmol).  The 
reaction was stirred for 5 min, warmed to room temperature, and stirred for 15 min.  The 
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solution was cooled to –78 °C and diisopropylzinc (1 mL, 1.0 M in toluene 1 mmol) was 
added.  After stirring for 20 min, the reaction flask was warmed to 0 ºC.  Under a steady 
flow of N2 (g), the rubber septum was replaced with a glass stopper coated with silicon 
grease and high vacuum was gradually applied to remove the volatile contents.  The 
resulting vinylzinc reagent was redissolved in toluene (1 mL) followed by addition of p-
tolualdehyde (0.22 mmol).  The reaction mixture was gradually warmed to ambient 
temperature and stirred until no aldehyde remained by TLC (usually 7-16 hrs).  It was 
quenched with saturated aq. NH4Cl (2 ml), followed by the addition of 2 N HCl (1 mL) 
and 5 mL of EtOAc.  The organic layer was separated and the aqueous layer was 
extracted successively with EtOAc (2 × 10 mL).  The combined organic layers were 
successively washed with saturated NaHCO3 and brine, dried over MgSO4, and filtered.  
The filtrate was concentrated in vacuo and the residue was purified by column 
chromatography on silica gel to yield a mixture of 1-53 (48 mg, 47.5%) and (Z)-5-(tert-
butyldiphenylsilyloxy)-2-isopropyl-1-p-tolylpent-2-en-1-ol (1-54) (10.0 mg, 9.6%) in a 
5:1 ratio, respectively.  1H NMR (CDCl3, 500 MHz): δ 7.72 (d, J = 7.8 Hz, 4H), 7.44 (m, 
6H), 7.26 (d, J = 7.9 Hz, 2H), 7.14 (d, J = 7.9 Hz, 2H), 5.63 (d, J = 3.0 Hz, 1H), 5.42 (t, 
J =7. 6 Hz, 1H), 3.74 (t, J = 6.4 Hz, 2H), 2.6 (m, 1H), 2.51 (m, 1H), 2.37 (s, 3H), 2.30 (d, 
J = 3.5 Hz, 1H), 2.10 (m, 1H), 1.87 (m, 1H), 1.10 (s, 9H), 0.99 (t, J = 7.4 Hz, 3H) ppm; 
13C{1H} NMR (CDCl3, 125 MHz): δ 144.9, 140.0, 136.6, 133.8, 129.9, 129.0, 127.9, 
126.7, 126.0, 122.8, 72.1, 64.0, 31.2, 27.1, 24.6, 21.3, 19.4, 13.0 ppm. 
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(Z)-2-(3-(tert-butyldiphenylsilyloxy)propylidene)-
1-p-tolylhexan-1-ol (1-55).  A dry 10 mL Schlenk 
flask, which was evacuated under vacuum and 
backfilled with N2 (g) three times, was charged with (4-bromobut-3-ynyloxy)(tert-
butyl)diphenylsilane (386.4 mg, 1 mmol) and toluene (1 mL) under a nitrogen 
atmosphere.  The solution was cooled to 0 ºC followed by slow addition of diethylborane 
(1 mL, 1.0 M in toluene, 1 mmol).  The reaction was stirred for 5 min, warmed to room 
temperature, and stirred for 15 min.  The solution was cooled to  –78 °C and dibutylzinc 
(3 mL, 1.0 M in heptane, 3 mmol) was added.  After stirring for 20 min, the reaction flask 
was warmed to 0 ºC.  Under a steady flow of N2 (g), the rubber septum was replaced with 
a glass stopper coated with silicon grease and high vacuum was gradually applied to 
remove the volatile contents.  The resulting vinylzinc reagent was redissolved in toluene 
(1 mL) followed by addition of p-tolualdehyde (0.67 mmol).  The reaction mixture was 
gradually warmed to ambient temperature and stirred until no aldehyde remained by TLC 
(usually 7-16 hrs).  It was quenched with saturated aq. NH4Cl (2 ml), followed by the 
addition of 2 N HCl (1 mL) and 5 mL of EtOAc.  The organic layer was separated and 
the aqueous layer was extracted successively with EtOAc (2 × 10 mL).  The combined 
organic layers were successively washed with saturated NaHCO3 and brine, dried over 
MgSO4, and filtered.  The filtrate was concentrated in vacuo and the residue was purified 
by column chromatography on silica gel to yield a mixture of 1-55 (55 mg, 15.7%) and 1-
53 (205 mg, 62%) in a 1:4 ratio, respectively.  1H NMR (CDCl3, 500 MHz): δ 7.71 (d, J 
= 7.6 Hz, 4H), 7.42 (m, 6H), 7.26 (d, J = 7.8 Hz, 2H), 7.10 (d, J = 7.8 Hz, 2H), 5.59 (d, J 
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= 2.7 Hz, 1H), 5.42 (t, J = 7.4 Hz, 1H), 3.73 (t, J = 6.2 Hz, 2H), 2.59 (m, 1H), 2.49 (m, 
1H), 2.36 (s, 3H), 2.29 (d, 3.5 Hz, 1H), 2.03 (m, 1H), 1.88 (m, 1H), 1.29 (m, 4H), 1.09 (s, 
9H), 0.86 (t, J = 7.1 Hz, 3H); 13C{1H} NMR (CDCl3, 125 MHz): δ 143.6, 140.0, 136.6, 
135.9, 133.8, 129.9, 129.0, 127.9, 126.0, 123.9, 72.2, 64.0, 31.9, 31.3, 31.2, 27.1, 22.9, 
21.3, 19.4, 14.2. 
 
(Z)-5-(tert-butyldiphenylsilyloxy)-2-methyl-1-p-
tolylpent-2-en-1-ol (1-52).  A dry 10 mL Schlenk 
flask, which was evacuated under vacuum and backfilled with N2 (g) three times, was 
charged with (4-bromobut-3-ynyloxy)(tert-butyl)diphenylsilane (386.4 mg, 1 mmol) and 
toluene (1 mL) under a nitrogen atmosphere.  The solution was cooled to 0 ºC followed 
by slow addition of diethylborane (1 mL, 1.0 M in toluene, 1 mmol).  The reaction was 
stirred for 5 min, warmed to room temperature, and stirred for 15 min.  The solution was 
cooled to  –78 °C and dimethylzinc (3 mL, 1.0 M, in toluene, 3 mmol) was added.  After 
stirring for 20 min, the reaction flask was warmed to 0 ºC.  Under a steady flow of N2 (g), 
the rubber septum was replaced with a glass stopper coated with silicon grease and high 
vacuum was gradually applied to remove the volatile contents.  The resulting vinylzinc 
reagent was redissolved in toluene (1 mL) followed by addition of p-tolualdehyde (0.67 
mmol).  The reaction mixture was gradually warmed to ambient temperature and stirred 
until no aldehyde remained by TLC (usually 7-16 hrs).  It was quenched by saturated aq. 
NH4Cl (2 mL), followed by the addition of 2 N HCl (1 mL) and 5 mL of EtOAc.  The 
organic layer was separated and the aqueous layer was extracted successively with 
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EtOAc (2 × 10 mL).  The combined organic layers were successively washed with 
saturated NaHCO3 and brine, dried over MgSO4, and filtered.  The filtrate was 
concentrated in vacuo and the residue was purified by column chromatography on silica 
gel to yield a mixture of 1-52 (67.6 mg, 23%) and 1-53 (172.2 mg, 56.7%) in a 1:2.5 
ratio, respectively.  1H NMR (CDCl3, 500 MHz): δ 7.75 (d, J = 7.1 Hz, 4H), 7.45 (m, 
6H), 7.25 (d, J = 7.9 Hz, 2H), 7.15 (d, J = 7.8 Hz, 2H), 5.62 (s, 1H), 5.40 (t, J = 7.4 Hz, 
1H), 3.76 (m, 2H), 2.55 (dt, J = 6.7 Hz, 6.4 Hz, 2H), 2.37 (s, 3H), 2.08 (d, J = 3.1 Hz, 
1H), 1.62 (s, 3 H), 1.12 (s, 9H) ppm; 13C{1H} NMR (CDCl3, 125 MHz): δ 139.6, 139.1, 
136.6, 135.8, 133.9, 129.9, 129.1, 127.9, 125.9, 124.7, 71.5, 64.0, 31.3, 27.1, 21.3, 19.4, 
18.5 ppm; HRMS-CI calcd for C29H36O2SiCl (M+Cl+): 479.2195, found 479.2189.   
 
1.6.7.2. Protonolysis of Intermediates in the Generation of Trisubstituted 
Vinylzinc Species (Scheme 1-26). 
 
(E)-tert-butyl(hex-3-enyloxy)diphenylsilane (1-58). A dry 10 
mL Schlenk flask, which was evacuated under vacuum and 
backfilled with N2 (g) three times, was charged with (4-bromobut-3-ynyloxy)(tert-
butyl)diphenylsilane (386.4 mg, 1 mmol) and toluene (1 mL) under a nitrogen 
atmosphere.  The solution was cooled to 0 ºC followed by slow addition of diethylborane 
(1mL, 1.0 M in toluene, 1 mmol).  The reaction was stirred for 5 min, warmed to room 
temperature, and stirred for 15 min.  The solution was cooled to –78 ºC and dimethylzinc 
(3 mL, 1.0 M, in toluene, 3 mmol) was added.  After stirring for 20 min, the reaction was 
quenched with MeOH.  Warming to ambient temperature, saturated aq. NH4Cl (2 ml) was 
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added and 5 mL of EtOAc.  The organic layer was separated and the aqueous layer was 
extracted successively with EtOAc (2 x 10 mL).  The combined organic layers were 
successively washed with saturated NaHCO3 and brine, dried over MgSO4, and filtered.  
The filtrate was concentrated in vacuo and the residue was purified by column 
chromatography on silica gel to yield a mixture of 1-58 and (E)-tert-butyl(pent-3-
enyloxy)diphenylsilane (1-57) in a 1:2.7 ratio, respectively.  For comparison, (E)-tert-
butyl(hex-3-enyloxy)diphenylsilane was also prepared using the same procedure and 
diethylzinc in the place of dimethylzinc.  1H NMR (CDCl3, 500 MHz): δ 7.70 (d, J = 6.5 
Hz, 4H), 7.41 (m, 6H), 5.52 (dt, J = 15.3, 6.1 Hz, 1H), 5.41 (dt, J = 15.3, 6.7 Hz, 1H), 
3.70 (t, J = 6.7 Hz, 2H), 2.28 (dt, J = 6.5, 6.7 Hz, 2H), 2.02 (dq, J = 6.5, 7.0 Hz, 2H), 
1.08 (s, 9H), 0.98 (t, J = 7.4 Hz, 3H); 13C{1H} NMR (CDCl3, 125 MHz): δ 135.8, 134.4, 
134.3, 129.7, 127.8, 125.7, 64.3, 36.2, 27.1, 25.9, 19.5, 14.0 ppm. 
 
(E)-tert-butyl(pent-3-enyloxy)diphenylsilane (1-57). For 
comparison the title compound was synthesized separately.  A 
dry 10 mL Schlenk flask, which was evacuated under vacuum and backfilled with N2 (g) 
three times, was charged with bromoalkyne (1 mmol) and toluene (1 mL) under a 
nitrogen atmosphere. The solution was cooled to 0 ºC followed by slow addition of either 
Br2BH•SMe2 (166 µL, 1 mmol). The reaction was stirred for 5 min, warmed to room 
temperature, and stirred for 15 min. The solution was cooled to −78 ºC and Me2Zn (2.25 
mL, 2.0 M in PhMe) was added.  After stirring at this temperature for 20 min, the 
reaction flask was warmed to 0 ºC.  Under a steady flow of N2 (g), the rubber septum was 
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replaced with a glass stopper coated with silicon grease and high vacuum was gradually 
applied to remove the volatile contents. The resulting vinylzinc reagent was redissolved 
in toluene (1 mL) followed by addition of p-tolualdehyde (78.5 µL, 0.67 mmol). The 
reaction mixture was gradually warmed to ambient temperature and stirred until no 
aldehyde remained by TLC (usually ~16 hrs).  Quenching by saturated aq. NH4Cl (2 ml), 
followed by addition of 2 N HCl (1 mL) and 5 mL of EtOAc. The organic layer was 
separated and the aqueous layer was extracted successively with EtOAc (2 × 10 mL). The 
combined organic layers were washed with saturated NaHCO3 followed by saturated 
NaCl, dried over MgSO4, and filtered.  The filtrate was concentrated in vacuo, and the 
residue was purified by column chromatography on silica gel to yield 1-57.  1H NMR 
(CDCl3, 500 MHz): δ 7.69 (d, J = 7.8 Hz, 4H), 7.41 (m, 6H), 5.45 (m, 2H), 3.69 (t, J = 
6.8 Hz, 2H), 2.27 (dt, J = 6.6, 6.3 Hz, 2H), 1.66 (d, 5.4 Hz, 3H), 1.07 (s, 9H) ppm; 
13C{1H} NMR (CDCl3, 125 MHz): 135.8, 134.3, 129.7, 127.9, 127.8, 127.2, 64.2, 36.2, 
27.1, 19.4, 18.2 ppm. 
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2.1. Introduction 
 
Enantioenriched diaryl-, aryl heteroaryl-, and diheteroarylmethanols are important 
intermediates and structural motifs in medicinal chemistry.  Diarylmethanols form the 
core of several biologically active compounds, including (R)-neobenodine, (R)-
orphenadrine and (S)-cetrizine.1-6  The 1-benzofuran derivatives 2-1a-c are intermediates 
in the synthesis of chiral azoles (2-2a-c, Figure 2-1).  Compounds 2-2a-c were initially 
examined as antifungal agents7 and have been found to be powerful nonsteroidal 
aromatase inhibitors.8-13  They are indicated in the treatment of hormone-dependent breast 
cancer.14  Likewise, diheteroarylmethanols have received recent attention.  For example, 
chiral dithienylmethanols have been evaluated as antiallergic and antiischemic agents (2-
3, Figure 2-1).15  Furthermore, enantioenriched diarylmethanols can be converted into 
diarylmethane derivatives via SN2 substitution at the C-O bond without loss of ee.1  The 
diarylmethane motif is found in antimuscarinics,16 antidepressants,17 and endothelin 
antagonists.18 
 
 
Figure 2-1. Biologically active heteroaryl- and diheteroarylmethanols. 
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The catalytic enantioselective synthesis of diarylmethanols has been the focus of many 
studies.19  The most efficient approach to their preparation is the arylation of aromatic 
aldehydes to generate a C-C bond and stereocenter in a single step.  Early studies by 
Seebach and coworkers employed Ph-Ti(O-iPr)3, generated from Cl-Ti(O-iPr)3 and PhLi, 
in combination with TADDOL-based titanium catalysts.20-22  To achieve high 
enantioselectivity, it was necessary to remove the LiCl byproduct formed during salt 
metathesis by centrifugation. 
Pioneering studies by Fu and coworkers23 with a planar-chiral catalyst, diphenylzinc, 
and 4-chlorobenzaldehyde furnished the diarylmethanol product with 57% ee.  A highly 
enantioselective catalyst was reported by Pu shortly thereafter.24  
 
Scheme 2-1. Asymmetric Arylation of 4-Chlorobenzaldehyde with Ph2Zn (A) and 
PhZnEt Generated from Ph2Zn and Et2Zn (B) or from PhB(OH)2 and Et2Zn (C). 
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These works inspired many subsequent investigations using diphenylzinc, as 
exemplified in Scheme 2-1A.25-30 
Despite the large number of studies with diphenylzinc, significant drawbacks remained.  
Diphenylzinc is prohibitively expensive and limited to phenyl transfer.25,31-34  
Furthermore, unlike dialkylzinc additions to aldehydes, which exhibit slow background 
reactions, the uncatalyzed addition of diphenylzinc to aldehydes is sufficiently rapid to 
compete with most catalyzed additions.34-36  The latter problem was addressed by Bolm 
and coworkers, who discovered that the mixed reagent EtZnPh33 exhibited a slower 
background reaction than diphenylzinc. EtZnPh also resulted in higher 
enantioselectivities with the same catalysts (Scheme 2-1B), in part from the reduced 
contribution of the background reaction.37-42  EtZnPh is easily generated by combining 
Ph2Zn and Et2Zn (Equation 2-1). 
 
 
 Equation 2-1 
 
The development of methods for the enantioselective transfer of substituted aryl groups 
to aldehydes remained a challenge for several years.  Although diarylzinc reagents can be 
easily prepared from ArLi or ArMgX and zinc halides (ZnX2), the salt byproducts LiX 
and MgX2 are Lewis acidic and readily promote the background reaction in the presence 
of enantioenriched catalysts, resulting in diarylmethanols with little or no ee.  To bypass 
this problem, Bolm and coworkers introduced a method whereby arylboronic acid 
derivatives underwent transmetallation with dialkylzinc reagents to provide access to salt-
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free arylzinc reagents, ArZnEt (Scheme 2-1C).30,42-48  In this procedure,44 2.4 equiv of the 
aryl boronic acid was heated with 7.2 equiv of diethylzinc for 12 h to generate ArZnEt.  
Dimethyl (polyethylene glycol) (DiMPEG, 10 mol %, MW~2,000) was used as an 
additive to inhibit the background reaction caused by achiral Lewis acidic ZnPh2 or 
ZnBr2.43,49,50  Further study and optimization by the groups of Pericàs and Magnus 
significantly reduced the transmetallation time.51,52  Braga demonstrated that the 
acceleration could be achieved by microwave irradiation.53  Based on Bolm’s 
breakthrough, several arylboron derivatives, such as triarylboranes42,43,50,54-57 and 
boroxines,52,58,59 were successfully employed in the asymmetric arylation of aldehydes. 
Highly enantioselective late transition metal-based catalysts can also be employed with 
boronic acid derivatives.60-62 
Main group metals other than zinc have been applied to the asymmetric arylation of 
aldehydes.  In 2008 Muramatsu and Harada63 introduced a method wherein Grignard 
reagents (1.2 equiv) could be added to titanium tetraisopropoxide (3 equiv) in the 
presence of 2 mol % 3-(3,5-Ph2-C6H3)-H8-BINOL and aldehydes to provide 
diarylmethanols with high ee.  In a similar vein, Gau and coworkers employed salt-free 
Ar3Al•THF reagents in combination with titanium tetraisopropoxide and either H8-
BINOL64 or sulfonamide alcohol-based ligands,65 which led to diarylmethanols with high 
enantioselectivities.  These reactions may proceed via an Ar-Ti intermediate.66 
At the outset of our research into the arylation of aldehydes in 2005, two major 
limitations existed.  The first was the necessity for salt-free arylzinc reagents.  The 
second was the use of costly aryl sources such as Ph2Zn and arylboronic acids, which are 
synthesized from aryl halides.  To address these problems, we deemed the following 
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criteria essential to a practical, cost effective and scalable protocol: 1) to use readily 
available aryl bromides, and 2) to avoid filtration or centrifugation20-22,43,67 of metal halide 
byproducts from the aryl organometallic reagent.  Herein we report the full details of the 
successful development of a method that fulfills these criteria.68  Thus, metallation of an 
aryl bromide with n-BuLi, transmetallation to zinc, and enantioselective addition to 
aldehydes in the presence of the MIB-based69,70 catalyst can now be performed in a one-
pot procedure (Equation 2-2).68  To circumvent the need for tedious sublimation, 
filtration, or centrifugation of the intermediate arylzinc reagents, we introduced a method 
to sequester the LiCl byproduct, enabling the generation of diarylmethanols with high 
levels of enantioselectivity in the presence of lithium chloride.  Unfortunately, this 
procedure was unsuccessful when applied to the generation of enantioenriched 
diheteroarylmethanols.  Therefore, an alternative procedure for heteroaryl additions to 
aldehydes was developed.  To our knowledge, these studies represent the first highly 
enantioselective catalytic asymmetric synthesis of enantioenriched 
diheteroarylmethanols. 
 
 
Equation 2-2 
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2.2. Prior Work in the Walsh Group 
 
The ultimate goal of these investigations was to develop a practical method for the 
addition of aryl and heteroaryl groups to aldehydes using readily available aryl and 
heteroaryl bromides.  Asymmetric additions with commercial diphenylzinc were used to 
evaluate catalyst enantioselectivity and for comparison with reactions using 
bromobenzene. 
 
2.2.1. Phenylation with Ph2Zn and MIB. 
 
Our first priority was to determine the enantioselectivity of the (–)-MIB-based catalyst 
in phenyl additions to aldehydes.  The substrate selected for these studies conducted by 
Dr. Jeung Gon Kim was 2-naphthaldehyde (Table 2-1), which was used with commercial 
ZnPh2 and 5 mol % (–)-MIB.   
 
Table 2-1. Solvent Screen in the Asymmetric Phenyl Addition to 2-Naphthaldehyde. 
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The phenyl addition proceeded with 94% ee in toluene and 60% ee in diethyl ether 
(entries 1 and 2).  Diethyl ether most likely binds to the MIB-based zinc catalyst, 
reducing its activity and, therefore, enantioselectivity.  When less coordinating tert-butyl 
methyl ether (TBME) was used, the diarylmethanol was obtained with 88% ee (entry 3).  
In the mixed solvent composed of 1:3 TBME:hexanes, 89% ee was observed at room 
temperature (entry 4) and 92% ee at 0 ºC (entry 5).  Of the solvents examined, only 
TBME was suitable for the salt metathesis of PhLi with ZnCl2. 
To evaluate the possibility of beginning with aryl bromides, we next generated ZnPh2 
by metallation of 4.5 equiv PhBr with 4 equiv n-BuLi in TBME followed by 
transmetallation with 2 equiv ZnCl2.  After addition of hexanes to precipitate additional 
LiCl, the in situ-generated Ph2Zn solution was used in place of the commercial Ph2Zn 
under otherwise identical conditions (Table 2-1, entry 6).  The expected alcohol product 
was isolated, but withs only 2% ee.  We hypothesized that the Lewis acidic LiCl, 
generated en route to ZnPh2, promoted the addition to form the racemate faster than the 
amino alcohol-based Lewis acid catalyst promoted the asymmetric addition.  Other 
researchers have had varying degrees of success employing either filtration or 
centrifugation of LiCl and MgX2 byproducts.20-22,33,67 These salt byproducts are often 
produced as a fine particulate and are difficult to remove.  Although these procedures are 
useful on laboratory scale, filtration or centrifugation of highly air-sensitive materials is 
less practical on large scale.  To overcome this problem, our strategy was to inhibit the 
LiCl byproduct rather than remove it.  A similar approach was devised by Bolm and 
coworkers involving the addition of Ph2Zn to aldehydes.  These researchers observed a 
beneficial effect of dimethoxypoly(ethylene glycol) (DiMPEG) on the catalyst 
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enantioselectivity43,50 and proposed that DiMPEG suppressed reactions catalyzed by trace 
achiral Lewis acids, including ZnBr2 and LiBr, allowing the arylation reaction to proceed 
via the ligand-accelerated71 pathway.19  Although selectivities reached 93% ee, yields 
ranged from 8-31% when Ph2Zn was generated from PhLi and ZnBr2.43  Furthermore, we 
had difficulties with reproducibility using DiMPEG in combination with the MIB-based 
catalyst for enantioselective vinylation of aldehydes.72,73 
 
2.2.2. Development of a Lithium Chloride Selective Inhibitor. 
 
The lack of enantioselectivity with Ph2Zn generated from PhBr in Table 2-1 (entry 6) 
suggested that the achiral LiCl is a more active Lewis acid than the (–)-MIB-based zinc 
catalyst.  There are three important differences between the lithium and zinc Lewis acids: 
1) the lithium is more electropositive and probably the stronger Lewis acid, 2) the lithium 
center is less sterically saturated than the zinc center in the MIB-based catalyst and 3) the 
lithium chloride has at least two available coordination sites while the MIB-based zinc 
catalyst has only one accessible site.  Based on this analysis, our strategy was to employ 
bidentate inhibitors that would chelate lithium and bind tightly, but coordinate in a 
monodentate fashion to the chiral zinc catalyst.  Support for this approach was gained 
through structures of [TMEDA•LiCl]n, which contain four-coordinate lithium centers 
with bridging chlorides.74,75 
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On the basis of this proposal, multidentate amines were screened by Dr. Jeung Gon 
Kim as LiCl inhibitors in the catalytic enantioselective phenylation of 2-naphthaldehyde 
with in situ prepared ZnPh2 (Table 2-2). 
 
Table 2-2. Examination of Possible LiCl Inhibitors. 
 
N,N,N’,N’-Tetraethylethylenediamine (TEEDA) was first examined, because the amino 
groups are slightly more hindered than the tetramethyl analog TMEDA.  Use of 0.2 equiv 
TEEDA resulted in an improvement from 2% ee in the absence of diamine to 55% ee 
(Table 2-2, entries 1 and 2).  Increasing the amount of TEEDA from 0.2–0.8 and 1.0 
equiv resulted in product enantioselecitvity of up to 83% ee.  A further increase in 
TEEDA to 1.2 equiv, however, resulted in a slower reaction and a decrease in the product 
ee to 77%, probably due to inhibition of the MIB-based zinc catalyst by the diamine.  It 
 108 
was found that addition of 5 equiv toluene (or hexanes) relative to TBME after 
transmetallation led to higher enantioselectivity (up to 89% ee, entry 7).  When the 
temperature of the addition was lowered from rt (entry 7) to 0 °C (entry 8) the 
enantioselectivity increased to 92% ee.  It is noteworthy that the same enantioselectivity 
was obtained with commercial Ph2Zn in Table 2-1 (entry 5), indicating that TEEDA is an 
excellent inhibitor of LiCl.  For comparison, TMEDA was examined in Table 2-2 (entries 
9 and 10) and found to be nearly as effective as TEEDA.  Pentamethyldiethylenetriamine 
inhibited LiCl at lower concentrations (0.2 equiv, 80% product ee, entry 12). 
 
2.2.3. Generation and Application of Mixed Aryl Alkyl Zinc Reagents 
 
As outlined in the Introduction 2.1, the background reaction of diarylzinc reagents with 
aldehydes is often competitive with, or faster than the ligand accelerated pathway71 with 
amino alcohol-based catalysts.  On the basis of the successful application of mixed aryl 
alkyl zinc reagents by Bolm and co-workers,33 we desired to develop an in situ route to 
these species to increase enantioselectivities in the aldehyde arylations.  To determine the 
benefit of the mixed organozinc reagents with MIB, our initial experiments involved 
conproportionation of a 1:1 ratio of commercial Ph2Zn and Et2Zn to generate PhZnEt 
(Equation 2-1) followed by addition of (–)-MIB and 2-naphthaldehyde at 0 ºC.  Under 
these conditions, the enantioselectivity increased from 92% ee with Ph2Zn (entry 5, Table 
2-1 and entry 8, Table 2-2) to 97% ee with the mixed PhZnEt (Table 2-3, entry 1). 
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To prepare the mixed aryl alkyl zinc reagents in situ we choose to avoid the use of 
dialkylzinc reagents, focusing on the more readily available alkyllithiums.  Thus, 
metallation of PhBr with n-BuLi (2 equiv each) and addition of 2.1 equiv ZnCl2 resulted 
in the generation of PhZnCl.  A second dose of n-BuLi (2 equiv) was then added to 
produce PhZnBu, which was used in combination with 0.8 equiv TEEDA in the 
asymmetric addition reaction (Table 2-3, entry 2).  Gratifyingly, the enantioselectivity 
with the in situ generated PhZnBu (97%) was equal to the salt-free PhZnEt, despite the 4 
equiv of LiCl in the reaction vessel.  
To determine the generality of this method, Dr. Jeung Gon Kim emplyed a series of 
aryl bromides and aldehydes (Table 2-3).  Bromobenzene and 4-substituted aryl bromides 
bearing OMe, F and Cl were used in the arylation of benzaldehyde derivatives with 93–
97% enantioselectivity.  2-Bromotoluene and 2-bromonaphthalene were added to 
benzaldehydes with ≥93% ee.  Aryl additions to α,β-unsaturated aldehydes occurred with 
81–90% ee (entries 3, 4, 8, 11, 12, 14 and 15).  The aliphatic substrate, 
cyclohexanecarboxaldehyde, underwent aryl addition with 78–82% ee (entries 9 and 18).  
The examples in Table 2-3 are the first examples of aldehyde arylation beginning with 
aryl bromides.68 
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Table 2-3. Catalytic Asymmetric Aryl Additions to Aldehydes with ArZnBu Generated 
from Aryl Bromides 
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Subsequent to our initial communication,68 a related report appeared by Pu76 employing 
aryl iodides, and two examples were reported by Harada.63,77  Woodward also developed a 
method using arylzinc halides in combination with trimethylaluminum based on the 
Schlenk equilibrium.78 
 
2.2.4. Formal Synthesis of (S)-BMS 184394. 
 
One example of a biologically active diarylmethanol is BMS 184394 (2-24, Scheme 
2-2), an RAR γ selective retinoid with activity against skin diseases and cancers, in 
particular breast cancer and acute promyelocytic leukemia.79-81  It was found that the (S)-
enantiomer is significantly more potent than the (R)-enantiomer.80  The enantioselective 
route to this drug candidate employed two sequential enzymatic kinetic resolutions that 
required 2 and 3.5 days (43% yield and 95% ee).80  Asymmetric reduction of the requisite 
diaryl ketone would likely be challenging due to the similar environments of the carbonyl 
lone pairs.82-84  
Using conditions outlined in Table 2-3 Dr. Jeung Gon Kim performed the synthesis of 
BMS 184394.  3.0 Equiv of aryl bromide 2-22 (Scheme 2-2) was employed to generate 
the mixed aryl butyl zinc reagent.  TEEDA (1.5 equiv) and hexanes were added followed 
by (+)-MIB (5 mol %) and aldehyde 2-21.  The addition product 2-23 was produced with 
87% ee in 88% yield (Scheme 2-2).  Conversion to (S)-BMS 184394 can be 
accomplished by saponification of the ester.80 
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Scheme 2-2. Synthesis of Enantioenriched 2-23, the Key Intermediate in the Synthesis 
of (S)-BMS 184394.   
 
2.3. Results and Discussion 
 
2.3.1. Attempted Heteroaryl Additions to Aldehydes. 
 
General, highly enantioselective additions of heteroaryl groups to aldehydes have not 
been developed.  To our knowledge, the only examples of highly enantioselective 
heteroaryl additions were published in 2008 by Gau and involved the addition of 2-furyl 
aluminum reagents to ketones.85  Heteroaryl groups are among the most important 
pharmacophores in medicinal chemistry and diheteroarylmethanols have been identified 
as biologically active structural motifs.15  Thus, not only would methods for heteroaryl 
additions to aldehydes increase the classes of enantioenriched diarylmethanols accessible, 
it would enable the catalytic asymmetric synthesis of diheteroarylmethanols that are 
currently not directly accessible. 
With the goal of introducing asymmetric heteroaryl additions to aldehydes, we applied 
our arylation procedure to metallation of 3-bromothiophene followed by addition to 
 113 
benzaldehyde.  The only modification was to maintain the temperature of the 
heteroaryllithium at –78 °C.  Unfortunately, no addition product was observed.  When the 
aryl bromides were used under the conditions outlined in Table 2-3, the salt metathesis 
was conducted at room temperature for 4.5 h.68  At this temperature the (3-thienyl)Li 
readily decomposes. 
We hypothesized that the absence of product was due to decomposition of the 
heteroaryllithium in the transmetallation step, which was complicated by the limited 
solubility of ZnCl2 in TBME at low temperature.  To address this problem, we envisaged 
a more soluble zinc source might undergo transmetallation at lower temperature.  Our 
choice of EtZnCl was based on the large reactivity difference of sp2 hybridized Zn-C 
bonds over their sp3 counterparts.  Another advantage of EtZnCl is that only a single 
equivalent of LiCl forms during the metathesis, whereas ZnCl2 produces two equivalents 
(Scheme 2-3).  Lower levels of salt byproduct facilitate inhibition of the LiCl-promoted 
background reaction. 
 
 
Scheme 2-3. Metathesis with EtZnCl for the Aryl and Heteroaryl Additions to 
Aldehydes. 
 
The synthesis of EtZnCl was initially performed following the method of Woodward 
and coworkers by combination of ZnCl2 and ZnEt2 in THF followed by removal of the 
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solvent under reduced pressure.86  Using EtZnCl prepared in this manner, the 
transmetallation proceeded at –78 °C and the desired heteroaryl addition products were 
obtained.  Unfortunately, product yields and ee’s varied greatly from run to run.  Our 
unsuccessful attempts to develop asymmetric heteroaryl additions convinced us to first 
focus on development of a low temperature transmetallation and then revisit 
enantioselective heteroaryl additions. 
 
2.3.2. Development of Low Temperature Transmetallation Conditions and 
Synthesis of Biologically Active 2-2a. 
 
Momentarily stepping away from the more challenging enantioenriched 
diheteroarylmethanols, we concentrated on developing low temperature conditions for 
lithium to zinc transmetallations.  We attributed the inconsistencies in the previously 
described heteroaryl additions to the presence of residual zinc-bound THF in the EtZnCl, 
which was observed by 1H NMR spectroscopy.86  THF is known to inhibit the MIB-based 
zinc Lewis acid catalyst.  On the basis of this hypothesis, an alternative synthesis of 
EtZnCl was pursued.87-89  Using toluene in place of THF required heating ZnEt2 and 
sparingly soluble ZnCl2 at 60 °C for 72 h, after which the solution was filtered to remove 
any unreacted ZnCl2.  The volatiles were then removed under reduced pressure to afford 
EtZnCl as a white solid that could be stored under nitrogen for months. 
The THF-free EtZnCl was first employed with bromobenzene (Equation 2-3).  The 
transmetallation was conducted at –78 °C to generate PhZnEt, and the addition to 2-
benzofurancarbaldehyde was performed at 0 °C.  After 12 h, the reaction mixture was 
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quenched with water, worked up, and purified on deactivated silica.  We were pleased to 
isolate the desired addition product 2-1a in 92% yield with 90% ee (Equation 2-3).  
Compound 2-1a was converted to the promising breast cancer treatment candidate 2-2a 
(Figure 2-1) without loss of ee in 41% unoptimized yield (84% based on recovered 2-1a 
of 90% ee) via a Mitsunobu reaction with imidazole.90SN2 substitutions of this type are 
known to be very difficult.1  Alternative methods for this transformation also appear 
potentially useful.92-95 
Recently promising diarylmethanes have been examined as possible inhibitors and 
receptor agonist candidates, but due to limited methods to synthesize the diarylmethanols 
enantioselectively, most of the studies employed racemic material.11,96,97 Synthesis of 2-1a 
with 90% ee suggests that this procedure can be used to prepare diarylmethanols and their 
derivatives with high ee. 
 
Equation 2-3 
 
2.3.3. Enantioselective Addition of Heteroaryl Groups to Aldehydes. 
 
The heteroaryl addition was attempted with 3-bromothiophene under the conditions 
employed with bromobenzene to generate 2-1a in Equation 2-3.  Thus, after metallation 
of 3-bromothiophene with n-BuLi, transmetallation was performed at –78 °C with THF-
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free EtZnCl.  The resulting solution was then warmed to 0 °C and TEEDA, (–)-MIB, and 
benzaldehyde were added (Table 2-4).  After stirring 12 h, followed by workup and 
purification, we were pleased to isolate the desired heteroaryl addition product in 68% 
yield with 90% ee (Table 2-4, entry 1).  These revised conditions led to reproducible 
product ee’s and yields. 
To explore the enantioselective synthesis of diheteroarylmethanols, the optimized 
conditions for addition of (3-thienyl)ZnEt to benzaldehyde were employed with 
heteroaromatic aldehydes.  Thus, addition to 5-methyl-2-furan carboxaldehyde, 2-
thiophenecarboxaldehyde and 3-benzofurancarboxaldehyde occurred with 92–94% 
enantioselectivity in 60–83% yield (Table 2-4, entries 2–4).  The differences in yields in 
entries 1–4 probably arise from a combination of the instability of the heteroaryl 
organometallic reagents and diminished electrophilicity of the heteroaromatic aldehydes.  
To develop practical and useful methods, scalability must be demonstrated.  Thus, for the 
synthesis of 2-27, precursor to potential drug candidate 2-3 (Figure 2-1), the asymmetric 
addition was scaled to produce 820 mg (83% yield and 93% ee, entry 3). 
Other heterocycles such as 3-bromobenzothiophene can also be used in the addition 
with very good enantioselectivities (81–88% ee, entries 5–7).  Employing 2-
bromothiophene and benzaldehyde afforded diarylmethanol in 90% ee and 57% yield 
(entry 8).  In a similar fashion 3-furanyl ethyl zinc can be added to benzaldehyde (93% 
ee, 86% yield, entry 9) and heteroaromatic aldehydes with excellent enantioselectivities 
(89–99% ee, entries 11–13). 5-Methyl-2-furan carboxaldehyde gave addition product of 
80% ee (entry 10).  Attempts to add 2-furanylzinc reagents to aldehydes, however, 
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resulted in poor enantioselectivities, probably due to the presence of the coordinating 
oxygen in close proximity to zinc. 
Table 2-4. Synthesis of Aryl Heteroaryl- and Diheteroarylmethanols using 5 mol % 
(–)-MIB (unless noted below). 
 
 
To determine if our method for addition of heteroaromatic groups to aldehydes could 
be extended to other catalysts, we examined the use of Chan’s ligand (L2, Figure 2-2)48,98 
with 3-bromothiophene and benzaldehyde under the conditions listed in Table 2-4, which 
led to product of 90% ee and 70% yield.  These results are virtually identical to those in 
entry 1 (Table 2-4) with MIB, indicating that our strategy employing TEEDA to inhibit 
LiCl is applicable to other amino alcohol-based catalysts. 
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Figure 2-2. Structure of Chan’s ligand (L2). 
 
2.3.4. Synthesis of Indole Methanols 
 
Indoles are regarded as privileged structures in medicinal chemistry and are 
substructures of an enormous variety of natural products.99,100  We therefore turned our 
attention toward the synthesis of enantioenriched diarylmethanols containing the indole 
motif.  Metallation of N-silyl-protected 4-bromoindole with n-BuLi was unsuccessful 
under a variety of conditions, including those in Table 2-4, most likely due to the electron 
rich nature of the heterocyclic π-system.  More challenging metal-halogen exchange 
reactions are generally performed with two equiv t-BuLi.101  In these reactions, the first 
equiv undergoes the metal-halogen exchange with the aryl bromide generating t-BuBr 
and the second drives the equilibrium by promoting elimination of the liberated t-BuBr to 
produce isobutylene and LiBr.  Unfortunately, diamines that inhibit LiCl had little impact 
when LiBr was formed.  Although we do not understand the intimate differences between 
LiCl and LiBr at this time, we speculate that weaker bridging Li-Br interactions in 
[(diamine)LiBr]n facilitate dissociation of the oligomers, opening a coordination site on 
lithium.  To avoid production of LiBr, a 1:1 ratio of 4-bromoindole to t-BuLi was 
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employed, furnishing indole-based diarylmethanols with 90% ee and 60–65% yield 
(Equation 2-4). 
 
 
Equation 2-4. 
 
It is noteworthy that enantioenriched indole 2-38 is a potential intermediate for the 
synthesis of (–)-aurantioclavine, which is illustrated in Scheme 2-4 along with related 
intermediates in the elegant synthesis of this alkaloid by Stoltz and coworkers.102  
 
Scheme 2-4. Structure of (–)-Aurantioclavine and Intermediates in its Synthesis by 
Stoltz and Coworkers.102 
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2.3.5. Tandem Asymmetric Aryl Addition/Diastereoselective Epoxidation. 
 
We recently developed a series of tandem reactions involving the asymmetric addition 
of alkyl,103-105 vinyl,73,103,106,107 or allyl108 groups to aldehydes and ketones followed by 
diastereoselective epoxidation to provide epoxy alcohols with three contiguous 
stereogenic centers.109  These one-pot procedures rapidly increase molecular complexity 
in a synthetically efficient fashion.  To explore the possibility of performing arylation and 
heteroarylation of enals followed by diastereoselective epoxidation, we examined 
asymmetric phenyl addition/oxidation with 3-methyl-2-butenal.  As shown in Scheme 
2-5A, using the conditions outlined in Table 2-4 the catalytic asymmetric phenyl addition 
was performed.  The resulting enantioenriched zinc allylic alkoxide was then treated with 
Et2Zn (1 equiv), TBHP (tert-butylhydroperoxide, 5 equiv), and 20 mol % titanium 
tetraisopropoxide at 0 ºC.  The epoxidation reached completion in 3 h, after which the 
reaction mixture was quenched, worked up, and the product purified by chromatography 
to afford the epoxy alcohol in 67% yield with 90% ee and >20:1 dr (as determined by 1H 
NMR).  The heteroarylation/epoxidation was examined with the TIPS protected 4-
bromoindole (Scheme 2-5B).  Metallation with t-BuLi, transmetallation with EtZnCl, and 
asymmetric addition as performed in Equation 2-4 was followed by addition of Et2Zn, 
TBHP and 20 mol % titanium tetraisopropoxide at 0 ºC.  Following workup and 
purification, the enantioenriched indole epoxy alcohol was isolated in 65% yield with 
90% ee and >20:1 dr.  Interestingly, attempted epoxidation of the isolated indole allylic 
alcohol product in Equation 2-4 with m-CPBA resulted in formation of the epoxy alcohol 
in low yield accompanied by several side products.  The examples in Scheme 2-5 indicate 
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that the asymmetric arylation and heteroarylation are compatible with our tandem 
diastereoselective epoxidation conditions and could be used to prepare an array of 
functionalized epoxy alcohols. 
 
 
Scheme 2-5. Tandem Asymmetric Arylation of Aldehydes/Diastereoselective 
Epoxidation. 
 
2.3.6. Synthesis of Ferrocenylzinc and Applications to Asymmetric Additions. 
 
Having developed successful methods for the enantioselective addition of aryl and 
heteroaryl groups to aldehydes, we focused on the generation of the ferrocenylzinc 
reagent, (Fc)ZnEt.  Highly enantioselective additions of ferrocenylzinc reagents to 
aromatic and heteroaromatic aldehydes would provide rapid access to heteroaryl 
ferrocenyl methanols.  Related motifs110,111 are precursors to important enantioenriched 
ferrocene-based ligands such as BoPhoz,112 Josiphos,113 FERRIPHOS,114,115 Pigiphos,116,117 
PPFA,118 Walphos,119 Taniaphos120 and Trap.112,121,122  The ferrocenyl methanol scaffold is 
often synthesized by CBS (Corey-Bakshi-Shibata)123-125 or Ru/BINAP (Noyori 
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asymmetric hydrogenation) reduction of ferrocenyl ketones.4,122,126  Asymmetric reduction 
of heteroaromatic ketone derivatives, however, resulted in only moderate 
enantioselectivity (X=O, 41% ee; X=S, 68% ee, Equation 2-5).127 
 
  
Equation 2-5. 
 
Beginning with ferrocenyl bromide (FcBr) and applying the conditions used in Table 
2-4 to the generation and addition of (Fc)ZnEt to benzaldehyde with (–)-MIB provided 
product with a disappointing 50% ee (Table 2-5, entry 1). 
Inspired by the importance of functionalized ferrocenyl methanols, we screened other 
amino alcohol ligands.  Fortunately, use of Chan’s48,98 amino alcohol L2 (Figure 2-2) 
with benzaldehyde provided the desired product in 86% yield with 98% ee (Table 2-5, 
entry 2).  Use of 2-thiophenecarboxaldehyde and 2-furfural in combination with L2 
provided the ferrocene-based ligand precursors with enantioselectivities of 96% and 
yields of 95% (entries 3 and 4). 
It is known that substitution of furyl groups for phenyl can lead to an increase in 
catalyst enantioselectivity.128 
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The high yields and stereochemical purity of functionalized ferrocenes make them 
attractive building blocks for the construction of new ferrocene-based ligands for 
asymmetric catalysis. 
 
Table 2-5. Asymmetric Addition of (Fc)ZnEt to Aldehydes. 
 
 
2.4. Summary and Outlook 
 
Herein we described versatile methods for the generation of diaryl- aryl heteroaryl-, 
and diheteroarylmethanols with high levels of enantioselectivity.  The significance of 
these methods is that asymmetric arylation of aldehydes can now be initiated with aryl 
bromides, many of which are readily available.  Key to the success of our procedures was 
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the introduction of a diamine, such as TEEDA.  In the absence of TEEDA the addition 
reaction was promoted by LiCl, generating racemic products.  The TEEDA inhibited the 
LiCl byproduct, allowing the asymmetric addition to proceed via the ligand accelerated 
pathway.71,129  Importantly, in the presence of the diamine it was not necessary to filter,43 
centrifuge,67 or isolate the pyrophoric arylzinc reagents as was required with previous 
procedures, making our method suitable for large scale applications.   
We also developed the first method for the synthesis of highly enantioenriched 
diheteroarylmethanols from readily available heteroaryl bromides.  A crucial feature of 
this approach was the use of EtZnCl in the transmetallation step with the 
heteroaryllithium at –78 °C, at which temperature decomposition of the heteroaryl 
organometallic species was minimized.  Use of EtZnCl in place of ZnCl2 also halves the 
amount of LiCl byproduct, which had been detrimental to the enantioselectivity in the 
asymmetric addition and which must be inhibited by diamine.  This method was also 
shown to be applicable to the tandem asymmetric addition/diastereoselective epoxidation 
to generate epoxy alcohols with two stereogenic centers in high enantio- and 
diastereoselectivity. 
The straightforward methods introduced herein make possible the synthesis of 
functionalized, previously inaccessible enantioenriched diheteroarylmethanols.  We 
anticipate that these methods will be useful in medicinal chemistry and asymmetric 
catalysis. 
Finally, we also described the first examples of generation and highly enantioselective 
addition of ferrocenyl zinc reagents to aldehydes, opening the door to new 
enantioenriched ferrocene-based ligands.  In particular we wanted to investigate the 
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possibility of synthesizing new ligands via ortho lithiation of ferrocenyl alcohols. The 
Ueberbacher group recently published a report in which they were able to perform the 
ortho lithiation employing the free ferrocenyl alcohol. Upon quenching with an 
electrophile they obtained the functionalized ferrocenyl methanols with excellent dr’s.  
Most of their examples employed the methyl-ferrocenyl methanol, but they also had one 
example employing phenyl ferrocenyl methanol (the racemic mixture of 2-44 reported 
herein in Table 2-5) where the electrophile used was benzophenone (Scheme 2-6).130 
 
 
Scheme 2-6. Ortho-Lithiation of a) Free Methyl Ferrocenyl Alcohols and b) Free 
Phenyl Ferrocenyl Alcohols. 
 
What we would like to do with the compounds synthesized in Table 2-5 is to use them 
as a scaffold for the synthesis of new chiral ligands.  The reaction of 2-44 using the 
method outlined above, followed by quenching with Ph2PCl was our first attempt.  
Unfortunately the desired product was not observed and the starting material could not be 
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recovered (Scheme 2-7).  More studies are necessary to solve this problem that could 
provide access to a new class of enantioenriched chiral ligands. 
 
 
Scheme 2-7. Designing Ferrocenyl Phosphorous Ligand via Ortho Lithiation of Free 
Ferrocenyl Phenyl Methanol. 
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2.5. Experimental Section 
 
General Considerations 
All reactions were performed under a nitrogen atmosphere with oven-dried glassware 
using standard Schlenk or vacuum-line techniques.  The progress of reactions was 
monitored by thin-layer chromatography (TLC) performed on Whatman precoated silica 
gel 60 Å K6F plates and visualized by ultra-violet light or by staining with cerium-
ammonium-molybdate. t-BuOMe was distilled from Na/benzophenone and toluene was 
dried through alumina columns.  TEEDA was distilled and stored under nitrogen.  The 1H 
NMR and 13C{1H} NMR spectra were obtained on a Brüker Fourier transform NMR 
spectrometer at either 300 or 500 and 75 or 125 MHz, respectively.  1H NMR spectra 
were referenced to tetramethylsilane in CDCl3 or residual protonated solvent; 13C{1H} 
NMR spectra were referenced to residual solvent. Analysis of enantiomeric excess was 
performed using a Hewlett-Packard 1100 Series HPLC and a chiral column.  
Alternatively, a Berger SFC PioNTo™® was employed when the compounds could not 
be resolved by HPLC. The optical rotations were recorded using a JASCO DIP-370.  
Infrared spectra were obtained using a Perkin-Elmer Spectrum 100 Series spectrometer. 
All reagents were purchased from Aldrich or Acros unless otherwise described. 3-
Benzofurancarboxaldehyde was synthesized according to known procedure starting from 
commercially available 3-methylbenzofuran.131  Binaphthyl amino alcohol ligand was 
synthesized according to Chan’s procedure.48,98 EtZnCl was synthesized following 
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Guerrero’s method.87,132 All aldehyde substrates were distilled prior to use.  Silica gel 
(Silicaflash P60 40-63 µm, Silicycle) was used for air-flashed chromatography. 
 
Caution. Dialkylzinc and alkyl lithium reagents are pyrophoric. Care and appropriate 
laboratory equipment must be used when handling these reagents. 
 
2.5.1. Arylation of Aldehydes.  
 
Preparation of (4-Fluoro-phenyl)-(4-methoxy-phenyl)-methanol (2-10):  A nitrogen 
purged Schlenk flask was charged with 4-bromoanisole (100.1 µL, 0.8 mmol) and t-
BuOMe (1 mL) and cooled to –78 ºC.  n-BuLi (0.32 mL, 2.5 M in hexanes, 0.8 mmol) 
was added dropwise and the solution was stirred for 1 h and the temperature raised to 0 
ºC.  ZnCl2 (114.5 mg, 0.84 mmol) was added to the reaction mixture and it was stirred for 
30 min.  Additional n-BuLi (0.32 mL, 2.5 M in hexanes, 0.8 mmol) was added to the 
reaction mixture and the resulting solution was allowed to warm to rt and stirred 4.5 h. 
Toluene (5 mL) and TEEDA (68 µL, 0.32 mmol) were added to the reaction vessel and 
the solution was stirred.  After 1 h (–)-MIB (4.8 mg, 0.02 mmol) was added and the 
reaction vessel was cooled to 0 ºC for 30 min.  Finally, 4-fluorobenzaldehyde (43 µL, 0.4 
mmol) was added and reaction mixture was stirred at 0 ºC and monitored by TLC.  After 
completion (12 h), the reaction mixture was quenched with H2O (20 mL) and extracted 
with ethyl acetate (3 × 20 mL).  The organic layer was dried over MgSO4, filtered, and 
the solvent was removed under reduced pressure.  The crude product was purified by 
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column chromatography on silica gel (hexanes:EtOAc, 95:5) to give 2-10 (77.7 mg, 84% 
yield) as a white crystalline solid (m. p. = 52 ºC).  The enantiomeric excess was 
determined by HPLC with a Chiralcel AS-H column (hexanes:2-propanol = 95:5, flow 
rate = 0.5 mL/min), tr (1) = 20.0 min, tr (2) = 22.1 min,  = +13.8 (c = 0.195, THF, 
93% ee); 1H NMR (C6D6, 300 MHz): δ 2.17 (s, 1H), 3.38 (s, 3H), 5.50 (s, 1H), 6.81-6.95 
(m, 4H), 7.17-7.29 (m, 4H); 13C{1H} NMR (C6D6, 75 MHz): δ 55.0, 75.3, 114.3, 115.4 (d, 
J = 21.2 Hz), 128.4, 128.7 (d, J = 8.0 Hz), 136.9, 141.0 (d, J = 3.0 Hz), 159.7, 162.6 (d, J 
= 243 Hz); IR (neat): 831, 1033, 1248, 1504, 1609, 2837, 2957, 3422 cm-1; HRMS calcd 
for C14H13FO2 (M)+: 232.0900, found: 232.0900. 
 
2.5.2. Synthesis and characterization of Heteroaryl- and Diheteroarylmethanols 
 
General Procedure A. A nitrogen purged Schlenk flask was charged with 3-
bromofuran (67.0 µL 0.75 mmol) and t-BuOMe (1 mL) and cooled to –78 °C.  n-BuLi 
(0.3 mL, 2.5 M in hexanes, 0.75 mmol) was then added dropwise and the solution was 
stirred for 1 h at this temperature.  During this time a white precipitate formed.  EtZnCl 
(97.0 mg, 0.75 mmol) was added to the reaction flask as a solid at –78 °C followed by 
toluene (3 mL).  The heterogeneous solution was stirred at –78 °C for 30 min and then 
warmed at 0 °C.  TEEDA (64 µL, 0.30 mmol) was added and the solution stirred for an 
additional 30 min.  (–)-MIB (190 µL, 0.1 M solution in hexanes, 0.019 mmol) was added 
to the reaction flask and the solution was stirred for 5 min before 2-
thiophenecarboxaldehyde (35 µL, 0.37 mmol, dissolved in 1.5 mL of toluene) was added 
 130 
over 1.5 h by syringe pump.  The reaction mixture was stirred at 0 °C and monitored by 
TLC until completion (approximately 10 h).  The reaction mixture was diluted with 3 mL 
EtOAc and quenched with water (5 mL). The organic layer was separated and the 
aqueous solution extracted with EtOAc (3 × 10 mL). The combined organic layer was 
washed with brine (5 mL), dried over MgSO4, filtered, and the solvent was removed 
under reduced pressure.  The crude product was purified by column chromatography on 
deactivated silica gel. 
 
General Procedure B. This procedure is exactly the same as General Procedure A 
except that the catalyst loading was 10% mol. 
 
Benzofuran-2-yl(phenyl)methanol  (2-1a). General Procedure 
A was applied to 2-benzofurancarboxaldehyde (36.5 mg, 0.25 
mmol) and bromobenzene (53 µL, 0.50 mmol). The crude product 
was purified by column chromatography on silica gel (hexanes/EtOAc : 95/5) to give 2-
1a (51.7 mg, 92% yield) as a yellow solid. The enantiomeric excess was determined by 
HPLC with a Chiralcel AS-H column (hexanes:2-propanol = 98:2, flow rate = 0.5 
mL/min), tr (1) = 44.6 min, tr (2) = 48.4 min,  = +3.5 (c = 0.041, CHCl3, 90% ee); 1H 
NMR (CDCl3, 300 MHz): δ 2.49 (d, J = 4.5 Hz, 1H), 5.97 (d, J = 4.5 Hz, 1H), 6.54 (s, 
1H), 7.18-7.24 (m, 3H), 7.33-7.44 (m, 3H), 7.49-7.53 (m, 3H); 13C{1H} NMR (CDCl3, 75 
MHz): δ 70.9, 104.3, 111.6, 121.4, 123.1, 124.5, 127.0, 128.3, 128.6, 128.9, 140.0, 155.3, 
158.0; IR (neat): 3389, 3019, 2960, 2925, 2873, 1706, 1597, 1496, 1452, 1264, 1200, 
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1124 cm-1; HRMS calcd for C15H11O (M-OH)+: 207.0810, found 207.0802. The data 
collected are in agreement with previously published results.133,134 
 
1-(benzofuran-2-yl(phenyl)methyl)-1H-imidazole (2-2a). A 10 
mL Schlenk flask was charged with benzofuran-2-
yl(phenyl)methanol (43.5 mg, 0.19 mmol) and THF (1 mL). PPh3 
(66.0 mg, 0.25 mmol) and imidazole (17.2 mg, 0.25 mmol) were 
quickly weighted into the flask and stirred at 0 °C for 5 min. Finally DIAD (diisopropyl 
azodicarboxylate) (50 μL, 0.25 mmol) was added and the reaction stirred at room 
temperature for 12 h.  The volatile materials were removed in vacuo and the oil thus 
obtained was dissolved in DCM (5 mL) and washed with water (3 mL). The water layer 
was then extracted with DCM (3 × 10 mL). The combined organic layer was washed with 
brine (5 mL) dried over MgSO4, filtered, and the volatile material were removed under 
reduced pressure. The crude product was purified by column chromatography on 
deactivated silica gel (hexanes/2-propanol : 95/5) to give 2-2a (22 mg, 41% yield) as a 
yellow solid. 18 mg of 1 (0.08 mmol) were recovered unreacted but with no loss of ee. 
Thus the yield based on recovered starting material was 84%. The enantiomeric excess 
was determined by HPLC with a Chiralcel AS-H column (hexanes:2-propanol = 90:10, 
flow rate = 0.5 mL/min), tr (1) = 24.6 min, tr (2) = 32.6 min,  = –2.7 (c = 0.027, 
CHCl3, 90% ee); 1H NMR (CDCl3, 300 MHz): δ 6.51 (t, J = 0.9 Hz, 1H), 6.62 (s, 1H), 
6.99 (t, J = 1.2 Hz, 1H), 7.14 (t, J = 1.2 Hz, 1H), 7.20-7.28 (m, 4H), 7.30-7.35 (m, 1H), 
7.39-7.42 (m, 3H) 7.45-7.49 (m, 1H) 7.53-7.57 (m, 2H); 13C{1H} NMR (CDCl3, 75 
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MHz): δ 59.5, 107.4, 111.7, 119.1, 121.5, 123.4, 125.3, 127.6, 129.1, 129.2, 129.7, 136.8, 
137.2, 154.1, 155.4; IR (neat): 3442, 3191, 3146, 3056, 2980, 2930, 1968, 1899, 1821, 
1721, 1590, 1483, 1453, 1437, 1373, 1310, 1279, 1254, 1226, 1196, 1120, 1072, 1028, 
997 cm-1; HRMS calcd for C18H15N2O (MH)+: 275.1184, found 275.1184. The data 
collected are in agreement with previously published results.8 
 
3-Methyl-1-phenylbut-2-en-1-ol (2-7). General Procedure A was 
applied to 3-methyl-2-butenal (24.2 μL, 0.25 mmol) and bromobenzene 
(53.0 μL, 0.5 mmol).  The crude product was purified by column 
chromatography on silica gel (hexanes/EtOAc : 95/5) to give 2-7 (35.1 mg, 85.9% yield) 
as an oil. The enantiomeric excess was determined by HPLC with a Chiralcel AD-H 
column (hexanes:2-propanol = 99:1, flow rate = 0.5 mL/min), tr (1) = 55.1 min, tr (2) = 
60.9 min,  = –118.3 (c = 0.106, CHCl3, 90% ee); 1H NMR (CDCl3, 500 MHz): δ 
1.74 (d, J = 1.1 Hz, 3H), 1.80 (d, J = 1.1 Hz, 3H), 1.86 (d, J = 2.9 Hz, 1H), 5.40 (dt, J = 
1.1, 8.8 Hz, 1H), 5.45 (dd, J = 3.0, 8.8 Hz, 1H), 7.22-7.27 (m, 1H), 7.31-7.39 (m, 4H); 
13C{1H} NMR (CDCl3, 125 MHz): δ 18.2, 25.8, 70.7, 125.8, 127.2, 127.7, 128.4, 135.2, 
144.2; IR (neat): 3335, 3085, 3062, 3029, 2972, 2913, 2792, 1948, 1880, 1806, 1674, 
1602, 1492, 1450, 1375, 1332, 1281, 1249, 1195, 1109, 1075 cm-1; HRMS calcd for 
C11H14ONa (M+Na)+: 185.0966, found 185.0948. The data collected are in agreement 
with previously published results.135 
 
 133 
Phenyl(thiophen-3-yl)methanol (2-25). General Procedure A was 
applied to benzaldehyde (38 μL, 0.38 mmol) and 3-bromothiophene (70 
μL, 0.75 mmol). The crude product was purified by column 
chromatography on silica gel (hexanes/EtOAc : 95/5) to give 2-25 (44.0 mg, 68% yield) 
as an oil. The enantiomeric excess was determined by HPLC with a Chiralcel AS-H 
column (hexanes:2-propanol = 99:1, flow rate = 0.5 mL/min), tr (1) = 65.5 min, tr (2) = 
69.0 min,  = –19.5 (c = 0.026, CHCl3, 90% ee); 1H NMR (CDCl3, 500 MHz): δ 2.18 
(d, J = 4.3 Hz, 1H), 5.88 (d, J = 4.3 Hz, 1H), 6.98 (dd, J = 1.5, 4.3 Hz, 1H), 7.16 (m, 1H), 
7.24-7.29 (m, 2H), 7.32-7.39 (m, 5H); 13C{1H} NMR (CDCl3, 125 MHz): δ 72.8, 121.6, 
126.1, 126.3, 126.4, 127.7, 128.5, 143.3, 145.2; IR (neat): 3944, 3756, 3691, 3595, 3054, 
2987, 2685, 2522, 2411, 2372, 2305, 2126, 2055, 1603, 1551, 1493, 1421, 1265, 1149, 
1080, 1020 cm-1; HRMS calcd for C11H9S (M-OH)+: 173.0425, found 173.0430. The data 
collected are in agreement with previously published results.136,137 
 
(5-methylfuran-2-yl)(thiophen-3-yl)methanol (2-26). General 
Procedure B was applied to 5-methyl-2-furancarboxaldehyde (37 μL, 
0.37 mmol) and 3-bromothiophene (70 μL, 0.75 mmol). The crude 
product was purified by column chromatography on silica gel (hexanes/EtOAc : 95/5) to 
give 2-26 (52.0 mg, 72% yield) as a yellow oil. The enantiomeric excess was determined 
by HPLC with a Chiralcel OD-H column (hexanes:2-propanol = 98:2, flow rate = 0.5 
mL/min), tr (1) = 57.8 min, tr (2) = 62.8 min,  = +11.5 (c = 0.024, CHCl3, 92% ee); 
1H NMR (CDCl3, 300 MHz): δ 2.30 (m, 4H), 5.85 (d, J = 5.1 Hz, 1H), 5.91 (m 1H), 6.04 
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(d, J = 3.7 Hz, 1H), 7.12 (m, 1H), 7.31 (m, 2H); 13C{1H} NMR (CDCl3, 75 MHz): δ 13.8, 
66.8, 106.4, 108.5, 122.4, 126.2, 126.7, 142.4, 152.6, 154.0; IR (neat): 3370, 3105, 2920, 
1560, 1420, 1262, 1218, 1148, 1018 cm-1; HRMS calcd for C10H10O2Na (M+Na)+: 
217.0299, found 217.0302. 
 
Thiophen-2-yl(thiophen-3-yl)methanol (2-27). General Procedure 
A was applied to 2-thiophenecarboxaldehyde (470 μL, 0.37 mmol) and 
3-bromothiophene (940 μL, 0.75 mmol). The crude product was purified by column 
chromatography on silica gel (hexanes/EtOAc : 95/5) to give 2-27 (820 mg, 83% yield) 
as a solid. The enantiomeric excess was determined by HPLC with a Chiralcel OD-H 
column (hexanes:2-propanol = 97:3, flow rate = 0.5 mL/min), tr (1) = 43.6 min, tr (2) = 
48.9 min,  = +5.0 (c = 0.015, CHCl3, 93% ee); 1H NMR (CDCl3, 300 MHz): δ 2.35 
(d, J = 4.5 Hz, 1H), 6.15 (d, J = 4.5 Hz, 1H), 6.96-6.98 (m 2H), 7.10-7.12 (m, 1H), 7.28-
7.29 (m, 1H), 7.31-7.33 (m, 2H); 13C{1H} NMR (CDCl3, 75 MHz): δ 69.1, 122.1, 125.1, 
125.6, 126.4, 126.6, 126.9, 144.8, 147.7; IR (neat): 3234, 3108, 2957, 2923, 1438, 1417, 
1362, 1291, 1274,1227, 1215, 1177, 1134, 1075, 1024 cm-1; HRMS calcd for C9H9OS2 
(MH)+: 197.0095, found 197.0095.  The title compound was observed as a byproduct but 
not fully characterized in the work of Ravikanth, thus a full characterization is herein 
reported.138 
 
Benzofuran-3-yl(thiophen-3-yl)methanol (2-28). General 
Procedure A was applied to 3-benzofurancarboxaldehyde (36.5 mg, 
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0.25 mmol) and 3-bromothiophene (47 μL, 0.5 mmol). The crude product was purified by 
column chromatography on silica gel (hexanes/EtOAc : 95/5) to give 2-28 (18.0 mg, 60% 
yield) as a thick oil. The enantiomeric excess was determined by HPLC with a Chiralcel 
OD-H column (hexanes:2-propanol = 97.5:2.5, flow rate = 0.5 mL/min), tr (1) = 76.2 
min, tr (2) = 83.9 min,  = +29.5 (c = 0.010, CHCl3, 94% ee); 1H NMR (CDCl3, 500 
MHz): δ 2.26 (d, J = 5.0 Hz, 1H), 6.16 (d, J = 4.0 Hz, 1H), 7.13-7.15 (m, 1H), 7.20-7.24 
(m, 1H), 7.29-7.38 (m, 3H), 7.49-7.52 (m, 2H), 7.58 (s, 1H); 13C{1H} NMR (CDCl3, 125 
MHz): δ 65.7, 111.6, 120.6, 122.2, 122.8, 123.4, 124.6, 126.0, 126.3, 126.4, 142.3, 143.7, 
155.8; IR (DCM): 3944, 3756, 3691, 3594, 3054, 2987, 2831, 2685, 2521, 2410, 2305, 
2126, 2054, 1579, 1551, 1421, 1265, 1135, 1105, 1075, 1010 cm-1; HRMS calcd for 
C13H10O2S (M)+: 230.0402, found 230.0406. 
 
Benzo[b]thiophen-3-yl(phenyl)methanol (2-29). General 
Procedure B was applied to benzaldehyde (37.8 μL, 0.37 mmol) 
and 3-bromobenzothiophene (98 μL, 0.75 mmol). The crude product was purified by 
column chromatography on silica gel (hexanes/EtOAc : 95/5) to give 2-29 (57 mg, 65% 
yield) as a white solid. The enantiomeric excess was determined by HPLC with a 
Chiralcel AS-H column (hexanes:2-propanol = 98:2, flow rate = 0.5 mL/min), tr (1) = 
50.7 min, tr (2) = 54.0 min,  = +7.0 (c = 0.020, CHCl3, 88% ee); 1H NMR (CDCl3, 
300 MHz): δ 2.26 (d, J = 4.2 Hz, 1H), 6.18 (d, J = 4.2 Hz, 1H), 7.27-7.39 (m, 6H), 7.45-
7.48 (m, 2H), 7.71-7.75 (m, 1H), 7.83-7.86 (m, 1H); 13C{1H} NMR (CDCl3, 75 MHz): δ 
72.5, 122.9, 123.1, 124.1, 124.3, 124.7, 127.1, 128.3, 128.9, 137.5, 138.8, 141.2, 142.4; 
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IR (neat): 3351, 3061, 3028, 2955, 2880, 1949, 1903, 1732, 1602, 1562, 1524, 1493, 
1455, 1428, 1366, 1334, 1288, 1256, 1196, 1174, 1156, 1110, 1089, 1055, 1018, 1004 
cm-1; HRMS calcd for C15H11S (M-OH)+: 223.0581, found 223.0565. The data collected 
are in agreement with previously published results.134 
 
Benzo[b]thiophen-3-yl(thiophen-2-yl)methanol (2-30). General 
Procedure B was applied to 2-thiophenecarboxaldehyde (35 μL, 
0.37 mmol) and 3-bromobenzothiophene (98 μL, 0.75 mmol). The 
crude product was purified by column chromatography on silica gel (hexanes/EtOAc : 
90/10) to give 2-30 (64.5 mg, 70% yield) as an oil. The enantiomeric excess was 
determined by SFC with a Chiralcel AS-H column (2-propanol:CO2:MeOH 30-80%, 
flow rate 2% min; oven temperature: 40 ºC, detection: 220 nm), tr (1) = 5.87 min, tr (2) = 
6.39 min,  = +9.8 (c = 0.017, CHCl3, 81% ee); 1H NMR (CDCl3, 300 MHz): δ 2.47 
(d, J = 4.2 Hz, 1H), 6.42 (dt, J = 0.9, 4.2 Hz, 1H), 6.97 (dd, J = 3.3, 4.8 Hz, 1H), 7.02 
(ddd, J = 0.6, 1.2, 3.6 Hz, 1H), 7.30 (dd, J = 1.2, 4.8 Hz, 1H), 7.32-7.36 (m, 2H), 7.53 (d, 
J = 0.9 Hz, 1H), 7.74-7.77 (m, 1H), 7.86-7.89 (m, 1H); 13C{1H} NMR (CDCl3, 75 MHz): 
δ 68.4, IR (neat): 3931, 3819, 3360, 3104, 3072, 2956, 2923, 2867, 2299, 1944, 1908, 
1791, 1667, 1609, 1562, 1524, 1459, 1428, 1366, 1290, 1263, 1228, 1174, 1137, 1120, 
1088, 1053, 1036, 1020 cm-1; HRMS calcd for C13H9S2 (M-OH)+: 229.0137, found 
229.0146. 
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Benzo[b]thiophen-3-yl(furan-2-yl)methanol (2-31). General 
Procedure B was applied to furfural (31 μL, 0.37 mmol) and 3-
bromobenzothiophene (98 μL, 0.75 mmol). The crude product was purified by column 
chromatography on silica gel (hexanes/EtOAc : 90/10) to give 2-31 (60.2 mg, 70% yield) 
as an oil. The enantiomeric excess was determined by HPLC with a Chiralcel AD-H 
column (hexanes:2-propanol = 97.5:2.5, flow rate = 0.5 mL/min), tr (1) = 60.2 min, tr (2) 
= 71.1 min,  = +17.6 (c = 0.017, CHCl3, 82% ee); 1H NMR (CDCl3, 300 MHz): δ 
2.46 (d, J = 4.8 Hz, 1H), 6.20 (d, J = 4.8 Hz, 1H), 6.23 (dt, J = 0.6, 3.3 Hz, 1H), 6.35 (dd, 
J = 1.8, 3.3 Hz, 1H), 7.34-7.37 (m, 2H), 7.43 (dd, J = 0.6, 1.2 Hz, 1H), 7.50 (d, J = 0.9 
Hz, 1H), 7.75-7.79 (m, 1H), 7.86-7.89 (m, 1H); 13C{1H} NMR (CDCl3, 75 MHz): δ 66.2, 
108.0, 110.6, 122.7, 123.1, 124.3, 124.4, 124.7, 136.0, 137.3, 141.1, 142.8, 154.9; IR 
(neat): 3937, 3418, 3115, 3060, 2924, 2634, 2303, 2082, 1945, 1910, 1713, 1562, 1523, 
1501, 1426, 1428, 1346, 1264, 1151, 1095 cm-1; HRMS calcd for C13H9OS (M-OH)+: 
213.0374, found 213.0371. 
 
Phenyl(thiophen-2-yl)methanol (2-32). General Procedure B was 
applied to benzaldehyde (37.8 μL, 0.37 mmol) and 2-bromothiophene 
(72.5 μL, 0.75 mmol). The crude product was purified by column chromatography on 
silica gel (hexanes/EtOAc : 95/5) to give 2-32 (39.4 mg, 57% yield) as a white solid. The 
enantiomeric excess was determined by HPLC with a Chiralcel AS-H column 
(hexanes:2-propanol = 99:1, flow rate = 0.5 mL/min), tr (1) = 65.0 min, tr (2) = 71.9 min, 
 = –9.0 (c = 0.030, CHCl3, 90% ee); 1H NMR (CDCl3, 300 MHz): δ 2.41 (d, J = 4.2 
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Hz, 1H), 6.11 (d, J = 4.2 Hz, 1H), 6.93-6.95 (m, 1H), 6.98-7.01 (m, 1H), 7.31-7.33 (m, 
1H), 7.36-7.45 (m, 3H), 7.49-7.52 (m, 2H); 13C{1H} NMR (CDCl3, 75 MHz): δ 72.7, 
125.2, 125.7, 126.6, 126.9, 128.3, 128.8, 143.2, 148.0; IR (DCM): 3944, 3757, 3691, 
3589, 3054, 2987, 2831, 2685, 2521, 2410, 2305, 2126, 2054, 1602, 1551, 1421, 1265, 
1156, 1016 cm-1; HRMS calcd for C13H10O2S (M-OH)+: 173.0425, found 173.0430. The 
data collected are in agreement with previously published results.139 
 
Furan-3-yl(phenyl)methanol (2-33). General Procedure A was 
applied to benzaldehyde (37.8 μL, 0.37 mmol) and 3-bromofuran (67 
μL, 0.75 mmol). The crude product was purified by column 
chromatography on silica gel (hexanes/EtOAc : 95/5) to give 2-33 (56.6 mg, 86% yield) 
as an oil. The enantiomeric excess was determined by HPLC with a Chiralcel AS-H 
column (hexanes:2-propanol = 99:1, flow rate = 0.5 mL/min), tr (1) = 61.6 min, tr (2) = 
67.2 min,  = –2.7 (c = 0.033, CHCl3, 93% ee); 1H NMR (CDCl3, 500 MHz): δ 2.10 
(d, J = 4.0 Hz, 1H), 5.80 (d, J = 4.0 Hz, 1H), 6.34-6.35 (m, 1H), 7.31-7.33 (m, 2H), 7.36-
7.39 (m, 3H), 7.41-7.43 (m, 2H); 13C{1H} NMR (CDCl3, 125 MHz): δ 69.8, 109.4, 126.6, 
128.1, 128.8, 129.2, 140.0, 143.2, 143.7; IR (neat): 3944, 3756, 3691, 3595, 3054, 2987, 
2685, 2521, 2410, 2305, 2126, 2054, 1601, 1551, 1492, 1421, 1265, 1157, 1024 cm-1; 
HRMS calcd for C11H10O2Na (M+Na)+: 197.0578, found 197.0577.  The data collected 
are in agreement with previously published results.140 
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Furan-3-yl(5-methylfuran-2-yl)methanol (2-34). General Procedure 
B was applied to 5-methyl-2-furalaldehyde (37 μL, 0.37 mmol) and 3-
bromofuran (67 μL, 0.75 mmol). The crude product was purified by 
column chromatography on silica gel (hexanes/EtOAc : 90/10) to give 2-34 (44.4 mg, 
67% yield) as an oil. The enantiomeric excess was determined by HPLC with a Chiralcel 
OD-H column (hexanes:2-propanol = 99:1, flow rate = 0.5 mL/min), tr (1) = 46.8 min, tr 
(2) = 51.5 min,  = +4.0 (c = 0.024, CHCl3, 80% ee); 1H NMR (CDCl3, 300 MHz): δ 
2.21 (d, J = 5.1 Hz, 1H), 2.30 (s, 3H), 5.73 (d, J = 5.1 Hz, 1H), 5.91-5.93 (m, 1H), 6.10-
6.11 (m, 1H), 6.47-6.48 (m, 1H), 7.41-7.42 (m, 1H), 7.47-7.48 (m, 1H); 13C{1H} NMR 
(CDCl3, 75 MHz): δ 13.8, 63.5, 106.4, 108.3, 109.6, 126.3, 140.3, 143.5, 152.6, 153.7; IR 
(neat): 3401, 3132, 2923, 1714, 1622, 1562, 1505, 1383, 1218, 1156, 1021 cm-1; HRMS 
calcd for C10H10O3Na (M+Na)+: 201.0528, found 201.0531. 
 
Furan-3-yl(thiophen-2-yl)methanol (2-35). General Procedure A 
was applied to 2-thiophenecarboxaldehyde (35 μL, 0.37 mmol) and 3-
bromofuran (67 μL, 0.75 mmol). The crude product was purified by column 
chromatography on silica gel (hexanes/EtOAc : 95/5) to give 2-35 (44.4 mg, 60% yield) 
as an oil. The enantiomeric excess was determined by HPLC with a Chiralcel OD-H 
column (hexanes:2-propanol = 97:3, flow rate = 0.5 mL/min), tr (1) = 40.4 min, tr (2) = 
47.1 min,  = +18.2 (c = 0.032, CHCl3, 99% ee); 1H NMR (CDCl3, 500 MHz): δ 2.27 
(d, J = 5.0 Hz, 1H), 6.04 (d, J = 5.0 Hz, 1H), 6.44-6.45 (m, 1H), 6.97-6.99 (m, 1H), 7.01-
7.02 (m, 1H), 7.30 (dd, J = 1.5, 5.0 Hz, 1H) 7.41 (t, J = 1.5 Hz, 1H), 7.45-7.46 (m, 1H); 
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13C{1H} NMR (CDCl3, 125 MHz): δ 65.8, 109.3, 125.0, 125.6, 126.9, 128.6, 140.1, 
143,7, 147.4; IR (neat): 3410, 3108, 2924, 2855, 1759, 1672, 1614, 1507, 1416, 1264, 
1230, 1156, 1022 cm-1; HRMS calcd for C9H7O2S (M-H)+: 179.0167, found 179.0169. 
 
Benzofuran-3-yl(furan-3-yl)methanol (2-36). General Procedure 
A was applied to 3-benzofuranecarboxaldehyde (19 mg, 0.13 mmol) 
and 3-bromofuran (23.5 μL, 0.26 mmol). The crude product was purified by column 
chromatography on silica gel (hexanes/EtOAc : 95/5) to give 2-36 (21.9 mg, 79% yield) 
as an oil. The enantiomeric excess was determined by HPLC with a Chiralcel OD-H 
column (hexanes:2-propanol = 97.5:2.5, flow rate = 0.5 mL/min), tr (1) = 54.6 min, tr (2) 
= 69.5 min,  = +12.9 (c = 0.010, CHCl3, 94% ee); 1H NMR (CDCl3, 300 MHz): δ 
2.11 (d, J = 4.5 Hz, 1H), 6.05 (d, J = 4.5 Hz, 1H), 6.44-6.45 (m, 1H), 7.21-7.34 (m, 2H), 
7.42-7.43 (m, 1H), 7.48-7.52 (m, 2H), 7.54-7.57 (m, 1H), 7.59-7.60 (m, 1H); 13C{1H} 
NMR (CDCl3, 75 MHz): δ 62.6, 109.4, 111.8, 120.8, 122.9, 123.3, 124.8, 126.2, 127.6, 
140.2, 142.4, 143.9; IR (neat): 3367, 3148, 3060, 2962, 2923, 2874, 1901, 1783, 1702, 
1596, 1579, 1502, 1477, 1452, 1333, 1276, 1216, 1184, 1158, 1103, 1075, 1024, 1009, 
959 cm-1; HRMS calcd for C13H10O3 (M)+: 214.0630, found 214.0622. 
 
Furan-2-yl(furan-3-yl)methanol (2-37). General Procedure A was 
applied to furfural (31 mg, 0.37 mmol) and 3-bromofuran (67 μL, 0.75 
mmol). The crude product was purified by column chromatography on silica gel 
(hexanes/EtOAc : 95/5) to give 2-37 (37.5 mg, 61% yield) as an oil. The enantiomeric 
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excess was determined by HPLC with a Chiralcel OD-H column (hexanes:2-propanol = 
97:3, flow rate = 0.5 mL/min), tr (1) = 35.6 min, tr (2) = 38.6 min,  = –1.2 (c = 
0.023, CHCl3, 89% ee); 1H NMR (CDCl3, 300 MHz): δ 2.21 (d, J = 5.1 Hz, 1H), 5.80 (d, 
J = 5.0 Hz, 1H), 6.25 (dt, J = 0.9, 3.3 Hz, 1H), 6.35 (dd, J = 0.3, 3.3 Hz, 1H), 6.47 (dd, J 
= 0.3, 0.9 Hz, 1H), 7.42-7.43 (m, 2H), 7.47-7.48 (m, 1H), 7.48-7.52 (m, 2H), 7.54-7.57 
(m, 1H), 7.59-7.60 (m, 1H); 13C{1H} NMR (CDCl3, 75 MHz): δ 63.5, 107.3, 109.5, 
110.5, 126.2, 140.3, 142.7, 143.6, 155.5; IR (neat): 3401, 3148, 2924, 1722, 1626, 1568, 
1504, 1466, 1391, 1315, 1222, 1158, 1072, 1014 cm-1; HRMS calcd for C9H9O3 (M-
OH)+: 165.0538, found 165.0546. 
 
2.5.3. Synthesis of Indole Methanols 
 
General Procedure C. A nitrogen purged Schlenk flask was charged with 4-bromo-1-
TIPS indole (106.5 mg, 0.3 mmol) and t-BuOMe (1 mL) and cooled to –78 °C. t-BuLi 
(0.18 mL, 1.7 M in pentane, 0.3 mmol) was then added dropwise and the solution was 
stirred for 1 h at this temperature.  During this time a white precipitate formed.  EtZnCl 
(39.6 mg, 0.3 mmol) was added to the reaction flask as a solid at –78 °C followed by 
toluene (3 mL).  The heterogeneous solution was stirred at –78 °C for 30 min and then 
warmed at 0 °C.  TEEDA (26 µL, 0.12 mmol) was added and the solution stirred for an 
additional 30 min.  (–)-MIB (150 µL, 0.1 M solution in hexanes, 0.015 mmol) was added 
to the reaction flask and the solution was stirred for 5 min before 3-methyl-2-butenal 
(14.7 µL, 0.15 mmol, dissolved in 1.5 mL of toluene) was added over 1.5 h by syringe 
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pump.  The reaction mixture was stirred at 0 °C and monitored by TLC until completion 
(approximately 10 h).  The reaction mixture was diluted with 3 mL EtOAc and quenched 
with water (5 mL). The organic layer was separated and the aqueous solution extracted 
with EtOAc (3 × 10 mL). The combined organic layer was washed with brine (5 mL), 
dried over MgSO4, filtered, and the solvent was removed under reduced pressure.  The 
crude product was purified by column chromatography on deactivated silica gel. 
 
3-Methyl-1-(1-(triisopropylsilyl)-1H-indol-4-yl)but-2-en-1-ol (2-
38). General Procedure C was applied to 3-methyl-2-butenal (14.5 
μL, 0.15 mmol) and 4-bromo-1-TIPS indole (106.5 mg, 0.3 mmol). 
The crude product was purified by column chromatography on silica gel (hexanes/EtOAc 
: 95/5) to give 2-38 (37.1 mg, 65% yield) as an oil. The enantiomeric excess was 
determined by HPLC with a Chiralcel OD-H column (hexanes:2-propanol = 99:1, flow 
rate = 0.5 mL/min), tr (1) = 44.2 min, tr (2) = 47.3 min,  = –61.5 (c = 0.049, CHCl3, 
90% ee); 1H NMR (CDCl3, 500 MHz): δ 1.13 (d, J = 7.33 Hz, 18H), 1.69 (sept, J = 7.3 
Hz, 1H), 1.75 (d, J = 1.3 Hz, 3H), 1.86 (d, J = 1.3 Hz, 3H), 1.88 (d, J = 3.0 Hz, 1H), 5.66 
(d apparent quintet, 1.3 Hz, 8.8 Hz, 1H), 5.81 (d, J = 8.8 Hz, 1H) 6.76 (m, 1H), 7.12 (d, J 
= 8.0 Hz, 1H), 7.16 (m, 1H), 7.25 (m, 1H), 7.42 (d, J = 8.0 Hz, 1H); 13C{1H} NMR 
(CDCl3, 125 MHz): δ 12.8, 18.1, 18.2, 25.8, 70.2, 103.2, 113.2, 116.5, 121.2, 127.2, 
128.8, 130.9, 135.1, 135.7, 141.2; IR (neat): 3392, 2948, 2868, 1669, 1599, 1514, 1464, 
1426, 1384, 1279, 1204, 1148, 1123, 1071 cm-1; HRMS calcd for C22H34NSi (M-OH)+: 
340.2451, found 340.2461. 
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Phenyl(1-(triisopropylsilyl)-1H-indol-4-yl)methanol (2-39). General 
Procedure C was applied to benzaldehyde (15 μL, 0.15 mmol) and 4-
bromo-1-TIPS indole (106.5 mg, 0.3 mmol). The crude product was 
purified by column chromatography on silica gel (hexanes/EtOAc : 95/5) to give 2-39 
(34.1 mg, 60% yield) as an oil. The enantiomeric excess was determined by HPLC with a 
Chiralcel OD-H column (hexanes:2-propanol = 99:1, flow rate = 0.5 mL/min), tr (1) = 
79.9 min, tr (2) = 89.9 min,  = +24.4 (c = 0.047, CHCl3, 90% ee); 1H NMR (CDCl3, 
500 MHz): δ 1.12 (d, J = 7.1 Hz, 18H), 1.68 (sept, J = 7.1 Hz, 3H), 2.30 (d, J = 3.6 Hz, 
1H), 6.24 (d, J = 3.0 Hz, 1H), 6.68 (d, J = 3.0 Hz, 1H), 7.10 (m, 2H), 7.23 (m, 2H), 7.32 
(t, J = 7.1 Hz, 2H), 7.44 (d, J = 7.1 Hz, 1H), 7.48 (d, J = 7.9 Hz, 2H); 13C{1H} NMR 
(CDCl3, 125 MHz): δ 12.7, 18.1, 74.9, 103.0, 113.5, 117.5, 121.2, 126.6, 127.1, 128.2, 
129.3, 131.2, 135.3, 141.1, 143.5; IR (neat): 3402, 3060, 3028, 2948, 2868, 2728, 1946, 
1892, 1807, 1715, 1601, 1582, 1514, 1493, 1478, 1463, 1453, 1427, 1391, 1368, 1279, 
1203, 1148, 1123, 1071 cm-1; HRMS calcd for C24H32NSi (M-OH)+: 362.2304, found 
362.2305. 
 
2.5.4. Diastereoselective Addition/Epoxidation Reaction 
 
General Procedure D. A nitrogen purged Schlenk flask was charged with 4-bromo-1-
TIPS indole (106.5 mg, 0.3 mmol) and t-BuOMe (1 mL) and cooled to –78 °C. Alkyl 
lithium (n-BuLi or t-BuLi, see below, 0.3 mmol) was added dropwise and the solution 
was stirred for 1 h. EtZnCl (39.6 mg, 0.3 mmol) was delivered to the reaction flask as a 
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solid at –78 °C. Toluene (3 mL) was next added giving a heterogenous mixture. The 
solution was warmed to –10 °C and stirred at that temperature for 3 h. Then TEEDA (26 
μL, 0.12 mmol) was added and the solution was stirred for an additional 30 min. (–)-MIB 
(150 µL, 0.1 M solution in hexanes, 0.015 mmol) was added to the reaction flask and the 
solution was stirred for 5 min before 3-methyl-2-butenal (14.7 µL, 0.15 mmol, dissolved 
in 1.5 mL of toluene) was delivered over 1.5 h by syringe pump. The reaction mixture 
was stirred at –10 °C and monitored by TLC until completion. Upon completion of the 
reaction the solution was warmed to 0 ºC.  ZnEt2 (0.15 mL, 1 M in hexanes, 0.15 mmol) 
was added followed by TBHP (0.14 mL, 5.5 M in decane, 0.77 mmol). After stirring for 
5 min Ti(O-iPr)4 (30 μL, 1 M in hexanes, 0.03 mmol) was added and the reaction stirred 
until the epoxidation reached completion (approximately 3 h). After the reaction was 
complete by TLC analysis, it was diluted with 3 mL EtOAc and quenched with water (5 
mL). The organic layer was separated and the aqueous solution extracted with EtOAc (3 
× 10 mL). The combined organic layer was washed with brine (5 mL), dried over MgSO4, 
filtered, and the volatile materials were removed under reduced pressure. The crude 
product was purified by column chromatography on deactivated silica gel. 
 
(3,3-Dimethyloxiran-2-yl)(phenyl)methanol (2-40). General 
Procedure D was applied to 3-methyl-2-butenal (24.2 μL, 0.25 mmol), 
bromobenzene (53.0 μL, 0.5 mmol) and n-BuLi (0.2 mL, 2.5 M in 
hexanes, 0.5 mmol). The crude product was purified by column chromatography on silica 
gel (hexanes/EtOAc : 90/10) to give 2-40 (30.3 mg, 67.8% yield) as an oil. The 
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diastereomeric ratio was determined by 1H NMR of the crude product (dr > 20:1);  = 
–23.1 (c = 0.043, CHCl3, 90% ee); 1H NMR (CDCl3, 500 MHz): δ 1.29 (s, 3H), 1.43 (s, 
3H), 2.60 (d, J = 2.9 Hz, 1H), 2.97 (d, J = 8.1 Hz, 1H), 4.55 (dd, J = 2.9, 8.1 Hz, 1H), 
7.29-7.34 (m, 1H), 7.36-7.39 (m, 4H); 13C{1H} NMR (CDCl3, 125 MHz): δ 19.6, 24.8, 
60.0, 68.0, 72.6, 125.9, 128.0, 128.6, 140.1; IR (neat): 3417, 3063, 3032, 2964, 2927, 
2741, 1955, 1888, 1812, 1764, 1634, 1604, 1586, 1494, 1455, 1427, 1380, 1323, 1282, 
1248, 1193, 1130, 1075 cm-1; HRMS calcd for C11H14ONa (M+Na)+: 201.0891, found 
201.0885. 
 
(3,3-Dimethyloxiran-2-yl)(1-(triisopropylsilyl)-1H-indol-4-
yl)methanol (2-41). General Procedure D was applied to 3-methyl-2-
butenal (14.5 μL, 0.15 mmol), 4-bromo-1-TIPS indole (106.5 mg, 0.3 
mmol) and t-BuLi (0.18 mL, 1.7 M in pentane, 0.3 mmol). The crude product was 
purified by column chromatography on silica gel (hexanes/EtOAc : 90/10) to give 2-41 
(36.6 mg, 64.9% yield) as an oil. The diastereomeric ratio was determined by 1H NMR of 
the crude product (dr > 20:1);  = –6.1 (c = 0.041, CHCl3, 90% ee); 1.13 (d, J = 7.6 
Hz, 18H), 1.29 (s, 3H), 1.43 (s, 3H), 1.69 (sept, J = 7.6 Hz, 3H), 2.48 (d, J = 3.0 Hz, 1H), 
3.31 (d, J = 8.1 Hz, 1H), 4.89 (dd, J = 3.0, 8.1 Hz, 1H), 6.80 (d, J = 3.3 Hz, 1H), 7.10-
7.14 (m, 1H), 7.30 (d, J = 3.3 Hz, 1H), 7.47 (dd, J = 2.8, 6.9 Hz, 1H); 13C{1H} NMR 
(CDCl3, 125 MHz): δ 12.8, 18.0, 19.5, 24.8, 60.1, 67.3, 72.2, 103.3, 113.9, 117.6, 121.1, 
129.2, 131.5, 141.3; IR (neat): 3445, 3135, 3081, 3048, 2948, 2892, 2868, 2760, 2729, 
2625, 2559, 2361, 2343, 2246, 2150, 2074, 1892, 1824, 1740, 1675, 1599, 1514, 1463, 
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1428, 1378, 1345, 1323, 1280, 1248, 1209, 1150, 1124, 1096, 1073 cm-1; HRMS calcd 
for C22H35NO2NaSi (M+Na)+: 396.2335, found 396.2321. 
 
2.5.5. Synthesis of Ferrocenyl Derivatives 
 
Phenyl(ferrocenyl)methanol (2-44). General Procedure A was applied 
to benzaldehyde (19 μL, 0.188 mmol), bromoferrocene (99 mg, 0.37 
mmol) and Chan’s ligand L2 (94 μL, 0.1 M in toluene, 0.0094 mmol). 
The crude product was purified by column chromatography on silica gel (hexanes/EtOAc 
: 95/5) to give 2-44 (47 mg, 86% yield) as a red solid. The enantiomeric excess was 
determined by HPLC with a Chiralcel AD-H column (hexanes:2-propanol = 93:7, flow 
rate = 0.5 mL/min), tr (1) = 26.7 min, tr (2) = 45.2 min,  = –94.4 (c = 0.016, CHCl3, 
98% ee); 1H NMR (CDCl3, 360 MHz): δ 2.42 (d, J = 3.24 Hz, 1H), 4.22 (s, 9H), 5.46 (d, 
J = 3.24 Hz, 1H), 7.30-7.40 (m, 5H); 13C{1H} NMR (CDCl3, 125 MHz): δ 66.2, 67.7, 
68.3, 68.4, 68.7, 72.3, 94.5, 126.4, 127.7, 128.4, 143.5; IR (DCM): 3944, 3757, 3691, 
3584, 3054, 2987, 2685, 2521, 2410, 2305, 2126, 2054, 1602, 1550, 1493, 1421, 1383, 
1265, 1172, 1105, 1079, 1045, 1016, 1002, 896 cm-1; HRMS calcd for C17H16O1Fe (M)+: 
292.0550, found 292.0559.  The data collected are in agreement with previously 
published results.44,141,142 
 
Thienyl(ferrocenyl)methanol (2-43). General Procedure A was 
applied to 2-thiophenecarboxaldehyde (17.5 μL, 0.188 mmol), 
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bromoferrocene (99 mg, 0.37 mmol) and Chan’s ligand L2 (94 μL, 0.1 M in toluene, 
0.0094 mmol). The crude product was purified by column chromatography on silica gel 
(hexanes/EtOAc : 95/5) to give 2-43 (52.9 mg, 95% yield) as a red solid. The 
enantiomeric excess was determined by HPLC with a Chiralcel AD-H column 
(hexanes:2-propanol = 95:5, flow rate = 0.5 mL/min), tr (1) = 42.7 min, tr (2) = 51.0 min, 
 = –73.3 (c = 0.023, CHCl3, 98% ee); 1H NMR (CDCl3, 500 MHz): δ 2.55 (d, J = 
3.5 Hz, 1H), 4.25 (s, 9H), 5.73 (d, J = 3.5 Hz, 1H), 6.94-6.95 (m, 2H), 7.24-7.25 (m, 1H); 
13C{1H} NMR (CDCl3, 125 MHz): δ 66.5, 67.5, 68.4, 68.5, 68.6, 68.9, 93.6, 124.6, 124.9, 
126.5 147.5; IR (neat): 3928, 3542, 3435, 3096, 2972, 2927, 2867, 2253, 2054, 1666, 
1532, 1437, 1411, 1393, 1292, 1260, 1231, 1191, 1158, 1106, 1041, 1002 cm-1; HRMS 
calcd for C15H14O1SFe (M)+: 298.0115, found 298.0104.  The data collected are in 
agreement with previously published results.142 
 
Furanyl(ferrocenyl)methanol (2-42). General Procedure A was 
applied to furfural (15.5 μL, 0.188 mmol), bromoferrocene (99 mg, 0.37 
mmol) and Chan’s ligand L2 (94 μL, 0.1 M in toluene, 0.0094 mmol). 
The crude product was purified by column chromatography on silica gel (hexanes/EtOAc 
: 95/5) to give 2-42 (50 mg, 95% yield) as a yellow oil. The enantiomeric excess was 
determined by HPLC with a Chiralcel OD-H column (hexanes:2-propanol = 95:5, flow 
rate = 0.5 mL/min), tr (1) = 37.6 min, tr (2) = 45.2 min,  = –30.0 (c = 0.022, CHCl3, 
96% ee); 1H NMR (CDCl3, 500 MHz): δ 2.36 (d, J = 5.1 Hz, 1H), 4.18 (s, 7H), 4.26-4.29 
(m, 2H), 5.48 (d, J = 5.1 Hz, 1H), 6.23-6.24 (m, 1H), 6.33-6.35 (m, 1H), 6.40-6.41 (m, 
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1H); 13C{1H} NMR (CDCl3, 75 MHz): δ 66.3, 67.2, 67.5, 68.4, 68.5, 68.9, 90.7, 106.7, 
110.3, 142.1, 155.8; IR (neat): 3928, 3401, 3095, 2920, 1637, 1504, 1467, 1411, 1301, 
1211, 1170, 1147, 1105, 1043, 1002 cm-1; HRMS calcd for C15H14O2NaFe (M+Na)+: 
305.0241, found 305.0244. The data collected are in agreement with previously published 
results.142,143 
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3. Appendix A:  1H and 13C{1H} NMR Spectra 
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Figure 3-1. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-a in CDCl3. 
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Figure 3-2. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-b in CDCl3. 
 158 
 
Figure 3-3. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-c in CDCl3. 
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Figure 3-4. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-d in CDCl3. 
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Figure 3-5. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-e in CDCl3. 
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Figure 3-6. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-1 in CDCl3. 
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Figure 3-7. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-2 in CDCl3. 
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Figure 3-8. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-3 in CDCl3. 
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Figure 3-9. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-4 in CDCl3. 
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Figure 3-10. 500 MHz 1Hand 125 MHz 13C{1H} NMR of Compound 1-5 in CDCl3. 
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Figure 3-11. 500 MHz 1Hand 125 MHz 13C{1H} NMR of Compound 1-6 in CDCl3. 
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Figure 3-12. 500 MHz 1Hand 125 MHz 13C{1H} NMR of Compound 1-7 in CDCl3. 
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Figure 3-13. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-8 in CDCl3. 
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Figure 3-14. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-9 in CDCl3. 
 170 
 
Figure 3-15. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-10 in CDCl3. 
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Figure 3-16. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-11 in CDCl3. 
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Figure 3-17. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-12 in CDCl3. 
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Figure 3-18. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-13 in CDCl3. 
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Figure 3-19. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-14 in CDCl3. 
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Figure 3-20. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-15 in CDCl3. 
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Figure 3-21. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-16 in CDCl3. 
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Figure 3-22. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-17 in CDCl3. 
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Figure 3-23. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-18 in CDCl3. 
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Figure 3-24. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-19 in CDCl3. 
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Figure 3-25. 500 MHz 1H NMR of Compound 1-19 in CDCl3 - generated with mCPBA. 
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Figure 3-26. 500 MHz 1H NMR of Compound 1-19 in CDCl3 - generated with VO(acac)2. 
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Figure 3-27. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-20 in CDCl3. 
 183 
 
Figure 3-28. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-21 in CDCl3. 
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Figure 3-29. 500 MHz 1H and 125 MHz 13C{1H} NMR of Derivative of Compound 1-8 in 
CDCl3. 
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Figure 3-30. 500 MHz 1H and 125 MHz 13C{1H} NMR of Derivative of Compound 1-20 
in CDCl3. 
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Figure 3-31. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-22 in CDCl3. 
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Figure 3-32. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-23 in CDCl3. 
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Figure 3-33. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-24 in CDCl3. 
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Figure 3-34. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-25 in CDCl3. 
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Figure 3-35. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-26 in CDCl3. 
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Figure 3-36. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-27 in CDCl3. 
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Figure 3-37. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-28 in CDCl3. 
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Figure 3-38. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-29 in CDCl3. 
 
 194 
 
Figure 3-39. 500 MHz 1H and 125 MHz 13C{1H} NMR of Derivative of Compound 1-28 
in CDCl3. 
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Figure 3-40. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-49 in CDCl3. 
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Figure 3-41. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-50 in CDCl3. 
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Figure 3-42. 500 MHz 1H NMR of Compound 1-49 and 1-50 in a mixture in CDCl3. 
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Figure 3-43. 500 MHz 1H NMR of Compound 1-50 and 1-51 in a mixture in CDCl3. 
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Figure 3-44. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-52 in CDCl3. 
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Figure 3-45. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-53 in CDCl3. 
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Figure 3-46. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-54 in CDCl3. 
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Figure 3-47. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 1-55 in CDCl3. 
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Figure 3-48. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-1a in CDCl3. 
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Figure 3-49. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-2a in CDCl3. 
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Figure 3-50. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-7 in CDCl3. 
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Figure 3-51. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-25 in CDCl3. 
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Figure 3-52. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-26 in CDCl3. 
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Figure 3-53. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-27 in CDCl3. 
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Figure 3-54. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-28 in CDCl3. 
 210 
 
Figure 3-55. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-29 in CDCl3. 
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Figure 3-56. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-30 in CDCl3. 
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Figure 3-57. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-31 in CDCl3. 
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Figure 3-58. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-32 in CDCl3. 
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Figure 3-59. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-33 in CDCl3. 
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Figure 3-60. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-34 in CDCl3. 
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Figure 3-61. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-35 in CDCl3. 
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Figure 3-62. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-36 in CDCl3. 
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Figure 3-63. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-37 in CDCl3. 
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Figure 3-64. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-38 in CDCl3. 
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Figure 3-65. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-39 in CDCl3. 
 221 
 
Figure 3-66. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-40 in CDCl3. 
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Figure 3-67. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-41 in CDCl3. 
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Figure 3-68. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-44 in CDCl3. 
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Figure 3-69. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-43 in CDCl3. 
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Figure 3-70. 500 MHz 1H and 125 MHz 13C{1H} NMR of Compound 2-42 in CDCl3. 
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4. Appendix B: X-Ray Structures’ Report 
 227 
X-ray Structure Determination of Derivative of 1-8 (#6122) 
 
 
Compound 6122, C25H26O4, crystallizes in the monoclinic space group P21 (systematic 
absences 0k0: k=odd) with a=12.631(3)Å, b=6.1265(13)Å, c=13.649(3)Å, β=91.167(5)°, 
V=1056.0(4)Å3, Z=2 and dcalc=1.228 g/cm
3.  X-ray intensity data were collected on a Rigaku 
Mercury CCD area detector employing graphite-monochromated Mo-Kα radiation (λ=0.71069 Å) 
at a temperature of 143K. Preliminary indexing was performed from a series of twelve 0.5° 
rotation images with exposures of 30 seconds. A total of 350 rotation images were collected with 
a crystal to detector distance of 35 mm, a 2θ swing angle of  -12°, rotation widths of 0.5° and 
exposures of 15 seconds: scan no. 1 was a φ-scan from 0° to 150° at ω = 10° and χ = 20°; scan 
no. 2 was an ω-scan from -20° to 5° at χ = -90° and  φ = 225°.  Rotation images were processed 
using CrystalCleari, producing a listing of unaveraged F2 and σ(F2) values which were then 
passed to the CrystalStructureii program package for further processing and structure solution on 
a Dell Pentium III computer. A total of 4760 reflections were measured over the ranges 5.98 
≤ 2θ ≤ 50 °,  -14 ≤ h ≤ 15,  -5 ≤ k ≤ 7,  -16 ≤ l ≤ 14 yielding 2967 unique reflections (Rint = 0.0253). 
The intensity data were corrected for Lorentz and polarization effects and for absorption using 
REQABiii (minimum and maximum transmission 0.768, 1.000). 
 228 
The structure was solved by direct methods (SIR97 iv). Refinement was by full-matrix least 
squares based on F2 using SHELXL-97v. All reflections were used during refinement (F2 ʼs that 
were experimentally negative were replaced by F2 = 0). The weighting scheme used was 
w=1/ [σ2(Fo2 )+ 0.0407P2 + 0.1112P] where P = (Fo2  + 2F c2 )/3. Non-hydrogen atoms were refined 
anisotropically and hydrogen atoms were refined using a "riding" model.  Refinement converged 
to R1=0.0437 and wR2=0.0888 for 2538 reflections for which F > 4σ(F) and R1=0.0542, 
wR2=0.0971 and GOF = 1.099 for all 2967 unique, non-zero reflections and 266 variables vi. The 
maximum Δ/σ in the final cycle of least squares was 0.001 and the two most prominent peaks in 
the final difference Fourier were +0.164 and -0.193 e/Å3. 
Table 4-1 lists cell information, data collection parameters, and refinement data.  Final 
positional and equivalent isotropic thermal parameters are given in Table 4-2.  Anisotropic 
thermal parameters are in Table 4-3.  Table 4-4 and Table 4-5 list bond distances and bond 
angles.  Figure 4-1 is an ORTEP vii representation of the molecule with 30% probability thermal 
ellipsoids displayed. 
 
 
Figure 4-1. ORTEP drawing of the title compound with 30% probability thermal ellipsoids. 
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Table 4-1. Summary of Structure Determination of Compound 6122 
 
Formula: C25H26O4 
Formula weight: 390.46 
Crystal class: monoclinic 
Space group: P21  (#4) 
Z 2 
Cell constants:  
 a 12.631(3)Å 
 b  6.1265(13)Å 
 c 13.649(3)Å 
 β 91.167(5)° 
 V  1056.0(4)Å3 
 µ 0.82 cm- 1  
crystal size, mm 0.38 x 0.14 x 0.08 
Dcalc 1.228 g/cm3 
F(000) 416 
Radiation: Mo-Kα (λ=0.71073Å) 
2θ range 5.98 – 50 ° 
hkl collected: -14≤ h ≤15;  -5≤ k ≤7;  -16≤ l ≤14 
No. reflections measured: 4760 
No. unique reflections: 2967 (Rint=0.0253) 
No. observed reflections 2538 (F>4σ) 
No. reflections used in refinement 2967 
No. parameters 266 
R indices (F>4σ) R1=0.0437 
 wR2=0.0888 
R indices (all data) R1=0.0542 
 wR2=0.0971 
GOF: 1.099 
Final Difference Peaks, e/Å3 +0.164, -0.193 
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Table 4-2. Refined Positional Parameters for Compound 6122 
 
Atom                         x                              y                                z                            Ueq, Å2 
C1 0.1932(2) 0.5140(5) 0.5653(2) 0.0309(7) 
C2 0.2235(2) 0.7517(5) 0.5711(2) 0.0289(6) 
C3 0.1200(2) 0.8712(5) 0.5399(2) 0.0329(7) 
H3a 0.0606 0.8190 0.5773 0.044 
H3b 0.1269 1.0276 0.5493 0.044 
C4 0.1049(2) 0.8154(5) 0.4299(2) 0.0305(7) 
H4a 0.0380 0.7420 0.4170 0.041 
H4b 0.1089 0.9448 0.3892 0.041 
C5 0.1988(2) 0.6632(4) 0.4140(2) 0.0248(6) 
C6 0.2905(2) 0.7670(5) 0.4762(2) 0.0249(6) 
C7 0.2735(2) 0.8255(5) 0.6671(2) 0.0408(8) 
H7a 0.2258 0.7972 0.7194 0.061 
H7b 0.2882 0.9790 0.6640 0.061 
H7c 0.3384 0.7470 0.6787 0.061 
C8 0.3905(2) 0.6233(5) 0.4797(2) 0.0355(7) 
H8a 0.4209 0.6181 0.4159 0.053 
H8b 0.3720 0.4783 0.4998 0.053 
H8c 0.4410 0.6838 0.5257 0.053 
C9 0.3211(2) 0.9980(5) 0.4486(2) 0.0318(7) 
H9a 0.3658 1.0589 0.4993 0.048 
H9b 0.2583 1.0853 0.4410 0.048 
H9c 0.3584 0.9959 0.3881 0.048 
C10 0.2244(2) 0.5988(5) 0.3108(2) 0.0276(6) 
C11 0.2660(2) 0.7544(5) 0.1550(2) 0.0311(7) 
H11 0.2237 0.6383 0.1241 0.041 
C12 0.3830(2) 0.7013(5) 0.1490(2) 0.0295(7) 
C13 0.4585(2) 0.8482(6) 0.1855(2) 0.0408(8) 
H13 0.4371 0.9785 0.2139 0.054 
C14 0.5659(2) 0.7993(6) 0.1793(2) 0.0494(9) 
H14 0.6161 0.8962 0.2046 0.066 
C15 0.5980(2) 0.6076(7) 0.1359(2) 0.0453(8) 
H15 0.6698 0.5761 0.1313 0.060 
C16 0.5235(2) 0.4629(6) 0.0993(2) 0.0421(8) 
H16 0.5450 0.3342 0.0696 0.056 
C17 0.4168(2) 0.5092(5) 0.1067(2) 0.0347(7) 
H17 0.3670 0.4096 0.0828 0.046 
C18 0.2378(2) 0.9703(5) 0.1107(2) 0.0355(7) 
H18 0.2606 1.0926 0.1455 0.047 
C19 0.1841(2) 1.0093(6) 0.0274(2) 0.0374(7) 
H19 0.1721 1.1559 0.0132 0.050 
C20 0.1412(2) 0.8544(5) -0.0450(2) 0.0355(7) 
C21 0.0472(2) 0.9079(6) -0.0960(2) 0.0462(9) 
H21 0.0148 1.0414 -0.0842 0.061 
C22 0.0020(2) 0.7668(7) -0.1632(2) 0.0505(9) 
H22 -0.0608 0.8050 -0.1955 0.067 
C23 0.0492(2) 0.5689(6) -0.1829(2) 0.0476(10) 
H23 0.0178 0.4728 -0.2275 0.063 
C24 0.1434(2) 0.5149(6) -0.1359(2) 0.0407(8) 
 231 
H24 0.1765 0.3832 -0.1498 0.054 
C25 0.1887(2) 0.6571(5) -0.0680(2) 0.0345(8) 
H25 0.2524 0.6193 -0.0371 0.046 
O1 0.17530(13) 0.4639(3) 0.46868(12) 0.0287(5) 
O2 0.1816(2) 0.3805(4) 0.62859(14) 0.0450(6) 
O3 0.23622(13) 0.7811(3) 0.25758(12) 0.0310(5) 
O4 0.2332(2) 0.4161(3) 0.28016(13) 0.0374(5) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cosγ+2U13aa*cc*cosβ+2U23bb*cc*cosα] 
 
Table 4-3. Refined Thermal Parameters (U's) for Compound 6122 
 
   Atom               U11                  U22                  U33                  U23                  U13                  U12 
C1 0.039(2) 0.024(2) 0.030(2) -0.0022(14) 0.0055(11) -0.0014(14) 
C2 0.037(2) 0.022(2) 0.0273(14) 0.0006(13) 0.0018(11) -0.0003(13) 
C3 0.036(2) 0.023(2) 0.040(2) -0.0033(14) 0.0098(11) 0.0018(14) 
C4 0.0253(13) 0.026(2) 0.040(2) 0.0016(14) -0.0002(11) 0.0016(13) 
C5 0.0279(13) 0.019(2) 0.0270(13) 0.0014(12) 0.0014(10) -0.0024(12) 
C6 0.0255(13) 0.022(2) 0.0269(13) -0.0007(13) 0.0013(10) 0.0004(13) 
C7 0.058(2) 0.032(2) 0.032(2) -0.0030(14) -0.0005(13) -0.005(2) 
C8 0.030(2) 0.030(2) 0.047(2) 0.000(2) -0.0025(12) 0.0041(14) 
C9 0.0311(14) 0.026(2) 0.038(2) -0.0008(14) 0.0006(11) -0.0050(14) 
C10 0.0256(14) 0.025(2) 0.032(2) -0.0016(14) -0.0022(10) -0.0017(13) 
C11 0.044(2) 0.028(2) 0.0221(14) -0.0020(13) 0.0029(11) 0.0017(14) 
C12 0.039(2) 0.027(2) 0.0218(13) 0.0015(12) 0.0041(11) 0.0007(13) 
C13 0.046(2) 0.040(2) 0.036(2) -0.006(2) 0.0077(12) -0.007(2) 
C14 0.040(2) 0.060(3) 0.048(2) -0.009(2) 0.0051(13) -0.012(2) 
C15 0.039(2) 0.058(2) 0.039(2) 0.001(2) 0.0033(13) 0.005(2) 
C16 0.052(2) 0.039(2) 0.036(2) 0.003(2) 0.0067(13) 0.010(2) 
C17 0.044(2) 0.029(2) 0.031(2) -0.0030(14) 0.0008(12) 0.000(2) 
C18 0.046(2) 0.029(2) 0.032(2) 0.0008(14) 0.0085(12) -0.0023(14) 
C19 0.044(2) 0.031(2) 0.037(2) 0.007(2) 0.0103(12) 0.002(2) 
C20 0.034(2) 0.042(2) 0.031(2) 0.010(2) 0.0065(11) 0.003(2) 
C21 0.038(2) 0.055(3) 0.046(2) 0.011(2) 0.0025(13) 0.006(2) 
C22 0.032(2) 0.071(3) 0.049(2) 0.014(2) -0.0036(13) -0.001(2) 
C23 0.043(2) 0.064(3) 0.036(2) 0.006(2) -0.0021(13) -0.009(2) 
C24 0.047(2) 0.043(2) 0.032(2) 0.000(2) 0.0042(13) 0.002(2) 
C25 0.033(2) 0.048(2) 0.0235(14) 0.005(2) 0.0020(11) -0.002(2) 
O1 0.0391(10) 0.0173(12) 0.0298(10) -0.0016(8) 0.0035(7) -0.0043(9) 
O2 0.076(2) 0.0260(13) 0.0336(11) 0.0046(10) 0.0112(10) -0.0033(11) 
O3 0.0426(11) 0.0223(12) 0.0283(10) -0.0007(9) 0.0071(8) -0.0005(10) 
O4 0.0544(13) 0.0261(13) 0.0319(11) -0.0042(10) 0.0024(9) -0.0044(10) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+ 2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)]. 
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Table 4-4. Bond Distances in Compound 6122, Å 
 
C1-O2 1.201(3) C1-O1 1.368(3) C1-C2 1.508(4) 
C2-C7 1.512(4) C2-C3 1.551(4) C2-C6 1.564(3) 
C3-C4 1.548(4) C4-C5 1.528(3) C5-O1 1.465(3) 
C5-C10 1.504(3) C5-C6 1.557(3) C6-C9 1.516(4) 
C6-C8 1.540(4) C10-O4 1.201(3) C10-O3 1.343(3) 
C11-O3 1.466(3) C11-C18 1.495(4) C11-C12 1.517(4) 
C12-C17 1.382(4) C12-C13 1.395(4) C13-C14 1.394(4) 
C14-C15 1.381(5) C15-C16 1.379(4) C16-C17 1.383(4) 
C18-C19 1.333(4) C19-C20 1.467(4) C20-C25 1.389(4) 
C20-C21 1.402(4) C21-C22 1.376(5) C22-C23 1.380(5) 
C23-C24 1.381(4) C24-C25 1.387(4)   
 
Table 4-5. Bond Angles in Compound 6122, ° 
 
O2-C1-O1 121.4(3) O2-C1-C2 130.9(3) O1-C1-C2 107.7(2) 
C1-C2-C7 115.8(2) C1-C2-C3 103.3(2) C7-C2-C3 115.6(2) 
C1-C2-C6 99.0(2) C7-C2-C6 118.4(2) C3-C2-C6 102.2(2) 
C4-C3-C2 104.4(2) C5-C4-C3 101.0(2) O1-C5-C10 107.9(2) 
O1-C5-C4 105.7(2) C10-C5-C4 118.3(2) O1-C5-C6 102.7(2) 
C10-C5-C6 116.5(2) C4-C5-C6 104.2(2) C9-C6-C8 109.2(2) 
C9-C6-C5 115.9(2) C8-C6-C5 112.6(2) C9-C6-C2 114.0(2) 
C8-C6-C2 113.4(2) C5-C6-C2 91.0(2) O4-C10-O3 125.1(2) 
O4-C10-C5 126.4(3) O3-C10-C5 108.5(2) O3-C11-C18 102.9(2) 
O3-C11-C12 110.2(2) C18-C11-C12 113.1(2) C17-C12-C13 118.9(3) 
C17-C12-C11 121.0(3) C13-C12-C11 120.1(3) C14-C13-C12 119.9(3) 
C15-C14-C13 120.2(3) C16-C15-C14 119.9(3) C15-C16-C17 120.0(3) 
C16-C17-C12 121.0(3) C19-C18-C11 128.1(3) C18-C19-C20 129.3(3) 
C25-C20-C21 117.2(3) C25-C20-C19 124.1(3) C21-C20-C19 118.7(3) 
C22-C21-C20 121.3(3) C21-C22-C23 120.5(3) C22-C23-C24 119.4(3) 
C23-C24-C25 120.0(3) C24-C25-C20 121.5(3) C1-O1-C5 105.8(2) 
C10-O3-C11 117.2(2)     
 
 233 
X-ray Structure Determination of Derivative of 1-20 (#6125) 
 
 
 
Compound 6125, C25H26O5, crystallizes in the orthorhombic space group P212121 (systematic 
absences h00: h=odd, 0k0: k=odd, and 00l: l=odd) with a=6.4191(8)Å, b=12.211(2)Å, 
c=27.390(4)Å, V=2146.9(5)Å3, Z=4 and dcalc=1.258 g/cm
3.  X-ray intensity data were collected on 
a Rigaku Mercury CCD area detector employing graphite-monochromated Mo-Kα radiation 
(λ=0.71069 Å) at a temperature of 143K. Preliminary indexing was performed from a series of 
twelve 0.5° rotation images with exposures of 30 seconds. A total of 244 rotation images were 
collected with a crystal to detector distance of 35 mm, a 2θ swing angle of  -12°, rotation widths of 
0.5° and exposures of 15 seconds: scan no. 1 was a φ-scan from 200° to 322° at ω = 10° and χ = 
20°.  Rotation images were processed using CrystalClearI, producing a listing of unaveraged F2 
and σ(F2) values which were then passed to the CrystalStructureII program package for further 
processing and structure solution on a Dell Pentium III computer. A total of 6608 reflections were 
measured over the ranges 5.58 ≤ 2θ ≤ 50.06 °,  -5 ≤ h ≤ 7,  -14 ≤ k ≤ 11,  -23 ≤ l ≤ 32 yielding 
3646 unique reflections (Rint = 0.0245). The intensity data were corrected for Lorentz and 
 234 
polarization effects and for absorption using REQABIII (minimum and maximum transmission 
0.817, 1.000). 
The structure was solved by direct methods (SIR97I V). Refinement was by full-matrix least 
squares based on F2 using SHELXL-97V. All reflections were used during refinement (F2 ʼs that 
were experimentally negative were replaced by F2 = 0). The weighting scheme used was 
w=1/ [σ2(Fo2 )+ 0.0479P2 + 0.6641P] where P = (Fo2  + 2F c2 )/3. Non-hydrogen atoms were refined 
anisotropically and hydrogen atoms were refined using a "riding" model.  Refinement converged 
to R1=0.0501 and wR2=0.1049 for 2887 reflections for which F > 4σ(F) and R1=0.0693, 
wR2=0.1225 and GOF = 1.119 for all 3646 unique, non-zero reflections and 275 variables .VI The 
maximum Δ/σ in the final cycle of least squares was 0.000 and the two most prominent peaks in 
the final difference Fourier were +0.191 and -0.219 e/Å3. 
Table 4-6 lists cell information, data collection parameters, and refinement data.  Final 
positional and equivalent isotropic thermal parameters are given in Table 4-7.  Anisotropic 
thermal parameters are in Table 4-8. Table 4-9 and Table 4-10 list bond distances and bond 
angles.  Figure 4-2 is an ORTEPV I I  representation of the molecule with 30% probability thermal 
ellipsoids displayed. 
 
Figure 4-2. ORTEP drawing of the title compound with 30% probability thermal ellipsoids. 
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Table 4-6. Summary of Structure Determination of Compound 6125 
 
Formula: C25H26O5 
Formula weight: 406.46 
Crystal class: orthorhombic 
Space group: P212121  (#19) 
Z 4 
Cell constants: 
 a 6.4191(8)Å 
 b  12.211(2)Å 
 c 27.390(4)Å 
 V  2146.9(5)Å3 
 µ 0.87 cm- 1  
crystal size, mm 0.32 x 0.26 x 0.05 
Dcalc 1.258 g/cm3 
F(000) 864 
Radiation: Mo-Kα (λ=0.71073Å) 
2θ range 5.58 – 50.06 ° 
hkl collected: -5≤ h ≤7;  -14≤ k ≤11;  -23≤ l ≤32 
No. reflections measured: 6608 
No. unique reflections: 3646 (Rint=0.0245) 
No. observed reflections 2887 (F>4σ) 
No. reflections used in refinement 3646 
No. parameters 275 
R indices (F>4σ) R1=0.0501 
 wR2=0.1049 
R indices (all data) R1=0.0693 
 wR2=0.1225 
GOF: 1.119 
Final Difference Peaks, e/Å3 +0.191, -0.219 
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Table 4-7. Refined Positional Parameters for Compound 6125 
 
Atom                           x                             y                                 z                         Ueq, Å2 
C1 0.3548(5) 0.8847(2) 0.43251(10) 0.0274(6) 
C2 0.1365(4) 0.9165(2) 0.41782(10) 0.0276(6) 
C3 0.0035(5) 0.8728(2) 0.46131(11) 0.0334(7) 
H3a 0.0597 0.8973 0.4923 0.044 
H3b -0.1401 0.8969 0.4586 0.044 
C4 0.0197(5) 0.7473(2) 0.45631(10) 0.0331(7) 
H4a 0.0808 0.7144 0.4852 0.044 
H4b -0.1155 0.7144 0.4503 0.044 
C5 0.1635(4) 0.7359(2) 0.41193(10) 0.0274(6) 
C6 0.0959(4) 0.8302(2) 0.37751(10) 0.0283(6) 
C7 0.1101(5) 1.0370(2) 0.40613(13) 0.0434(8) 
H7a 0.1519 1.0800 0.4338 0.065 
H7b -0.0333 1.0516 0.3987 0.065 
H7c 0.1951 1.0556 0.3785 0.065 
C8 0.2388(5) 0.8412(3) 0.33285(11) 0.0391(8) 
H8a 0.3809 0.8468 0.3434 0.059 
H8b 0.2016 0.9057 0.3148 0.059 
H8c 0.2231 0.7780 0.3123 0.059 
C9 -0.1310(5) 0.8245(3) 0.36008(11) 0.0397(8) 
H9a -0.1471 0.7640 0.3380 0.060 
H9b -0.1666 0.8914 0.3436 0.060 
H9c -0.2212 0.8145 0.3877 0.060 
C10 0.1753(5) 0.6242(2) 0.39000(12) 0.0319(7) 
C11 0.3854(5) 0.4676(2) 0.37307(10) 0.0307(7) 
H11 0.2483 0.4332 0.3695 0.041 
C12 0.5210(5) 0.3985(2) 0.40487(10) 0.0301(7) 
C13 0.6914(5) 0.4403(3) 0.42960(12) 0.0369(8) 
H13 0.7192 0.5150 0.4281 0.049 
C14 0.8207(5) 0.3733(3) 0.45647(13) 0.0443(8) 
H14 0.9335 0.4029 0.4732 0.059 
C15 0.7819(5) 0.2611(3) 0.45852(12) 0.0440(8) 
H15 0.8684 0.2155 0.4766 0.059 
C16 0.6140(5) 0.2181(3) 0.43344(12) 0.0404(8) 
H16 0.5885 0.1431 0.4344 0.054 
C17 0.4839(5) 0.2858(2) 0.40699(11) 0.0357(7) 
H17 0.3707 0.2562 0.3904 0.047 
C18 0.4836(5) 0.4840(2) 0.32354(11) 0.0342(7) 
H18 0.6292 0.5081 0.3239 0.046 
C19 0.4218(5) 0.4180(2) 0.28055(11) 0.0366(7) 
H19 0.5334 0.4063 0.2567 0.049 
C20 0.2601(5) 0.3317(3) 0.28094(10) 0.0336(7) 
C21 0.0598(5) 0.3504(3) 0.29777(12) 0.0417(8) 
H21 0.0211 0.4205 0.3075 0.056 
C22 -0.0831(5) 0.2659(3) 0.30019(12) 0.0446(8) 
H22 -0.2160 0.2786 0.3124 0.059 
C23 -0.0279(6) 0.1623(3) 0.28436(12) 0.0477(9) 
H23 -0.1238 0.1052 0.2857 0.064 
C24 0.1698(6) 0.1439(3) 0.26652(12) 0.0466(9) 
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H24 0.2061 0.0746 0.2554 0.062 
C25 0.3142(6) 0.2274(3) 0.26508(11) 0.0413(8) 
H25 0.4479 0.2139 0.2535 0.055 
O1 0.3685(3) 0.7732(2) 0.42886(7) 0.0277(5) 
O2 0.4988(3) 0.9392(2) 0.44650(8) 0.0361(5) 
O3 0.3627(3) 0.5762(2) 0.39478(7) 0.0319(5) 
O4 0.0264(3) 0.5820(2) 0.37091(8) 0.0426(6) 
O5 0.3566(3) 0.5313(2) 0.28565(8) 0.0399(5) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cosγ+2U13aa*cc*cosβ+2U23bb*cc*cosα] 
 
Table 4-8. Refined Thermal Parameters (U's) for Compound 6125 
 
Atom           U11                 U22                     U33                    U23                              U13                   U12 
C1 0.028(2) 0.0251(14) 0.0289(14) -0.0019(13) 0.0031(13) 0.0027(14) 
C2 0.0235(14) 0.029(2) 0.0309(14) -0.0017(13) -0.0026(12) 0.0032(13) 
C3 0.026(2) 0.039(2) 0.035(2) -0.0091(14) 0.0040(14) -0.0011(14) 
C4 0.030(2) 0.036(2) 0.033(2) -0.0013(14) 0.0046(13) -0.0025(14) 
C5 0.0184(14) 0.030(2) 0.034(2) -0.0027(13) 0.0043(12) -0.0004(13) 
C6 0.029(2) 0.029(2) 0.0274(14) 0.0009(13) 0.0000(12) 0.0004(13) 
C7 0.047(2) 0.030(2) 0.054(2) -0.007(2) -0.009(2) 0.010(2) 
C8 0.046(2) 0.042(2) 0.030(2) 0.002(2) 0.0025(14) 0.001(2) 
C9 0.036(2) 0.046(2) 0.038(2) -0.004(2) -0.0093(14) 0.006(2) 
C10 0.024(2) 0.030(2) 0.041(2) -0.0007(14) 0.0049(14) 0.0011(14) 
C11 0.035(2) 0.0221(14) 0.035(2) -0.0060(13) 0.0014(14) 0.0029(13) 
C12 0.034(2) 0.0266(14) 0.0293(14) 0.0009(13) 0.0046(13) 0.0040(13) 
C13 0.036(2) 0.031(2) 0.044(2) -0.004(2) -0.001(2) 0.0013(14) 
C14 0.042(2) 0.040(2) 0.051(2) -0.006(2) -0.005(2) 0.002(2) 
C15 0.048(2) 0.042(2) 0.043(2) 0.002(2) -0.006(2) 0.015(2) 
C16 0.053(2) 0.026(2) 0.042(2) 0.004(2) 0.001(2) 0.006(2) 
C17 0.043(2) 0.028(2) 0.035(2) -0.0007(13) 0.000(2) -0.002(2) 
C18 0.036(2) 0.031(2) 0.036(2) 0.0054(14) 0.0026(14) 0.0044(14) 
C19 0.043(2) 0.035(2) 0.032(2) -0.001(2) 0.0021(14) 0.009(2) 
C20 0.040(2) 0.033(2) 0.0275(14) -0.0003(14) -0.0039(14) 0.005(2) 
C21 0.039(2) 0.040(2) 0.046(2) -0.009(2) -0.011(2) 0.009(2) 
C22 0.042(2) 0.048(2) 0.043(2) -0.006(2) -0.012(2) 0.001(2) 
C23 0.060(2) 0.040(2) 0.043(2) 0.000(2) -0.013(2) -0.007(2) 
C24 0.065(2) 0.039(2) 0.036(2) -0.005(2) -0.005(2) 0.003(2) 
C25 0.050(2) 0.041(2) 0.033(2) -0.002(2) 0.000(2) 0.006(2) 
O1 0.0236(10) 0.0251(10) 0.0346(10) -0.0018(9) -0.0022(9) 0.0027(9) 
O2 0.0252(11) 0.0315(11) 0.0515(13) -0.0055(10) -0.0041(10) -0.0031(9) 
O3 0.0313(11) 0.0245(10) 0.0399(11) -0.0056(9) -0.0001(9) 0.0037(9) 
O4 0.0272(12) 0.0392(12) 0.0615(14) -0.0131(11) -0.0002(11) -0.0023(10) 
O5 0.0465(13) 0.0349(11) 0.0384(12) 0.0075(10) -0.0021(11) 0.0052(11) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+ 2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)]. 
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Table 4-9. Bond Distances in Compound 6125, Å 
 
C1-O2 1.202(3) C1-O1 1.368(3) C1-C2 1.508(4) 
C2-C7 1.514(4) C2-C6 1.549(4) C2-C3 1.560(4) 
C3-C4 1.543(4) C4-C5 1.532(4) C5-O1 1.468(3) 
C5-C10 1.492(4) C5-C6 1.550(4) C6-C9 1.534(4) 
C6-C8 1.535(4) C10-O4 1.205(4) C10-O3 1.345(4) 
C11-O3 1.460(3) C11-C12 1.493(4) C11-C18 1.509(4) 
C12-C13 1.384(4) C12-C17 1.398(4) C13-C14 1.379(4) 
C14-C15 1.393(5) C15-C16 1.382(5) C16-C17 1.381(4) 
C18-O5 1.440(4) C18-C19 1.481(4) C19-O5 1.452(4) 
C19-C20 1.479(4) C20-C21 1.385(4) C20-C25 1.390(4) 
C21-C22 1.383(5) C22-C23 1.384(5) C23-C24 1.378(5) 
C24-C25 1.378(5)     
 
Table 4-10. Bond Angles in Compound 6125, ° 
 
O2-C1-O1 121.7(3) O2-C1-C2 131.1(3) O1-C1-C2 107.2(2) 
C1-C2-C7 114.2(2) C1-C2-C6 99.9(2) C7-C2-C6 119.4(3) 
C1-C2-C3 102.5(2) C7-C2-C3 115.6(3) C6-C2-C3 102.7(2) 
C4-C3-C2 103.6(2) C5-C4-C3 101.6(2) O1-C5-C10 111.4(2) 
O1-C5-C4 105.1(2) C10-C5-C4 115.6(2) O1-C5-C6 102.2(2) 
C10-C5-C6 116.6(2) C4-C5-C6 104.3(2) C9-C6-C8 108.9(2) 
C9-C6-C2 114.3(2) C8-C6-C2 114.1(2) C9-C6-C5 114.9(2) 
C8-C6-C5 112.5(2) C2-C6-C5 91.4(2) O4-C10-O3 124.5(3) 
O4-C10-C5 121.7(3) O3-C10-C5 113.9(3) O3-C11-C12 109.5(2) 
O3-C11-C18 106.7(2) C12-C11-C18 110.9(2) C13-C12-C17 118.5(3) 
C13-C12-C11 122.6(3) C17-C12-C11 118.8(3) C14-C13-C12 121.2(3) 
C13-C14-C15 119.8(3) C16-C15-C14 119.5(3) C17-C16-C15 120.3(3) 
C16-C17-C12 120.6(3) O5-C18-C19 59.6(2) O5-C18-C11 117.7(2) 
C19-C18-C11 122.0(3) O5-C19-C20 118.4(3) O5-C19-C18 58.8(2) 
C20-C19-C18 124.7(3) C21-C20-C25 119.2(3) C21-C20-C19 122.4(3) 
C25-C20-C19 118.4(3) C22-C21-C20 120.6(3) C21-C22-C23 119.9(3) 
C24-C23-C22 119.7(3) C25-C24-C23 120.7(3) C24-C25-C20 120.0(3) 
C1-O1-C5 105.9(2) C10-O3-C11 116.4(2) C18-O5-C19 61.6(2) 
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X-ray Structure Determination of Derivative of 1-28 (#6151) 
 
 
Compound 6151, C26H28O4, crystallizes in the orthorhombic space group P212121 (systematic 
absences h00: h=odd, 0k0: k=odd, and 00l: l=odd) with a=6.3122(7)Å, b=12.1530(13)Å, 
c=28.515(3)Å, V=2187.4(4)Å3, Z=4, and dcalc=1.228 g/cm3 . X-ray intensity data were collected on 
a Rigaku Mercury CCD area detector employing graphite-monochromated Mo-Kα radiation 
(λ=0.71073 Å) at a temperature of 143(1)K. Preliminary indexing was performed from a series of 
twelve 0.5° rotation images with exposures of 30 seconds. A total of 580 rotation images were 
collected with a crystal to detector distance of 35 mm, a 2θ swing angle of -12°, rotation widths of 
0.5° and exposures of 60 seconds:  
 
scan no. scan type ω χ φ 
1 φ 10.0 20.0 20.0 — 270.0 
2 ω -20.0 — +20.0 -90.0 0.0 
Rotation images were processed using CrystalClear,I producing a listing of unaveraged F2 and 
σ(F2) values which were then passed to the CrystalStructureII program package for further 
processing and structure solution on a Dell Pentium 4 computer. A total of 15440 reflections were 
measured over the ranges 2.72 ≤ θ ≤ 24.11°, -6 ≤ h ≤ 7, -13 ≤ k ≤ 13, -32 ≤ l ≤ 32 yielding 3475 
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unique reflections (Rint = 0.0314). The intensity data were corrected for Lorentz and polarization 
effects and for absorption using REQABIII (minimum and maximum transmission 0.8170, 1.0000). 
The structure was solved by direct methods (SIR97IV). Refinement was by full-matrix least 
squares based on F2 using SHELXL-97.V All reflections were used during refinement. The 
weighting scheme used was w=1/[σ2(Fo2 )+ (0.0588P)2 + 0.2107P] where P = (Fo 2 + 2Fc2)/3. Non-
hydrogen atoms were refined anisotropically and hydrogen atoms were refined using a riding 
model.  Refinement converged to R1=0.0430 and wR2=0.1030 for 3150 observed reflections for 
which F > 4σ(F) and R1=0.0487 and wR2=0.1081 and GOF =1.112 for all 3475 unique, non-zero 
reflections and 275 variables.VI The maximum Δ/σ in the final cycle of least squares was 0.000 
and the two most prominent peaks in the final difference Fourier were +0.133 and -0.200 e/Å3. 
Table 4-11 lists cell information, data collection parameters, and refinement data. Final 
positional and equivalent isotropic thermal parameters are given in Table 4-12 and Table 4-13.  
Anisotropic thermal parameters are in Table 4-14.  Table 4-15 and Table 4-16 list bond distances 
and bond angles.  Figure 4-3 is an ORTEPVII representation of the molecule with 30% probability 
thermal ellipsoids displayed. 
 
 
Figure 4-3. ORTEP drawing of the title compound with 30% probability thermal ellipsoids. 
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Table 4-11. Summary of Structure Determination of Compound 6151 
 
Empirical formula  C26H28O4 
Formula weight  404.48 
Temperature  143(1) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P212121 
Cell constants:   
a  6.3122(7) Å 
b  12.1530(13) Å 
c  28.515(3) Å 
Volume 2187.4(4) Å3 
Z 4 
Density (calculated) 1.228 Mg/m3 
Absorption coefficient 0.082 mm-1 
F(000) 864 
Crystal size 0.34 x 0.10 x 0.10 mm3 
Theta range for data collection 2.72 to 24.11° 
Index ranges -6 ≤ h ≤ 7, -13 ≤ k ≤ 13, -32 ≤ l ≤ 32 
Reflections collected 15440 
Independent reflections 3475 [R(int) = 0.0314] 
Completeness to theta = 24.11° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.0000 and 0.8170 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3475 / 0 / 275 
Goodness-of-fit on F2 1.112 
Final R indices [I>2sigma(I)] R1 = 0.0430, wR2 = 0.1030 
R indices (all data) R1 = 0.0487, wR2 = 0.1081 
Absolute structure parameter 0.5(11) 
Largest diff. peak and hole 0.133 and -0.200 e.Å-3 
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Table 4-12. Refined Positional Parameters for Compound 6151 
 
Atom x y z Ueq, Å2 
C1 0.5103(4) 0.16809(19) 0.24102(8) 0.0452(6) 
C2 0.7287(4) 0.15283(18) 0.22142(8) 0.0433(5) 
C3 0.8598(4) 0.2405(2) 0.24849(8) 0.0525(6) 
C4 0.7762(4) 0.35245(19) 0.22960(7) 0.0444(5) 
C5 0.6027(3) 0.31377(17) 0.19606(7) 0.0337(5) 
C6 0.6975(3) 0.20916(17) 0.17280(7) 0.0364(5) 
C7 0.8101(5) 0.0363(2) 0.22358(9) 0.0592(7) 
C8 0.5391(4) 0.14993(18) 0.14128(8) 0.0441(5) 
C9 0.9042(4) 0.22689(18) 0.14643(8) 0.0419(5) 
C10 0.5015(3) 0.39813(17) 0.16481(7) 0.0342(5) 
C11 0.5819(3) 0.53050(16) 0.10550(7) 0.0368(5) 
C12 0.4922(3) 0.47868(16) 0.06182(7) 0.0359(5) 
C13 0.6068(4) 0.39925(18) 0.03735(8) 0.0471(6) 
C14 0.5258(5) 0.3553(2) -0.00393(9) 0.0574(7) 
C15 0.3354(5) 0.3905(2) -0.02112(8) 0.0569(7) 
C16 0.2211(5) 0.4690(2) 0.00285(9) 0.0615(7) 
C17 0.3004(4) 0.51316(19) 0.04396(9) 0.0505(6) 
C18 0.7750(4) 0.59809(18) 0.09509(7) 0.0437(5) 
C19 0.8641(4) 0.67339(19) 0.13131(8) 0.0513(6) 
C20 0.7572(4) 0.72265(18) 0.08956(8) 0.0480(6) 
C21 0.5519(4) 0.78331(16) 0.09202(7) 0.0447(6) 
C22 0.4663(4) 0.82168(18) 0.13393(8) 0.0510(6) 
C23 0.2815(5) 0.88348(19) 0.13421(9) 0.0562(6) 
C24 0.1793(5) 0.90836(19) 0.09296(9) 0.0553(7) 
C25 0.2600(5) 0.8702(2) 0.05113(9) 0.0594(7) 
C26 0.4428(5) 0.8087(2) 0.05088(8) 0.0540(6) 
O1 0.4354(2) 0.26769(11) 0.22569(5) 0.0405(4) 
O2 0.4058(3) 0.11094(14) 0.26717(6) 0.0601(5) 
O3 0.6530(2) 0.44534(11) 0.13832(4) 0.0378(4) 
O4 0.3159(2) 0.41975(12) 0.16255(5) 0.0423(4) 
Ueq=1/3[U11(aa*)2+U22(bb*)2+U33(cc*)2+2U12aa*bb*cos γ+2U13aa*cc*cos β+2U23bb*cc*cosα] 
 243 
Table 4-13. Positional Parameters for Hydrogens in Compound 6151 
 
Atom x y z Uiso, Å2 
H3a 1.0099 0.2323 0.2421 0.070 
H3b 0.8365 0.2345 0.2820 0.070 
H4a 0.7190 0.3977 0.2546 0.059 
H4b 0.8860 0.3930 0.2132 0.059 
H7a 0.8029 0.0102 0.2553 0.089 
H7b 0.9545 0.0344 0.2130 0.089 
H7c 0.7249 -0.0098 0.2038 0.089 
H8a 0.5121 0.1938 0.1139 0.066 
H8b 0.4091 0.1387 0.1581 0.066 
H8c 0.5963 0.0801 0.1320 0.066 
H9a 0.9627 0.1569 0.1377 0.063 
H9b 1.0027 0.2652 0.1662 0.063 
H9c 0.8776 0.2697 0.1188 0.063 
H11 0.4740 0.5766 0.1205 0.049 
H13 0.7373 0.3756 0.0486 0.063 
H14 0.6017 0.3016 -0.0200 0.076 
H15 0.2831 0.3615 -0.0490 0.076 
H16 0.0907 0.4923 -0.0086 0.082 
H17 0.2233 0.5668 0.0598 0.067 
H18 0.8799 0.5626 0.0748 0.058 
H19a 1.0170 0.6797 0.1333 0.068 
H19b 0.7911 0.6778 0.1612 0.068 
H20 0.8562 0.7532 0.0665 0.064 
H22 0.5339 0.8057 0.1621 0.068 
H23 0.2263 0.9083 0.1625 0.075 
H24 0.0565 0.9507 0.0933 0.074 
H25 0.1909 0.8860 0.0231 0.079 
H26 0.4952 0.7832 0.0224 0.072 
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Table 4-14. Refined Thermal Parameters (U's) for Compound 6151 
 
Atom U11 U22 U33 U23 U13 U12 
C1 0.0432(14) 0.0493(12) 0.0429(13) 0.0076(11) 0.0045(10) 0.0050(11) 
C2 0.0389(13) 0.0488(12) 0.0421(12) 0.0068(10) 0.0025(10) 0.0062(10) 
C3 0.0412(14) 0.0778(16) 0.0386(12) 0.0060(12) -0.0051(10) 0.0073(13) 
C4 0.0409(13) 0.0565(12) 0.0358(11) -0.0069(10) -0.0079(10) 0.0009(11) 
C5 0.0288(11) 0.0405(10) 0.0318(10) -0.0014(9) 0.0047(9) -0.0015(9) 
C6 0.0345(12) 0.0377(10) 0.0369(10) 0.0002(9) 0.0046(9) 0.0001(9) 
C7 0.0560(17) 0.0590(14) 0.0626(15) 0.0182(12) 0.0145(13) 0.0185(12) 
C8 0.0444(14) 0.0426(11) 0.0453(12) -0.0067(10) 0.0029(11) -0.0053(10) 
C9 0.0346(13) 0.0474(11) 0.0438(12) 0.0003(10) 0.0072(10) 0.0019(10) 
C10 0.0349(13) 0.0364(10) 0.0313(10) -0.0062(9) 0.0019(9) -0.0047(9) 
C11 0.0344(12) 0.0363(10) 0.0398(11) 0.0040(9) 0.0002(9) -0.0008(9) 
C12 0.0364(12) 0.0317(9) 0.0396(11) 0.0047(9) 0.0022(9) -0.0024(8) 
C13 0.0509(15) 0.0477(12) 0.0427(12) -0.0008(11) -0.0024(11) 0.0108(11) 
C14 0.077(2) 0.0493(13) 0.0459(13) -0.0054(11) -0.0033(13) 0.0083(13) 
C15 0.079(2) 0.0465(13) 0.0450(13) -0.0003(11) -0.0168(14) -0.0086(13) 
C16 0.0524(17) 0.0625(15) 0.0697(16) -0.0011(14) -0.0226(14) -0.0021(13) 
C17 0.0389(14) 0.0480(12) 0.0645(14) -0.0055(12) -0.0060(12) 0.0022(10) 
C18 0.0379(13) 0.0484(12) 0.0447(12) -0.0023(10) 0.0043(10) -0.0069(10) 
C19 0.0421(14) 0.0596(14) 0.0521(13) -0.0011(12) -0.0014(11) -0.0137(12) 
C20 0.0531(15) 0.0465(12) 0.0443(12) 0.0006(10) 0.0046(11) -0.0205(12) 
C21 0.0556(15) 0.0362(11) 0.0424(12) 0.0011(10) 0.0006(11) -0.0195(11) 
C22 0.0706(18) 0.0426(12) 0.0397(12) -0.0003(11) -0.0050(12) -0.0094(12) 
C23 0.0744(18) 0.0443(12) 0.0497(13) 0.0004(11) 0.0029(13) -0.0017(13) 
C24 0.0662(18) 0.0383(11) 0.0615(15) 0.0068(11) -0.0022(14) -0.0096(12) 
C25 0.071(2) 0.0530(13) 0.0536(15) 0.0088(12) -0.0104(14) -0.0105(14) 
C26 0.0683(18) 0.0580(14) 0.0356(12) 0.0038(11) -0.0014(12) -0.0126(13) 
O1 0.0366(8) 0.0456(8) 0.0392(8) 0.0065(7) 0.0096(7) 0.0045(7) 
O2 0.0562(11) 0.0628(10) 0.0613(10) 0.0242(9) 0.0186(9) 0.0081(9) 
O3 0.0330(8) 0.0446(7) 0.0358(7) 0.0026(6) 0.0010(7) 0.0001(6) 
O4 0.0289(9) 0.0442(8) 0.0537(9) 0.0057(7) 0.0022(7) -0.0008(6) 
The form of the anisotropic displacement parameter is: 
exp[-2π2(a*2U11h2+b*2U22k2+c*2U33l2+2b*c*U23kl+2a*c*U13hl+2a*b*U12hk)] 
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Table 4-15. Bond Distances in Compound 6151, Å 
 
C1-O2 1.214(3) C1-O1 1.371(3) C1-C2 1.499(3) 
C2-C7 1.507(3) C2-C3 1.554(3) C2-C6 1.559(3) 
C3-C4 1.555(3) C4-C5 1.528(3) C5-O1 1.464(2) 
C5-C10 1.501(3) C5-C6 1.554(3) C6-C9 1.521(3) 
C6-C8 1.525(3) C10-O4 1.202(2) C10-O3 1.347(2) 
C11-O3 1.465(2) C11-C18 1.499(3) C11-C12 1.506(3) 
C12-C17 1.379(3) C12-C13 1.394(3) C13-C14 1.390(3) 
C14-C15 1.366(4) C15-C16 1.378(4) C16-C17 1.383(3) 
C18-C19 1.490(3) C18-C20 1.526(3) C19-C20 1.494(3) 
C20-C21 1.493(4) C21-C22 1.392(3) C21-C26 1.395(3) 
C22-C23 1.388(4) C23-C24 1.375(4) C24-C25 1.377(4) 
C25-C26 1.375(4)     
 
Table 4-16. Bond Angles in Compound 6151, ° 
 
O2-C1-O1 120.9(2) O2-C1-C2 131.1(2) O1-C1-C2 107.92(18) 
C1-C2-C7 114.5(2) C1-C2-C3 102.67(18) C7-C2-C3 116.3(2) 
C1-C2-C6 99.26(17) C7-C2-C6 119.47(18) C3-C2-C6 101.99(17) 
C2-C3-C4 104.32(17) C5-C4-C3 101.01(17) O1-C5-C10 107.28(16) 
O1-C5-C4 105.87(15) C10-C5-C4 117.79(17) O1-C5-C6 102.20(15) 
C10-C5-C6 117.99(16) C4-C5-C6 104.05(17) C9-C6-C8 109.76(17) 
C9-C6-C5 115.18(17) C8-C6-C5 112.64(18) C9-C6-C2 113.17(18) 
C8-C6-C2 113.56(17) C5-C6-C2 91.62(15) O4-C10-O3 124.64(19) 
O4-C10-C5 126.56(19) O3-C10-C5 108.79(17) O3-C11-C18 105.35(17) 
O3-C11-C12 110.35(15) C18-C11-C12 111.77(17) C17-C12-C13 118.8(2) 
C17-C12-C11 120.6(2) C13-C12-C11 120.6(2) C14-C13-C12 119.9(2) 
C15-C14-C13 120.5(2) C14-C15-C16 120.0(2) C15-C16-C17 120.0(2) 
C12-C17-C16 120.9(2) C19-C18-C11 120.39(19) C19-C18-C20 59.35(15) 
C11-C18-C20 120.3(2) C18-C19-C20 61.52(15) C21-C20-C19 123.6(2) 
C21-C20-C18 123.3(2) C19-C20-C18 59.13(15) C22-C21-C26 117.2(2) 
C22-C21-C20 122.9(2) C26-C21-C20 119.9(2) C23-C22-C21 120.8(2) 
C24-C23-C22 120.6(3) C23-C24-C25 119.5(3) C26-C25-C24 119.9(2) 
C25-C26-C21 122.0(2) C1-O1-C5 105.84(16) C10-O3-C11 116.22(16) 
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